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Purpose:  Respiratory motion causes substantial uncertainty in radiotherapy treatment 
planning.  Four-dimensional computed tomography (4D-CT) is a useful tool to image tumor 
motion during normal respiration.  Treatment margins can be reduced by targeting the 
motion path of the tumor.  The expense and complexity of 4D-CT, however, may be cost-
prohibitive at some facilities.  We developed an image processing technique to produce 
images from cine CT that contain significant motion information without 4D-CT.  The 
purpose of this work was to compare cine CT and 4D-CT for the purposes of target 
delineation and dose calculation, and to explore the role of PET in target delineation of lung 
cancer. 
Methods:  To determine whether cine CT could substitute 4D-CT for small mobile lung 
tumors, we compared target volumes delineated by a physician on cine CT and 4D-CT for 27 
tumors with intrafractional motion greater than 1 cm.  We assessed dose calculation by 
comparing dose distributions calculated on respiratory-averaged cine CT and respiratory-
averaged 4D-CT using the gamma index.  A threshold-based PET segmentation model of 
size, motion, and source-to-background was developed from phantom scans and validated 
with 24 lung tumors.  Finally, feasibility of integrating cine CT and PET for contouring was 
assessed on a small group of larger tumors. 
Results:  Cine CT to 4D-CT target volume ratios were (1.05±0.14) and (0.97±0.13) for high-
contrast and low-contrast tumors respectively which was within intraobserver variation.  
Dose distributions on cine CT produced good agreement (< 2%/1 mm) with 4D-CT for 71 of 
73 patients.  The segmentation model fit the phantom data with R2 = 0.96 and produced 
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PET target volumes that matched CT better than 6 published methods (-5.15%).  Application 
of the model to more complex tumors produced mixed results and further research is 
necessary to adequately integrate PET and cine CT for delineation. 
Conclusions:  Cine CT can be used for target delineation of small mobile lesions with 
minimal differences to 4D-CT.  PET, utilizing the segmentation model, can provide additional 
contrast.  Additional research is required to assess the efficacy of complex tumor 
delineation with cine CT and PET.  Respiratory-averaged cine CT can substitute respiratory-
averaged 4D-CT for dose calculation with negligible differences.     
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Chapter 1  INTRODUCTION AND BACKGROUND 
1.1 Introduction 
In 2009, an estimated 220,000 new cases of lung cancer were diagnosed, 87% of 
which were non-small cell lung cancer (NSCLC).  Deaths from lung cancer in 2009 were 
projected to reach nearly 160,000, substantially higher than deaths attributed to prostate, 
breast, and colorectal cancer combined.  Lung cancer deaths account for 28% of all cancer 
deaths in the United States (ACS, 2009).  Radiation therapy is one important treatment 
option for both early and later stage NSCLC.   Shown to be an effective alternative to 
surgical resection, radiation therapy can produce 5-year survival rates up to 27% for stage I 
patients unfit or unwilling to undergo surgical resection (Dosoretz et al., 1992; Gauden et 
al., 1995).  Stage III patients are often treated with radiation therapy alone or a combination 
of radiation therapy and chemotherapy, which, in terms of one-year survival, was 
demonstrated to be statistically superior to radiation therapy alone (Sause et al., 1995).  
The increasing use of radiation therapy in treatment of lung cancer has driven great 
technological advances in the last decade, including intensity-modulated radiation therapy 
(IMRT) and image-guided radiation therapy (IGRT).  Treatment planning technology has, 
necessarily, kept pace. 
When patients are slated for radiation therapy, they first receive an imaging exam 
on which the radiation treatment is planned.  This exam, typically a computed tomography 
(CT) exam, is performed in the treatment position and is often called a CT “simulation,” 
referring to the fact that imaging geometry and patient setup mimic the geometry in the 
treatment room.  There are many uncertainties in treatment planning, but for lung cancer 
patients, respiratory motion is especially significant.  Typical helical CT scans can cause 
significant image artifacts (Chen et al., 2004) which could lead to inaccurate targeting of the 
tumor.   
In 2004, a new imaging technology was introduced for CT simulation of lung cancer.  
Four-dimensional computed tomography (4D-CT) enables physicists to capture a 3-D movie 
of the patient’s respiratory pattern, thereby accurately representing the movement of the 
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tumor and allowing physicians to account for motion in the treatment plan (Keall et al., 
2004; Low et al., 2003; Pan et al., 2004; Rietzel et al., 2005).  Typically, physicians will aim 
radiation beams at the entire motion path of the tumor to ensure that the tumor stays 
within the beam during the entire respiratory cycle. 
A huge technological breakthrough, 4D-CT has become very popular in the last 5 
years and has been adopted for CT simulation of lung cancer treatment at many centers 
around the world including M. D. Anderson in Houston, Texas.  The American Association of 
Physicists in Medicine (AAPM) Task Group 76 highlights 4D-CT as a technique to effectively 
assess tumor motion (Keall et al., 2006). 
Parallel to the impressive advancement of medical technology in the last few 
decades, however, is the steep increase in healthcare costs.  The implementation of 4D-CT 
is an example of one of these increases.  The acquisition of 4D-CT imaging is a complex 
process:  Besides the scanner itself, additional hardware from a different vendor is required 
to track the respiratory pattern of the patient.  Such hardware may cost an additional 
$75,000.  In the General Electric implementation of 4D-CT, two additional pieces of 
software are required to create 4D-CT images which, along with the proprietary workstation 
on which the software runs, together may cost $300,000.  After installation of the 
technology, trained physicists and technicians must be present to ensure high-quality image 
acquisition which, of course, will incur additional costs.  Though such costs may be minimal 
to an institution like M. D. Anderson or comparable university hospitals across the United 
States, many smaller hospitals and clinics cannot afford such expenses after purchasing the 
scanner itself. 
Fortunately, there may be a way to make sophisticated imaging technology available 
to the majority of hospitals with average resources.  By manipulating CT images that are 
used to create 4D-CT through re-sorting and image processing, we can create image sets 
which contain significant motion information without additional hardware and minimal 
software (Pan et al., 2006; Pan et al., 2007).  These images could be used to plan radiation 
therapy at a fraction of the cost of 4D-CT.   
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The purpose of this dissertation was to determine if these alternative image sets, 
generated by a process called “cine CT,” could, in conjunction with functional imaging such 
as PET, be used for treatment simulation in place of 4D-CT.  The work focused on 
demonstrating equivalence of target delineation and dose calculation using cine CT and PET 
compared with 4D-CT. 
1.2 Background and Significance 
Patients with NSCLC are staged according to the Revised International System for 
Staging Lung Cancer which was adopted by the American Joint Committee on Cancer in 
1997 (NCI, 2010).  The system utilizes combinations of TNM classification to stratify patients 
and is summarized in Table 1.1.  “T” is generally determined by measuring tumor size.  “N” 
is found by assessing spread to regional lymph nodes.  “M” is essentially a binary value 
indicating whether or not the patient has distant metastasis.  Because definitive radiation 
therapy is particularly important for stage I and stage III NSCLC, the following investigations 
are focused on these particular stages. 
 
Table 1.1:  Non-small cell lung cancer staging system based on TNM classification 
IA IB IIA IIB IIIA IIIB IV 
T1 N0 M0 T2 N0 M0 T1 N1 M0 T2 N1 M0 T1 N2 M0 T* N3 M0 T* N* M1 
   T3 N0 M0 T2 N2 M0 T4 N* M0  
    T3 N1 M0   
    T3 N2 M0   
* = any numerical value 
T = tumor stage 
N = regional nodal status 
M = distal metastasis 
 
Computed tomography (CT) has revolutionized the treatment planning process for 
radiation therapy, facilitating the transition from two-dimensional planning to three-
dimensional treatment simulation.  CT, like conventional radiography, is a projection x-ray 
modality.  In current “third-generation” CT scanners, x-rays are produced in a fan beam by 
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an x-ray tube rotating around the patient on a slip-ring gantry.  The detector array rotates 
with the gantry, capturing projections from different angles through the patient.  
Projections are acquired at typical diagnostic energies such as 120 kVp, which provides a 
mean energy of 60-70 kV for a polyenergetic x-ray spectrum.  At these energies, the 
photoelectric effect dominates total attenuation coefficient and produces useful contrast in 
the x-ray projections.  Transverse images are reconstructed using filtered backprojection.  
Iterative reconstruction algorithms have been investigated (Marin et al., 2010), but are 
computationally intensive.  Graphics processing unit (GPU) reconstruction may expedite the 
process (Xu et al., 2007).  Obviously, scanner characteristics vary with manufacturer and 
model, but many modern scanners are capable of multi-slice helical CT in which the 
detector array consists of many individual detectors in the longitudinal direction (through 
the scanner bore) that can be binned together to detect photons over a certain area.  The 
height of this binned area in the longitudinal direction defines the slice thickness.  The 
number of slices is defined by the number of data channels available.  Helical acquisition is 
performed by continuously moving the couch while the beam is on and acquiring data in a 
“candy-stripe” pattern around the patient.  Helical projection data is interpolated to form 
projections at evenly spaced transverse slices (Bushberg, 2002). 
The ability to localize tumors and define regions of interest (ROIs) in 3-D is a huge 
advantage of CT simulation for radiation therapy.  For lung cancer, however, respiratory 
motion remains a huge source of uncertainty for radiotherapy planning, and increasing 
treatment margins is undesirable due to additional normal tissue that will be irradiated in 
the process.  Furthermore, standard helical CT can induce severe artifacts when imaging 
thoracic lesions due to respiratory motion (Chen et al., 2004).  One proposed solution is 
“slow” CT scanning, which uses a 4 second gantry rotation to capture breathing motion in 
one rotation of the x-ray gantry (Lagerwaard et al., 2001).  Although the AAPM Task Group 
76 report advocates the use of slow scanning (Keall et al., 2006), significant image artifacts 
can occur due to assumptions made in the filtered back-projection reconstruction process 
that are violated by the slow scan technique (Bacharach, 2007). 
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Four-dimensional computed tomography (4D-CT) overcomes these issues by 
collecting multiple images at a single couch position, thereby capturing different phases of 
the respiratory cycle (Keall et al., 2004; Low et al., 2003; Pan et al., 2004; Rietzel et al., 
2005).  In the image-binning approach to 4D-CT reconstruction provided by one commercial 
vendor (General Electric Healthcare, Waukesha, WI), image acquisition occurs in “cine 
mode,” in which the couch is stationary and the gantry rotates around the patient 
continuously acquiring data (Pan et al., 2004; Rietzel et al., 2005).  Images are reconstructed 
at pre-defined intervals and are sorted according to respiratory phase determined by a 
respiratory surrogate, such as an external monitor of the location of the external patient 
surface (Real-Time Positioning Management [RPM] system, Varian, Palo Alto, CA).  Ten 3-D 
image sets representing each phase of the respiratory cycle are formed (0% to 90%, where 
0% represents end-inspiration and 50% represents end-expiration).  The utility of 4D-CT was 
recognized immediately in the radiation oncology community and several studies have 
shown the use of 4D-CT in measuring lesion or organ motion (Brandner et al., 2006; Liu et 
al., 2007) and implementing 4-D treatment planning (Kang et al., 2007; Rietzel et al., 2006; 
Underberg et al., 2004). 
One drawback to treatment planning with 4D-CT is the increased delineation 
workload.  Gross tumor volume (GTV) is defined in the International Commission on 
Radiation Units and Measurements (ICRU) report 62 as “gross demonstrable extent and 
location of malignant growth” (International Commission on Radiation Units and 
Measurements., 1999) and is contoured by the radiation oncologist.  For NSCLC, the GTV is 
expanded with an isotropic margin (barring any anatomical boundaries to extension of gross 
tumor) to the clinical target volume (CTV), which includes microscopic extension, and 
expanded again to the internal target volume (ITV) which accounts for physiological motion 
with the internal margin (International Commission on Radiation Units and Measurements., 
1999).  One last margin for setup uncertainty expands the ITV to the planning target volume 
(PTV).  ICRU treatment volumes are illustrated in Figure 1.1 (left).  
ICRU 62, however, was written in 1999, several years before 4D-CT was 
commercially available and does not consider the consequences of 4-D imaging.  For 
 example, ITV was originally intended as a generic expansion for physiological motion.  Now,
it is possible to obtain patient
generic ITV expansion confusing and obsolete.  Strictly interpreted from ICRU guidelines, 
GTV should be contoured on each phase of 4D
ten-fold.   
 
Figure 1.1:  Target volumes as described by ICRU 62 (left) and M. D. Anderson convention 
(right).  GTV = gross tumor volume.  CTV = clinical target volume.  ITV = internal target 
volume.  PTV = planning target volume.  IGTV = internal gross tumor volume
ICTV = internal clinical target volume.  EE = end
D. Anderson approach utilizes 4D
characterized by IGTV. 
 
Various techniques have been investigated to overcome this obstacle, including rigid 
registration techniques (Ezhil et al., 2009; Liu et al., 2007
projection (MIP) (Bradley et al., 2006; Keall et al., 2006; Muirhead et al., 2008; Rietzel et al., 
2006; Rietzel et al., 2008; Underberg et al., 2005)
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processed from 4D-CT data.  Each voxel displays the maximum CT value it encountered 
throughout the 10 phases of the respiratory cycle.  Because of the substantial difference in 
electron density between the tumor, which is similar to “soft tissue,” and the surrounding 
lung parenchyma, which is typically about 1/4 the density of soft tissue (Khan, 2003), the 
MIP, in essence, displays the “motion envelope” of the tumor, a record of everywhere the 
tumor moves over a respiratory cycle.   
Because radiation oncologists typically target the motion envelope of the tumor for 
radiation therapy (treatment delivery technology is not yet sophisticated enough to reliably 
track the tumor during treatment, though this is an active area of research (Suh et al., 
2009)), various institutions have independently modified ICRU target volume definitions to 
incorporate 4-D imaging into the simulation procedure.  At M. D. Anderson, the internal 
gross tumor volume or “IGTV” has been defined as the motion envelope of the gross tumor 
which is expanded for microscopic disease to the internal clinical target volume (ICTV), 
illustrated in Figure 1.1 (right).  A recent study found that IGTV contoured on MIP was 
significantly larger than GTV contoured on helical CT, which implies a more “inclusive” 
method of GTV determination thus less chance of geographic miss (Bradley et al., 2006).  
Several studies have shown that contouring IGTV with MIP produces volumes similar to the 
union of 10 phase GTVs from 4D-CT (Park et al., 2009; Rietzel et al., 2005; Rietzel et al., 
2008; Underberg et al., 2005), suggesting that MIP could be used to define targets for 
radiation therapy instead of all 10 phases of 4D-CT.   
Similar image processing techniques can be applied to 4D-CT data to produce other 
useful image sets, such as the minimum intensity projection (min-ip), which displays the 
minimum voxel value instead of maximum voxel value, and the respiratory-averaged CT 
(RACT), which is the arithmetic average of the 10 phases of 4D-CT.  The RACT appears as a 
motion-blurred CT image and can be used for dose calculation (Admiraal et al., 2008; Glide-
Hurst et al., 2008) and attenuation correction of positron emission tomography (Chi et al., 
2007; Pan et al., 2005).  Examples of end-inspiration and end-expiration phase images from 
4D-CT, as well as MIP and RACT, are shown in Figure 1.2. 
 Figure 1.2:  (A) maximum intensity projection and 
End-expiration and end-inspiration, the extremes of respiratory motion, are shown in 
CT phase images (C) 50% phase and (D) 0% phase. 
 
Recently, a technique was developed to produce RACT
the purpose of attenuation correction of diagnostic thoracic PET/CT 
performed (Pan et al., 2006).  In this case, RACT is formed by averaging 
each couch position (between 20
instead of a 10-phase subset as determined by 4D
MIP processing; instead of taking the MIP of the 10 phases of 4D
of all images reconstructed from the cin
sets from which MIP and RACT are derived are denoted by a subscript.  For example, MIP 
processed from cine CT is “MIP
that 4D-CT is no longer required to form MIP which, according to t
used for target definition of the IGTV.  This suggests that creating MIP directly from cin
may be a way to bypass the complex and expensive 4D
substantial motion information into the treatment p
A significant drawback of MIP, however, is the lack of contrast when tumors are 
located near structures of equal or greater density 
2008; Rietzel et al., 2005; Rietzel et al., 2008; Underberg et al., 2005)
example, a tumor located just superior to the liver.  The liver moves substantially during 
respiratory motion and can “overwrite” the inferior motion envelope of the
it nearly impossible to determine the inferior extent of the tumor’s motion (
Another example of this problem is a tumor a
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Figure 1.3:  Image processing of 4D
maximum intensity projection, RACT = respiration
Reproduced with permission from Riegel 
 
9 
-CT imaging versus raw cine CT imaging.  MIP = 
-averaged computed tomography
et al. (Riegel et al., 2009) 
 
.  
  
Figure 1.4:  Sagittal views of a moving lesion obscured by the liver.  (A) MIP without 
contour.  (B) MIP with end-inspiration
with contour drawn for reference.
impossible to delineate with the MIP alone.
 
 
 
Figure 1.5:  Sagittal CT image of tumor near the chest wall.  
projection.  (right) Respiratory
al. (Riegel et al., 2009) 
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  Note that the inferior border of the tumor is nearly 
 
(left) Maximum intensity 
-averaged CT.  Reproduced with permission from Riegel 
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It is plausible, however, that additional image sets could be used to supplement 
MIPcine and provide enough information for accurate target definition.  Consider the 
example of the tumor near the chest wall:  The tumor is easily defined in the superior, 
inferior, and anterior directions on the MIPcine image (Figure 1.5, left), but the contrast is 
poor in the posterior direction.  The RACTcine image, however, provides good contrast for 
the posterior extent of the tumor due to a density gradient caused by motion blurring 
(Figure 1.5, right).  Used together, it is feasible that the MIPcine and RACTcine could be used 
for IGTV delineation of small, highly mobile tumors (Pan et al., 2007).  For larger, more 
complicated tumors, however, it is likely that cine CT alone will not provide enough 
information for IGTV delineation.  This hypothesis is supported by a result publication by 
Muirhead et al. in which target delineation on MIP4D-CT was compared with 4D-CT phase 
imaging in patients stratified by lung cancer stage.  The authors found that MIP could be 
reliably substituted for 4D-CT in stage I lesions, but not stage II or III (Muirhead et al., 2008). 
Lesion/normal tissue contrast may be enhanced by adding a second imaging 
modality.  The integration of fluorodeoxyglucose positron emission tomography (FDG-PET) 
into the treatment planning process is another recent development in radiation oncology, 
facilitated by the hardware fusion of PET/CT scanners.  Several studies have analyzed the 
impact of including PET data in GTV delineation for NSCLC and have yielded noteworthy 
results, mostly due to the inclusion of lymph nodes and the exclusion of atelectasis 
(Ashamalla et al., 2005; Bradley et al., 2004; Erdi et al., 2002; Nestle et al., 1999; van 
Baardwijk et al., 2006).   
PET imaging provides quantitative data regarding the metabolic behavior of the 
patient.  In that sense, it is a functional imaging modality, as opposed to CT which is a 
structural imaging modality.  To acquire a PET scan, a patient is injected with a radiotracer, 
that is, a compound that follows metabolic pathways but has a radioactive isotope attached 
to it.  In almost all oncological PET imaging, the compound used is fluorodeoxyglucose 
(FDG).  FDG behaves like glucose (except with a radioactive 18F atom attached) and follows 
the glycolytic pathway until it becomes phosphorylated by hexokinase and becomes 
trapped in the cell.  The 18F nucleus decays to 18O by positron (β+) decay.  The ejected 
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positron travels a certain distance (the “range” of the positron, which is unique to the 
isotope and is related to the initial energy of the positron after decay) and undergoes 
annihilation with an electron, emitting two 511 keV photons at approximately 180° from 
each other.  These photons are detected by a ring of detectors positioned around the 
patient that discriminate detection events based on energy (a window around 511 keV) and 
time.  Each event is recorded as a line of response, which is placed in a sinogram and is 
reconstructed using an iterative reconstruction technique such as maximum likelihood 
expectation maximization (Lange et al., 1984; Shepp et al., 1972) or, more recently, ordered 
subsets expectation maximization (OSEM) (Hudson et al., 1994).   
One advantage of using PET images to delineate that GTV is the application of auto-
segmentation techniques.  Currently, there is very little guidance on exactly how to 
incorporate PET information into the delineation process, and, consequently, different 
physicians can produce different GTVs (Riegel et al., 2006).  Auto-segmentation would 
standardize this process, thereby decreasing interobserver variation and simplifying the 
delineation process.   
Target volume delineation of lung cancer with PET/CT has been extensively reported 
in the literature (Biehl et al., 2006; Black et al., 2004; Brambilla et al., 2008; Caldwell et al., 
2003; Davis et al., 2006; Drever et al., 2007; Erdi et al., 1997; Nestle et al., 2005; Okubo et 
al., 2008; Park et al., 2008; Paulino et al., 2004), yet little consensus exists on exactly how to 
use PET to define a GTV (Nestle et al., 2006).  Some studies recommend using an absolute 
SUV threshold such as 2.5 g/mL (Paulino et al., 2004), while others advocate a fixed 
percentage threshold of maximum activity concentration or standardized uptake value 
(SUV) (Erdi et al., 1997; Okubo et al., 2008).  Biehl et al., however, have shown that a single 
threshold for all lung lesions is inadequate and recommend thresholds varying from 15% of 
maximum activity concentration for tumors greater than 5 cm and 42% of maximum activity 
concentration for tumors less than 3 cm (Biehl et al., 2006).  Black et al. derived a linear 
relationship for optimal thresholds from phantom scans as a function of mean SUV, which 
is, in turn, a function of background activity and target volume (Black et al., 2004).  
Brambilla et al. found that both target size and source-to-background ratio were significant 
 factors in determining appropriate activity concentration thresholds and recommended 
that both variables be included in automatic segmentation algorithms
2008).  Van Baardwijk et al., by way of thresholds determined by Daisne
2003), included both variables in their segmentation algorithm, applied the method to 
patients, and found good correlation with pathological specimen
2007). 
Figure 1.6:  PET image of 37 mm diam
sinusoidal motion. 
 
One significant variable that most of these studies ignore is motion.  
acquisition occurs over several m
respiratory motion on PET imaging is a blurring of the tumor:  Activity is spread out over 
voxels in the motion path of the tumor 
quantification (Boucher et al., 2004)
The aforementioned segmentation studies focused either on stationary o
phantom or moving objects in PET compared with a free
Comparison with free-breathing CT will most likely be inaccurate due to the possib
motion artifacts (Chen et al., 2004)
will be inappropriate because, typically, a breath
when 4D-CT is available.  Recall that 4D
lung lesions to define the IGTV, the motion envelope of the tumor.  
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It seems logical, then, to compare PET to 4D-CT to determine an optimal 
segmentation method.  Caldwell et al. found that PET could indeed be used to determine 
IGTV for radiation therapy planning but that, as a result of their moving phantom study, 
conventional threshold values (acquired at rest) produced volumes that were too small.  
They reduced the threshold to 15% of maximum activity concentration to adequately 
capture what the authors called “ITV” (Caldwell et al., 2003).  Similarly, Yaremko et al. found 
that hot spheres moving in air required a reduced threshold (25%) to capture the IGTV 
(Yaremko et al., 2005).  To date, however, there have not been studies optimizing activity 
concentration thresholds using 4D-CT as the reference for phantoms or patients, though 
some of the aforementioned segmentation studies have called for just such an investigation 
(Biehl et al., 2006; Okubo et al., 2008). 
If a robust segmentation protocol could be developed for moving lung tumors, then 
radiation oncologists could apply such a protocol to radiation therapy treatment planning 
with the confidence that PET is providing accurate targeting information.  Recall that the 
main drawback with target delineation using MIPcine and RACTcine was the lack of contrast 
for tumors with complicated structure.  By using cine CT image sets and PET together 
(utilizing the segmentation protocol), there may be enough information for target 
delineation and treatment planning. 
The purpose of this dissertation was to develop a treatment planning technique 
using image sets processed from cine CT in conjunction with PET imaging as a substitute for 
4D-CT.  The work is split into 4 chapters:  First, we examined the use of MIPcine and RACTcine 
for the purpose of contouring stage I NSCLC; second, we examined the use of RACTcine for 
dose calculation; third, we developed a threshold-based auto-segmentation model to 
accurately contour moving lung tumors; finally, we assessed the feasibility of using cine CT 
image sets and the PET auto-segmentation algorithm together to contour stage III NSCLC.   
If successful, thoracic radiotherapy treatment planning with cine PET/CT may rival 
conventional 4D-CT plans at a fraction of the cost, thereby enabling small, local treatment 
centers to provide motion-encompassing treatment plans to lung cancer patients.   
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1.3 Summary of Chapters 
1.3.1 Chapter 2:  Target Delineation of Stage I Non-Small Cell Lung Cancer with Cine 
CT 
Early-stage lung tumors are often small, well-defined, and can be very mobile.  Our 
first task was to use MIPcine and RACTcine to contour early stage lung cancer for group of 
patients slated for stereotactic body radiation therapy (SBRT).  The purpose was to 
determine if target definition with MIPcine and RACTcine was similar to target definition with 
4D-CT.  Chapter 2 was split into 2 parts:  The phantom study and the patient study.  
Phantoms were used to assess differences between cine CT and 4D-CT in a controlled 
environment and patients were used for clinical significance.   
In the phantom study, a body phantom with 6 spheres was placed on a motion 
platform and moved in an irregular respiratory pattern while cine CT was acquired.  MIPcine 
and MIP4D-CT were formed and auto-segmented in a treatment planning system for volume 
comparison.  In the patient study, cine CT images obtained during treatment simulation 
were used to form MIPcine and RACTcine image sets.  These image sets then were used 
together to define IGTVs.  Patients were included if tumor motion was greater than 1 cm.  
Lesions were contoured first using MIPcine and RACTcine, then with MIP4D-CT along with 10-
phase image sets.  Mean ratios of volume magnitude were compared with intraobserver 
variation, the variation expected by a physician contouring the same region multiple times.  
Mean shifts in centroid location were calculated, and volume overlap was assessed with the 
normalized Dice similarity coefficient index. 
The patient studies demonstrated that IGTV defined on cine imaging was similar to 
or slightly larger than IGTV defined on 4D-CT.  Phantom studies of irregular motion 
confirmed that IGTV defined on cine CT imaging was indeed larger and therefore more 
accurately captured the maximum motion extent of irregular respiration. 
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1.3.2 Chapter 3:  Dose Calculation with Cine Respiratory-Averaged CT 
Dose calculation for thoracic radiotherapy is commonly performed on a free-
breathing helical CT despite artifacts caused by respiratory motion.  Some centers now use 
RACT4D-CT, the pixel-by-pixel average of the 10 phases of 4D-CT, for dose calculation.  
RACTcine, however, may be a means to incorporate motion information into dose calculation 
without performing 4D-CT.  The purpose of this chapter was to determine if RACTcine could 
be substituted for RACT4D-CT for the purposes of dose calculation, and if increasing the cine 
duration can decrease differences between the dose distributions.  Cine CT data and 
corresponding 4D-CT simulations for 23 patients with at least 2 breathing cycles per cine 
duration were retrieved.  RACT was generated four ways:  (1) from 10 phases of 4D-CT, (2) 
from 1 breathing cycle of images, (3) from 1.5 breathing cycles of images, and (4) from 2 
breathing cycles of images.  The clinical treatment plan was transferred to each RACT and 
dose was recalculated.  Planar dose distributions were exported on orthogonal planes 
through the isocenter (coronal, sagittal, and transverse orientations).  The resulting dose 
distributions were compared using the gamma (γ) index within the planning target volume 
(PTV).  Failure criteria were set to 2%/1mm.  A follow-up study with 50 additional lung 
cancer patients was performed to increase sample size.  The same dose recalculation and 
analysis was performed.   
In the primary patient group, 22 of 23 patients had 100% of points within the PTV 
pass γ criteria.  The average maximum and mean γ indices were very low (well below 1), 
indicating good agreement between dose distributions.  Increasing the cine duration 
generally increased the dose agreement.  In the follow-up study, 49 of 50 patients had 100% 
of points within the PTV pass the γ criteria.  The average maximum and mean γ indices were 
again well below 1, indicating good agreement.  Dose calculation on RACTcine is negligibly 
different from dose calculation on RACT4D-CT.  Differences can be decreased further by 
increasing the cine duration of the cine CT scan. 
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1.3.3 Chapter 4:  Segmentation of Moving Targets with PET/CT:  Correlation of 
Thresholds with Lesion Size, Motion Extent, and Source-to-Background Ratio 
 Several studies consider size and source-to-background ratio (SBR) in their 
automatic segmentation methods but neglect respiratory motion.  The purpose of this 
chapter was to model the relationship between optimal activity concentration threshold, 
tumor volume, motion extent, and SBR using multiple regression techniques.  An extensive 
series of phantom scans simulating tumors of varying size, SBR, and motion amplitudes was 
performed.  Regions of interest delineated on PET were compared with the “motion 
envelope” of the moving sphere defined on cine CT.   
 A NEMA IEC thorax phantom containing 6 spheres of inner diameters 10, 13, 17, 22, 
28, 37 mm was filled to 6 SBRs (5:1, 10:1, 15:1, 20:1, 30:1, 50:1) and was placed on a motion 
platform and moved sinusoidally at 0, 5, 10, 15, 20, 25, 30 mm amplitudes (252 
combinations of experimental parameters).  PET images were acquired for 18 minutes and 
split into three 6-minute acquisitions to assess reproducibility.  The spheres (blurred on PET 
images due to motion) were segmented at 1% intervals of maximum activity concentration.  
The optimal threshold was determined by comparing threshold volume surfaces with a 
reference volume surface defined on cine CT.  Optimal activity concentration thresholds 
were normalized to background and multiple regression was used to determine the 
relationship between optimal threshold, volume, motion, and SBR.  Standardized regression 
coefficients were used to assess the relative influence of each variable.   
 The model was validated using patient data.  PET and 4D-CT were performed in the 
same imaging session for 23 patients (24 tumors) for radiation therapy planning.  IGTVs 
were segmented on MIPcine and activity concentration thresholds which best matched were 
determined.  IGTVs were delineated on PET imaging using our segmentation model and 
following methods for comparison:  15%, 35%, and 42% of maximum activity concentration, 
SUV of 2.5 g/mL, 15% of mean activity concentration plus background, a linear function of 
mean SUV, and our motion-inclusive model derived from phantom scans.  Threshold values 
produced from each method were correlated with best-matched threshold values.  PET 
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target volumes were geometrically compared to cine CT target volumes using volume 
magnitude and surface separation.     
 The resulting model and coefficients provided a functional form that fit the phantom 
data with an adjusted R2 = 0.96. The most significant contributor to threshold level was SBR.  
Our technique yielded threshold values well-correlated with measured optimal thresholds 
(slope = 0.8991, R2 = 0.8577) and produced PET to CT volume differences smaller than the 6 
other methods (-5.15%) and surface separation smaller than 5 other methods (1.6 mm).  
IGTVs at 35% and 42% maximum activity concentration substantially underestimated the 
motion envelope of the tumor in most patients. 
1.3.4 Chapter 5:  Target Delineation of Stage III Non-Small Cell Lung Cancer with Cine 
PET/CT 
 The segmentation model developed in Chapter 4 was applied to 5 patients with 
NSCLC: 4 patients with stage III disease, 1 with stage I disease.  Feasibility of using the PET 
segmentation model in conjunction with MIPcine was assessed qualitatively.  The 
segmentation model produced reasonable target volumes for 3 of 5 patients.  Tumors of 2 
patients, however, were not delineated accurately.  Further research is required for this 
application of the segmentation model.  Accounting for nodal involvement was not 
investigated in this chapter but is critical for accurate segmentation of stage III NSCLC and 
therefore should be explored in the future. 
1.3.5 Chapters 6 and 7:  Discussion and Conclusions 
 Results from Chapters 2, 3, 4, and 5 are discussed in the context of the cine PET/CT 
workflow.  Recommendations are made based on experimental results. 
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Chapter 2  TARGET DELINEATION OF STAGE I NON-SMALL CELL LUNG CANCER WITH 
CINE CT 
2.1 Introduction 
Radiation therapy is an important treatment option for stage I NSCLC.  Though 
surgery is still the standard of care, stereotactic body radiation therapy (SBRT) has been 
shown to be as effective as resection for inoperable stage I NSCLC (Chang et al., 2007; 
Timmerman et al., 2007) and multicenter clinical trials are underway to assess the efficacy 
of SBRT in operable NSCLC.  In contrast with conventionally-fractionated radiation therapy, 
SBRT utilizes a hypofractionated approach.  At M. D. Anderson, for example, the tumor 
receives 60 Gy in 4 fractions, or 15 Gy per fraction, as compared with 66 Gy in 2 Gy fractions 
in conventional radiation therapy.  Beyond the convenience of four-fraction treatment for 
the patient, the combination of hypofractionation, multiple fields, and image guidance 
allows higher ablative doses to be delivered to the tumor while keeping normal tissue 
toxicity at an acceptable level (Timmerman et al., 2007).  High doses per fraction, however, 
mean that accuracy becomes even more critical to avoid geometric miss.   
To account for respiratory motion in the SBRT treatment plan, a 4D-CT exam is used 
to image 10 phases of the patient’s respiratory cycle and target the motion path of the 
tumor.  Earlier, the complexity and cost of 4D-CT was briefly described.  The 4D-CT imaging 
process is explained here in more detail to highlight the differences between the 
conventional 4D-CT approach and the cine CT approach.   
The scanner setup is slightly different for 4D-CT simulation than for standard helical 
CT simulation.  In addition to the flat table-top and wing board, the patient’s respiration is 
monitored and recorded (Real-Time Positioning Management, Varian, Palo Alto, CA).  The 
system consists of an infrared camera and a CCD detector docked on the end of the couch 
and a small plastic box with two reflective markers which is placed on the patient’s 
abdomen (Figure 2.1).  The box acts as the surrogate for the patient’s respiratory pattern, 
moving up and down with each inhalation and exhalation of breath.   
  For GE CT scanners, images are acquired in “cine” mode 
stationary, and the x-ray tube rotates around the patient multiple times acquiring a 
continuous stream of projection data.  After enough da
turned off and the couch moves to the next bed position and acquisition begins again.  
 
Figure 2.1:  Respiratory surrogate setup for 4D
the movement of the infrared reflector on the patient’s abdomen to record the 
respiratory motion trace.   
 
Several user paramet
(typically quoted as the gantry rotation p
depending on the scanner model.
are acquired at each bed position, in other words, the “beam on” time.  Typically, the CD is 
chosen to reflect the average breathing period of the patient plus one second to 
that a complete set of project
acquisition (Pan et al., 2004).  Because cine data is a long stream of projection data, the user 
must define how the stream will be split into reconstructed images (i.e. which projections 
belong to which reconstruction).  The cine interval (CI) defines the temporal separation 
between adjacent image reconstructions.  The cine interval need not be limited by gantry 
rotation speed (one projection per one gantry rotation); projections can be used in 
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in which the couch is 
ta has been collected, the beam is 
-CT acquisition.  The infrared camera tracks 
ers define the cine acquisition.  Gantry rotation “speed” 
eriod) typically runs between 0.3 s and 1 s 
  The cine duration (CD) is the amount of time projections 
ions exists for reconstruction at the beginning and end of
 
 
ensure 
 cine 
multiple 
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image reconstructions to produce finer temporal sampling.  In clinical practice, this is often 
the case.  Typical CI’s range from 0.2 to 0.3 s with a gantry speed of 0.5 s.  When the CI is 
finer than the gantry rotation speed, projection data is used redundantly in adjacent 
images.  The trade-off to finer temporal sampling, however, is an increased number of 
images.  Typically, 10-30 images are reconstructed per cine duration.  To scan 20-25 cm of 
anatomy with 2.5 mm slice thickness, 2400-3000 images are generated.  Currently, the 
number of images generated from cine acquisition is limited to 3000 due to reconstruction 
time and storage limitations. 
This large set of images is commonly referred to as “cine CT.”  Each image captures a 
distinct moment in time and space like a frame in a movie reel.  It is at this point where our 
experimental method detours from the conventional 4D-CT technique.  The experimental 
method will be discussed shortly. 
Because of the time required to move the couch from one position to the next, the 
series of cine CT images captures a different starting phase of the breathing cycle each time.  
This effect is demonstrated in Figure 1.3.  Reconstructing 3-D image sets based on image 
number, then, would be non-sensical (image 1 of couch position 1 does not match the same 
part of the respiratory cycle of image 1 of couch position 2.)  Irregular respiration further 
complicates this problem.  The cine CT images must therefore be sorted into different 
respiratory states and then combined to form 3-D image sets for each respiratory state.  
The respiratory state is provided by the trace recorded by the respiratory monitoring 
device.  Typically, the respiratory cycle is divided into 10 equidistant phase-bins from one 
inspiration to the next.  Proprietary software is used to match cine CT images with their 
appropriate phase by examining the midscan time of each cine CT image and comparing it 
with the respiratory trace.  The result is 10 3-D image sets, each one representing a 
different phase of respiration (hence the term “4D-CT”).   
As described in section 1.2, contouring the tumor on 4D-CT is time-consuming and 
labor-intensive.  The maximum intensity projection (MIP) is often used to display the 
“motion envelope” of the tumor in a single image set.  Several studies have shown that 
target delineation on MIP is similar to target delineation on 4D-CT (Rietzel et al., 2005; 
22 
 
Rietzel et al., 2008; Underberg et al., 2005).  Clinically, at M. D. Anderson, MIP4D-CT and 4D-
CT phase images are used together to define the tumor and its motion extent (Ezhil et al., 
2009). 
Recall that our experimental method deviates from 4D-CT acquisition at the series of 
cine CT images, just before the sorting into phase bins.  We have developed software to 
create MIP directly from the cine CT images, bypassing the sorting process of 4D-CT (Pan et 
al., 2007).  The differences between the 4D-CT approach to MIP and cine CT approach to 
MIP are shown diagrammatically in Figure 1.3.  As described in the background and 
significance section, this could eliminate significant costs of 4D-CT simulation while still 
providing useful motion information for planning purposes.   
2.2 Purpose 
In this chapter, we compared two methods of IGTV segmentation on highly mobile 
early stage lung tumors:  First, the conventional 4D-CT approach utilizing phase imaging 
from 4D-CT and MIP processed from 4D-CT and second, the experimental “cine CT” 
approach utilizing MIPcine and RACTcine.  The goal of this chapter was to show that the 
experimental method can produce target volumes similar to the conventional 4D-CT 
method.   
2.3 Methods 
2.3.1 Phantom Study 
Because 4D-CT is essentially a subset of cine CT, we anticipated that generating a 
MIP from 10 phase image sets would yield a target volume different from a MIP generated 
from all images captured during the cine duration (20-30 images) when the motion is 
irregular, which is usually the case with patient scanning.  The objective of the phantom 
study was to show that MIPcine visualized the full extent of irregular motion more precisely 
 than MIP4D-CT.  In other words, we wanted to demonstrate 
MIPcine were larger than those from MIP
 
Figure 2.2:  NEMA IEC thorax phantom (Data Spectrum, Chapel Hill, NC) placed on
motion platform driven by a 
Note the RPM block placed on the 
 
A body phantom made in accordance with National Electrical Manufacturers 
Association (NEMA) and International Electrotechnical 
was used (Data Spectrum, Chapel Hill, NC).  The phantom
was scanned using a cine CT protocol on
Healthcare, Waukesha, WI), the CT portion of which is a
tank was filled with air.  The phantom was placed on a platform 
dimensionally, driven by a single
Experimental setup is shown in 
Starkschall et al. (Starkschall et al., 2007)
frequency respectively varying from 0.7 to 1.1
following cine scan protocol was repeated 10 times on the moving phantom:  120 kV, 50 
mA, 2.5 mm slice thickness, gantry rotation of 0.5 s, cine interval of 0.2 s, cine duration of 
7.5 s (twice the average breathing cycle of the irregular patt
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that volumes segmented on 
4D-CT.   
 
single-axis stepper motor (Velmex Inc., Bloomfield, NY)
phantom.   
Commission (IEC) recommendations 
 contained 6 water
 a PET/CT scanner (Discovery ST, General Electric 
n 8-slice scanner.  The background 
and moved one
-axis stepper motor (Velmex Inc., Bloomfield, NY)
Figure 2.2.  The irregular motion (previously described in
) was nearly sinusoidal with amplitude and 
 cm and 15 to 20 cycles per minute.  The 
ern plus one gantry rotation).  
 a 
.  
-filled spheres 
-
.  
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Images were reconstructed with filtered backprojection (Brooks et al., 1975) to a 512 by 512 
image matrix with 50 cm field of view (FOV).  MIP4D-CT and MIPcine were reconstructed.   
Images were transferred to a commercial radiation treatment planning system 
(Pinnacle3, version 7.6, Philips Medical Systems, Madison, WI) for contouring and a -700 
Hounsfield unit (HU) threshold was used to segment IGTVs on MIPcine and MIP4D-CT image 
sets (denoted IGTVcine and IGTV4D-CT respectively).  Volume measurements were recorded 
for each of the 6 spheres on the 10 scans, and a paired t-test was used to measure 
statistically significant differences between the mean volume magnitudes of IGTV4D-CT and 
IGTVcine. 
2.3.2 Patient Study 
 We reviewed the radiation oncology patient database at M. D. Anderson to identify 
patients with stage I NSCLC who had been treated with SBRT, received 4D-CT simulation, 
and had tumor motion extent greater than 1 cm. Between January of 2005 and April of 
2007, 26 patients (27 tumors) fit the criteria.  The study protocol was DR07-0809, approved 
by the institutional review board (IRB).  We determined the extent of tumor motion by 
visually assessing the displacement between extreme phases of the 4D-CT (usually 0% and 
50%).  Motion extent greater than 1 cm was included because this feature represents the 
“worst case” scenario for motion artifact.  According to Liu et al., approximately 10% of 
stage I and stage III tumors move more than 1 cm (Liu et al., 2007).  If target delineation on 
cine CT is similar to 4D-CT for the larger motions, the method demonstrated in this study 
could easily be applied to scenarios where motion is less severe.   
Patients were divided into two groups:  12 patients were in the “high contrast” 
group (13 tumors), with lesions in the middle of the lung parenchyma, and 14 were in the 
“low contrast” group, with lesions adjacent to structures of equal or higher density.  
Patients were separated in this fashion to reflect the concerns of previous studies that the 
MIP does not provide enough contrast to determine the tumor edges when the target is 
adjacent to dense structures (Rietzel et al., 2005; Underberg et al., 2005).  Furthermore, we 
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did not want the success of segmentation in the high-contrast cases to blur statistically 
significant differences from the low-contrast cases. 
In the course of 4D-CT simulation, each patient received a cine CT scan during which 
the patient’s respiratory signal was acquired.  Two sets of images were reconstructed: 4D-
CT images derived from the 10 phase images and produced by the proprietary 4D-CT 
software, and processed images from cine CT.  4D-CT images included 10 phase images, 
MIP4D-CT, and RACT4D-CT.  Cine CT images included MIPcine and RACTcine and were produced 
directly from the cine CT images using in-house software (Pan et al., 2007).  All cine scans 
were performed at 120 kV and 100 mA, with the exception of two patients, whose scans 
were performed at 150 mA and 80 mA.  Gantry rotation period for all patients was 0.5 s.   
 First, IGTV was auto-segmented on MIPcine and MIP4D-CT for 11 high-contrast lesions 
that were not adjacent to dense structures.  A seed-based region-growing algorithm in the 
treatment planning software was used for contouring.  It should be noted, however, that, 
although the treatment planning software documentation defines the algorithm as “region 
growing,” the technique differs from conventionally-defined region growing.  Typically, 
region growing occurs on a pixel-by-pixel basis radiating outwards from the seed point until 
a threshold is reached (Beutel, 2000).  Region growing in the treatment planning system 
occurs by searching pixels to the right of the seed point until a threshold is reached, and the 
closed boundary around the structure is contoured.  The resulting contours were compared 
with a paired t-test to investigate patient contouring while minimizing the influence of a 
human observer.  
 One radiation oncologist who specialized in thoracic SBRT delineated the tumors for 
all patients using the commercial radiation treatment planning system.  The radiation 
oncologist first contoured IGTVcine in all patients from high- and low-contrast tumor groups 
using MIPcine and RACTcine concurrently.  Then, the radiation oncologist contoured IGTV4D-CT 
according to the current M. D. Anderson clinical protocol:  MIP4D-CT was used to outline an 
IGTV and this volume was then edited based on the 4D-CT phase images.  All contours were 
drawn using the “lung” window/level. 
 
26 
 
2.3.3 Analysis 
For the phantom study, mean volume magnitudes were compared with a paired t-
test to assess observer-independent differences in contouring on cine and 4D-CT image sets 
(α = 0.05). 
For the patient study, auto-segmented IGTVs were compared with a paired t-test (α 
= 0.05).  Physician-drawn IGTV4D-CT and IGTVcine volume magnitudes were compared 
statistically by taking the ratio of the volume magnitudes and constructing 95% confidence 
intervals around the mean ratio and comparing these confidence intervals to the 
intraobserver variation.  Three lesions in the high contrast group and 3 lesions in the low 
contrast group were re-contoured on 4D-CT phase imaging by the radiation oncologist at 
least 2 months after initial contouring.  Resulting IGTVs were compared with initial 4D-CT 
results and the average percent differences represented the intraobserver variation for 
each group.  Difference in centroid location between IGTV4D-CT and IGTVcine was compared 
statistically using a log-normal distribution.  95% confidence intervals were constructed 
around the mean centroid shift (geometric mean was used with the logarithmic 
transformation) to assess the variability of centroid shift.   
Volume overlap was assessed with the Dice Similarity Coefficient index (DSC), which 
is a measure of the degree of overlap between two areas or volumes (Dice, 1945; Zou et al., 
2004).  If A is a “reference” volume and B is a “test” volume to be compared to the 
reference,  
 
, 
  ||||||     ( 1 ) 
 
Though the DSC is similar to the concordance index in that small changes in volume yield 
large changes in DSC when the volumes analyzed are small, the DSC is normalized to the 
sum of the two volumes rather than the union (Giraud et al., 2002).   As with any manual 
segmentation, some uncertainty exists in the tumor delineation.  By normalizing the DSC, 
we take both volume size and segmentation uncertainty into account by dividing the DSC in 
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equation ( 1 ) by an “uncertainty index” (UI).  UI is defined as the DSC of the reference 
volume with the reference volume contracted by 1 mm (A-1).  This value was chosen 
because it reflects the width of one CT pixel in the transverse plane using a 50 cm FOV and 
512 by 512 image matrix (which is the typical protocol for CT simulation at M. D. Anderson).  
The normalized DSC (NDSC), therefore, was given by 
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It is helpful to consider the limiting cases when interpreting this index.  Higher DSCs 
mean greater agreement between the experimental and reference volumes.  If the NDSC is 
greater than 1, the DSC of the experimental-to-reference volumes is greater than the 
uncertainty index, implying that the volumes agreed to less than 1 mm uncertainty.  In the 
current study, the reference volume was IGTV4D-CT and the comparison volume was IGTVcine. 
2.4 Results 
2.4.1 Phantom Study 
Ten sets of IGTVcine and IGTV4D-CT auto-segmented at a -700 HU threshold on MIPcine 
and MIP4D-CT image sets respectively were compared with a paired t-test.  For all 6 spheres 
in the phantom, the IGTVcine was significantly larger than IGTV4D-CT (Table 2.1).  Most 
differences between IGTVcine and IGTV4D-CT occurred in the most superior and inferior slices 
of the motion envelope and, by visual inspection, were not caused by in-slice motion 
artifact (the spiral patterns often seen when the sphere is present in some projections but 
not others were not present).  This suggests that the larger IGTVcine better captured the full 
extent of motion because MIPcine included images in the maximum intensity processing 
which were not present in the 4D-CT.  Processing from cine CT, therefore, more accurately 
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captures the extremes of a naturally varying waveform because more samples of the 
waveform are included. 
 
Table 2.1:  Significance values for phantom study 
 MIP4D-CT (cm
3
) MIPcine (cm
3
)  
Sphere 
Diameter (cm) 
Mean 
Volume 
Standard 
Deviation 
Mean 
Volume 
Standard 
Deviation 
p 
3.7 49.8 0.8 51.0 1.1 <0.01 
2.8 24.9 0.5 25.7 0.8 <0.01 
2.2 13.7 0.3 14.1 0.4 0.02 
1.7 7.9 0.2 8.2 0.3 <0.01 
1.3 4.4 0.2 4.6 0.2 0.04 
1.0 2.5 0.1 2.7 0.1 0.01 
MIP = maximum intensity projection 
 
2.4.2 Patient Study 
 For the auto-segmented volumes of 11 high-contrast lesions, the IGTVcine was 
significantly larger than IGTV4D-CT (p=0.02).   These results are consistent with the phantom 
results of section 2.4.1.   
 Table 2.2 and Table 2.3 list IGTVcine and IGTV4D-CT measurements and    
IGTVcine/IGTV4D-CT ratios of manually segmented volumes for the high- and low-contrast 
patient groups respectively.  IGTVcine and IGTV4D-CT volumes were not significantly different 
(as found by a paired t-test) in patients with high-contrast tumors (p=0.32) or patients with 
low-contrast tumors (p=0.29).  Comparisons of mean IGTV ratios with intraobserver 
variation for high-contrast and low-contrast patient groups are shown in Figure 2.3.  The 
95% confidence intervals of the low-contrast group indicate the variation between 
contouring on cine CT and 4D-CT was within measured intraobserver variation (p<0.05) 
(Feng et al., 2006).  Interestingly, for the high-contrast group, the distribution was shifted 
slightly higher, implying IGTVcine was slightly larger than IGTV4D-CT .  This is, however, 
consistent with our phantom and patient auto-segmentation results shown above.  Mean 
centroid shift was 0.9 mm for the high-contrast group and 1.4 mm for the low-contrast 
29 
 
group.  The upper 95% confidence interval was 1.5 mm and 2.0 mm for high- and low-
contrast lesions respectively, indicating that cine CT produces volumes positioned similarly 
to those drawn on 4D-CT in high- and low-contrast scenarios. 
 
 
 
Table 2.2:  Internal gross tumor volume (IGTV) measurements for high-contrast patients.   
Patient # IGTVcine  
(cm
3
) 
IGTV4D-CT  
(cm
3
) 
Ratio DSC NDSC 
1 12.6 9.8 1.28 0.83 0.95 
2 11.0 12.6 0.87 0.84 0.98 
3 4.8 3.9 1.26 0.78 0.96 
4 6.6 6.7 1.00 0.90 1.07 
5 15.2 13.8 1.10 0.90 1.01 
6 4.3 3.6 1.20 0.81 1.05 
7 2.9 2.8 1.04 0.78 0.98 
8 11.5 11.2 1.02 0.88 1.02 
9* 2.0 2.1 0.94 0.75 0.97 
10* 15.1 13.8 1.09 0.86 0.99 
11 2.9 2.9 0.99 0.81 0.99 
12 6.1 7.3 0.83 0.84 0.97 
13 18.6 18.8 0.99 0.87 0.96 
Average 8.7 8.4 1.05 0.84 0.99 
SD 5.5 5.4 0.14 0.05 0.04 
CI95   ±0.08   
CI90   ±0.07   
Asterisks (*) indicate bisynchronous lesions. 
SD = standard deviation 
CI95 = 95% confidence interval 
CI90 = 90% confidence interval 
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Table 2.3:  Internal gross tumor volume (IGTV) measurements for low-contrast patients. 
Patient # IGTVcine  
(cm
3
) 
IGTV4D-CT  
(cm
3
) 
Ratio DSC NDSC 
14 5.0 5.8 0.86 0.84 0.99 
15 12.1 11.7 1.04 0.85 0.99 
16 21.6 20.2 1.07 0.85 0.95 
17 4.1 4.1 0.99 0.82 0.97 
18 5.8 6.8 0.84 0.79 0.93 
19 8.1 7.9 1.03 0.86 0.98 
20 3.0 3.3 0.90 0.74 0.96 
21 2.4 2.5 0.97 0.86 1.08 
22 22.4 27.1 0.83 0.83 0.92 
23 14.0 15.4 0.91 0.88 1.01 
24 14.8 15.8 0.93 0.84 0.95 
25 38.1 37.5 1.02 0.88 0.97 
26 22.1 24.2 0.91 0.82 0.91 
27 8.5 6.4 1.33 0.84 0.97 
Average 13.1 13.5 0.97 0.84 0.97 
SD 10.1 10.5 0.13 0.04 0.04 
CI95   ±0.07   
CI90   ±0.06   
SD = standard deviation 
CI95 = 95% confidence interval 
CI90 = 90% confidence interval 
 
 Figure 2.3:  Mean volume magnitudes for high and low contrast tumors.  Red error bars 
are the 95% confidence interval around the mean.  Black error bars represent mean 
intraobserver variation for 3 re
Riegel et al. (Riegel et al., 2009)
 
 Table 2.2 and Table 2
groups respectively.  DSCs were well over 0.7, which is considered good overlap
1991; Zou et al., 2004).  The mean NDSC for high
NDSC for low-contrast tumors was 0.97.  Because both values are slightl
implies that the volumes were slightly below the threshold for agreement within 1 mm 
uncertainty. 
 Examples of low-contrast tumors are shown in 
1.5, as previously described in section 
chest wall and the anterior, superior, and inferior
are clearly defined on the MIP
density chest wall and the border is
additional information, however, the edges become much more apparent; the degraded 
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-contoured patients.  Reproduced with permission from 
 
.3 list results of the DSC analyses for high- and low
-contrast tumors was 0.99.  The mean 
y less than 1, this
Figure 1.5 and Figure 
1.2, the lung tumor is positioned adjacent to the 
 edges of the tumor that border the lung 
cine.   The posterior edge, however, is adjacent to 
 difficult to discern.  By using the RACTcine
 
-contrast 
 (Bartko, 
 
2.4.  In Figure 
the higher-
 to provide 
 density of the RACTcine provides contrast to define 
liver obscures the lesion on the 
extent of the tumor.   
 
Figure 2.4:  Transverse CT image of tumor adjacent to the liver.  (left) Maximum intensity 
projection.  (right) Respiratory
al. (Riegel et al., 2009) 
2.5 Discussion 
Our results indicate that 
or slightly larger than those drawn by full 10
Bradley et al. found that contours based on MIP
those based on helical CT and RACT
would presumably be less prone to geometric miss
more inclusive (Bradley et al., 2006)
demonstrated that MIP4D-CT underestimated
moving irregularly (Cai et al., 2007)
the variability of the respiratory pattern.  
and “incomplete sampling strategy” as causes fo
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the posterior border.  In Figure 
transverse MIPcine, but the RACTcine reveals th
-averaged CT.  Reproduced with permission from Riegel 
SBRT targets drawn with cine CT images sets are similar to 
-phase 4D-CT image sets.   
4D-CT were significantly larger than 
4D-CT and concluded that volumes drawn on MIP
 due to the fact they were larger and 
.  A recent dynamic MRI study by Cai et al.
 the true extent of tumor motion
.  Furthermore, the underestimation was
The authors identified limited temporal resolution 
r the underestimation.  A second study 
2.4, the 
e transverse 
 
et 
4D-CT 
, however, 
 for lesions 
 proportional to 
 using 4D-CT to scan a phantom under irregular motion (similar to the current study) found 
results consistent with our findings
that segmenting on MIPcine produces larger IGTVs
findings of Bradley and Cai, p
of the MIP4D-CT image set because it includes the complete set of cine images at each couch 
position, not just a 10-phase subset.  
 
Figure 2.5:  Observed motion extent in 4D
MIPcine.  Note that in 4D-CT, images that reflected the full motion extent were not 
included in the phase imaging.  In MIP
motion extent is imaged.  Reproduced with permission from Riegel 
2009) 
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 (Park et al., 2009).  In the current study, we have shown 
 in phantoms and patients
rocessing the MIP from cine CT improves the limited sampling 
 
-CT (top) versus observed motion extent in 
cine, however, all images are included and maximum 
et al. (Ri
.  Following the 
 
egel et al., 
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When more than one breathing cycle of a naturally varying respiratory waveform is 
imaged in 4D-CT acquisition, it is possible that the end inspiration (0%) and end expiration 
(50%) phases will not include the images that represent the largest motion extent of a 
tumor.   Including more samples in the MIP process will increase the chances that the 
largest motion extent is imaged.  This most likely explains the results of the phantom and 
patient auto-segmentation studies (where IGTVcine was significantly larger than IGTV4D-CT) 
and this effect is demonstrated diagrammatically in Figure 2.5.  As we previously found that 
90% of patients have average breathing cycle periods of less than 6 s (Pan et al., 2006), we 
recommended that cine durations of 6 s be chosen for cine CT acquisition (Chi et al., 2007).  
One can increase the cine duration beyond one average breathing cycle, however, to 
provide better sampling of the varying respiratory waveform and produce a more 
encompassing MIPcine image set.   
One limitation of our method is that processing directly from cine CT will include 
rare respiratory irregularities such as coughing in the image sets.  This is undesirable 
because such discontinuities represent relatively infrequent events that should not be 
included in treatment planning.  Isolating these effects by manually removing cine CT 
images affected by such an event is possible (Pan et al., 2007). 
In the manual segmentation study of patient images, cine-CT-based radiation 
treatment planning performed as well as 4D-CT.  The results of our study show that 
including RACTcine in the delineation process with MIPcine is sufficient in producing IGTVs 
similar (within intraobserver variability) to those formed with full 4D-CT for lesions adjacent 
to tissue of equal or greater density.  Several authors have cautioned against using MIP in 
these cases  (Muirhead et al., 2008; Rietzel et al., 2005; Rietzel et al., 2008; Underberg et al., 
2005), and one group has recommended that RACT not be used for contouring because the 
edges of the tumor are blurred by motion (Bradley et al., 2006).  A group from the 
Netherlands, however, has advocated using RACT with a colormap to highlight degrees of 
motion (Cover et al., 2006).  Figure 1.5 and Figure 2.4 demonstrate the benefit of using MIP 
and RACT together for moving tumors.   
 Figure 2.6:  Maximum intensity projections 
(bottom row).  Red contours are IGTV
captures several slices of tumor motion beyond that captured by 4D
permission from Riegel et al
 
It is interesting that IGTV
group of tumors, where the lesions were 
was larger, though not significantly, than IGTV
to two factors:  First, the average volume of high
thirds the average volume of low
between IGTVcine and IGTV4D-
the first group than in the second, which would affect the volume ratio.  Second, as 
described in the discussion above, MIP
processing (between 20-30 images pe
processing (10 images per slice location).  The larger IGTV
high-contrast tumors is consistent with the results of the patient and phantom auto
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processed from 4D-CT (top row) and cine CT 
cine and green are IGTV4D-CT.  Note that cine CT 
-CT.  Reproduced with 
. (Riegel et al., 2009) 
4D-CT and IGTVcine were not equivalent in the high
not adjacent to dense structures.  Mean IGTV
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segmentation studies.  Figure 2.6 illustrates this effect for patient 1, whose IGTVcine/IGTV4D-
CT volume ratio was the second largest of all 27 patients.  MIP4D-CT and MIPcine images are 
shown that highlight the region of increased density at the inferior region of the tumor in 
the MIPcine, which is not present in the MIP4D-CT.   
Though cine- and 4D-CT-defined tumor contours for treatment planning showed 
good agreement over the entire sample, individual cases still demonstrated the pitfalls of 
using MIP for contouring.  Three patients with the lowest NDSC values (patients 18, 22, 26) 
all had lesions near the diaphragm where it was difficult to determine inferior extent 
because of overlap with the liver, even when contouring with RACT image data.  These 
patients could potentially benefit from target definition with PET.  In section 5.4.1, patient 
26 is revisited using MIPcine and PET together for contouring.   
Cine acquisition mode is not unique to General Electric CT scanners and other 
groups have explored cine CT with scanners of different manufacture (Low et al., 2003; 
McClelland et al., 2006), but cine acquisition on other CT scanners is more complicated and 
less efficient than the GE implementation.  Other manufacturers use a series of axial 
acquisitions at the same couch position rather than continuously acquiring data and 
reconstructing an image series retrospectively.  Furthermore, the ability to scan a large area 
seems to be limited by protocol setup.  For 4D-CT, Philips and Siemens both use a low-pitch 
helical acquisition mode which requires a respiratory trace to reconstruct images (Keall et 
al., 2004; Pan, 2005).  In theory, low-pitch helical data could be subjected to “cine type” 
processing discussed in this chapter, but data that are not included in 4D-CT reconstruction 
cannot be accessed easily after reconstruction is completed due to the prospective nature 
of the scan.  In the future, it may be possible to implement a similar reconstruction process 
to low-pitch helical data, but no such method has yet been developed.   
Curiously, the GE 4D-CT sorting software enables the user to create MIP and RACT 
directly from cine CT instead of the 10 phases, but a respiratory trace is still required to 
initialize the program even though it is not used for the desired operation.  Our software 
operates on a simple personal computer and bypasses the need for a respiratory trace. 
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2.6 Conclusions 
As described in section 1.2, 4D-CT is complex and costly for many cancer centers.  
The motion information it provides, however, is extremely important in accurately targeting 
lung cancer and reducing treatment margins, thereby sparing additional normal tissue.  This 
chapter has presented a cost-effective alternative to 4D-CT for treatment planning that 
does not require additional hardware or commercial software beyond that already available 
on scanners already in use.  Creating MIP and RACT directly from the cine CT images and 
using these images sets together to define targets for SBRT produces volumes that are 
similar to those drawn by full 10-phase 4D-CT. 
 The results of this chapter pertain mainly to small, mobile lesions.  We anticipated 
that, for larger tumors and later-stage lung cancer (such as stage III, for which IMRT in 
conjunction with chemotherapy is a curative treatment modality for inoperable disease 
(Furuse et al., 1999; Govindan, 2003)), the use of cine CT in treatment planning will be 
limited because of more complicated involvement with surrounding tissue (Muirhead et al., 
2008).  In chapters 4 and 5, attempts to incorporate positron emission tomography (PET) 
into the cine CT treatment planning process are described.  PET/CT may provide additional 
contrast for target definition in cases with complicated tumor involvement with 
surrounding tissue.  Several studies have analyzed the impact of including PET data in GTV 
delineation for NSCLC and have yielded noteworthy results, mostly due to the inclusion of 
lymph nodes and exclusion of atelectasis (Bradley et al., 2004; Nestle et al., 1999; van 
Baardwijk et al., 2006).  Those studies suggest that metabolic information from PET helps 
physicians discriminate between normal and malignant tissue that is indistinguishable on CT 
alone, which can sometimes occur when using MIP. 
 Another subject not covered in this chapter yet still an important aspect of 
treatment planning is dose calculation.  This topic is covered in chapter 3. 
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Chapter 3  DOSE CALCULATION WITH CINE RESPIRATORY-AVERAGED CT 
3.1 Introduction 
In the previous chapter, the important aspect of tumor delineation on MIPcine and 
RACTcine was discussed.  In this chapter, dose calculation with RACTcine is explored.  After the 
tumor is delineated, the appropriate margins are added, and beam arrangements have 
been planned, the resulting dose distribution is calculated.  Convolution-superposition, a 
typical calculation algorithm, operates by integrating the product of the primary photon 
fluence from each beam, a convolution kernel or “dose spread array” that can be obtained 
by measurement or Monte Carlo simulation, and the mass attenuation coefficient provided 
by the CT image set (Khan, 2003).  Note that linear attenuation coefficients obtained at 
diagnostic energies must be scaled for use in the therapeutic (megavoltage) range.  
Typically, dose is calculated on a free-breathing helical CT data set.  However, artifacts 
during image acquisition due to respiratory motion are well-known (Chen et al., 2004; 
Gagne et al., 2004). 
Dose calculation based on 4D-CT data sets has been explored (Flampouri et al., 
2006; Guckenberger et al., 2007; Keall et al., 2004; Rietzel et al., 2005).  These calculation 
methods generally apply a 3-D treatment plan to each phase of the 4D-CT data set, equally 
divide the number of monitor units among each of the phases, and register the resulting 
dose distributions to a reference phase using rigid or deformable registration.  Though not 
truly 4-D treatment planning, this calculation methodology should provide a more accurate 
estimate of how dose is distributed over a respiratory cycle than calculation on a single, 
presumably stationary image set.  Currently, however, this methodology is not commonly 
used clinically. 
Guckenberger et al. compared dose calculation on 3-D and 4-D image sets by 
recalculating dose on different phases of the 4D-CT and comparing these distributions to 4-
D dose calculation described above.  This study demonstrated minimal dosimetric 
differences for GTV and ITV in the two methods (Guckenberger et al., 2007), suggesting that 
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full 4-D dose calculation using all phases of imaging may not be necessary to estimate dose 
to a moving target.  Producing 3-D image sets that reflect respiratory motion, however, still 
requires 4D-CT; end-inspiration and end-expiration scans are generally not reliable (Pan et 
al., 2005).  Admiraal et al. demonstrated that dose calculation on RACT4D-CT, the pixel-by-
pixel average of the 10 phases of 4D-CT, produces similar results to the dose calculation 
methodology described above (Admiraal et al., 2008).  The use of RACT4D-CT for dose 
calculation has been adopted at M. D. Anderson because RACT4D-CT represents moving 
structures more accurately than free-breathing helical CT or end-inspiration/expiration 
imaging over a fraction of radiation. 
As the last chapter explored the use of MIPcine and RACTcine for target delineation, a 
logical question is whether or not RACTcine could replace RACT4D-CT for dose calculation.  
RACTcine, however, averages all the images at each couch position, which can over- or 
under-emphasize different parts of the respiratory cycle in the CT number averaging 
process (Chi et al., 2007).  This can be demonstrated with a simple example.  From calculus, 
the mean of any function is: 
 
 !""""""  # $%&'%&() *+,   ( 3 ) 
 
If we consider the respiratory trace as a simple sine function, the mean of the sine function 
is: 
 
 !""""""  -+./0%%   ( 4 ) 
 
Figure 3.1 illustrates the sine function and the mean of the sine function.  When x = 
2πk (where k are integers), cos!  1 and  !""""""  0.  This is comparable to RACT4D-CT:  Ten 
image sets are chosen to represent equally-spaced phases of one respiratory cycle, like 1 
period of a sine wave (k = 1).  When x ≥ 2π,   !"""""" reaches a maximum at x ≈ 3π or 1.5 
breathing cycles.  RACTcine, therefore, will be most different from RACT4D-CT when 
 approximately 1.5 breathing cycles
“weighted” towards one-half of the respiratory pattern more than the other
have a significant impact on dose calculation
feature of Figure 3.1 is the presence of 
overall function to decrease with increasing 
images acquired at each couch position (e.g. increasing the 
similar to RACT4D-CT. 
 
Figure 3.1:  sin(x) and the average of sin(x).
al. (Riegel et al., 2008)  
3.2 Purpose 
 The purpose of this chapter was to evaluate the difference in dose calculation on 
RACT4D-CT and RACTcine.  We hypothesized that differences between the dose distributions 
would be negligible and that differences 
imaging samples of the respiratory cycle are included in the averaging process).  
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access to 4D-CT.  This, in conjunction with the results of Chapter 2 , lends further support to 
our over-arching hypothesis that image sets processed from cine CT can replace 4D-CT 
image sets for treatment planning purposes with negligible differences.   
3.3 Methods 
3.3.1 Patient Study 
Twenty-three lung cancer patients who received 4D-CT simulation as part of their 
radiation therapy were retrospectively included in the “primary” patient group.  These 
patients had an average of at least 2 breathing cycles per CD.  The respiratory patterns were 
classified as “regular” or “irregular” by calculating the coefficient of variation (COV) of the 
respiratory period over the duration of the scan.  The COV was defined as the standard 
deviation over the mean expressed as a percentage.  COVs <10% were considered regular 
and those >10% were considered irregular.  We anticipated the over/under-emphasis 
phenomenon will affect patients with regular breathing cycles more because the same 
fraction of the breathing cycle will be averaged for every couch position, though the phase 
will be different (Figure 3.2).  Table 3.1 summarizes the patient respiratory characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.2:  Overemphasis of sections of the respiratory pattern.  The yellow
region represents one period of the respiratory cycle and the orange
part of the breathing cycle averaged twice in RACT
towards the repeated phase of the breathing cycle.
Riegel et al.  
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Table 3.1:  Primary group patient characteristics. 
Patient # Location Avg. T (s) CD/Avg. T COV (%) Tx 
1 Lung 2.2 2.0 4.3 IMRT 
2 Lung 2.7 2.2 4.4 IMRT 
3 Lung 2.3 2.2 4.8 IMRT 
4 Liver 2.5 2.2 6.4 3DCRT 
5 Esophageal 1.8 2.5 6.7 IMRT 
6 Lung 2.1 2.4 6.8 IMRT 
7 Lung 2.7 2.2 7.8 SBRT 
8 Lung 1.9 2.1 7.9 SBRT 
9 Lung 1.6 2.5 8.0 IMRT 
10 Lung 2.1 2.1 8.9 SBRT 
11 Liver 3.0 2.3 9.7 IMRT 
12 Lung 2.6 2.2 11.2 IMRT 
13 Lung 2.3 2.2 12.9 SBRT 
14 Lung 2.2 2.3 13.0 IMRT 
15 Lung 3.5 2.1 16.1 IMRT 
16 Lung 3.2 2.2 18.9 3DCRT 
17 Lung 2.7 2.2 20.5 IMRT 
18 Esophageal 1.9 2.3 20.5 IMRT 
19 Lung 3.1 2.3 22.6 IMRT 
20 Esophageal 2.6 2.3 26.2 3DCRT 
21 Lung 2.2 2.3 34.0 IMRT 
22 Lung 2.3 2.3 37.0 IMRT 
23 Lung 2.6 2.5 37.2 IMRT 
Average  2.4 2.3   
Standard Dev.  0.5 0.1   
Avg. T = average breathing cycle 
CD = cine duration 
COV = coefficient of variation 
Tx = treatment technique 
IMRT = intensity modulated radiation therapy 
SBRT = stereotactic body radiation therapy 
3DCRT = 3-D conformal radiation therapy. 
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All 4D-CT simulations were performed on an 8-slice General Electric Discovery ST 
PET/CT scanner (GEMS, Waukesha, WI) in cine mode with 2.5 mm slice thickness, 50 cm 
field-of-view, and 512 by 512 image matrix producing a pixel size of 0.97 × 0.97 × 2.5 mm3.  
RACTcine was processed from the same cine CT from which the simulation 4D-CT was 
formed, thereby eliminating the need to expose the patient to further irradiation.  A 
different number of images were included in each RACTcine to simulate fractions of the 
breathing cycle being captured at each couch position (1 breathing cycle, 1.5 breathing 
cycles, and 2 breathing cycles).  These image sets are designated RACTcine1, RACTcine1.5, and 
RACTcine2 in this chapter.  
The clinical treatment plan was copied to each RACTcine image set and dose was 
recalculated using CCC on a 4 mm isotropic grid with Pinnacle3 version 7.6.  Sagittal, 
coronal, and transverse dose planes through the isocenter were interpolated to 1 mm pixels 
and exported for RACT4D-CT, RACTcine1, RACTcine1.5, and RACTcine2 treatment plans.   
 Because the clinical protocol for 4D-CT is to set the CD to 1 breathing cycle plus 1 
gantry rotation (Pan et al., 2004), the number of patients in the study is small.  
Furthermore, the average breathing period of these patients was relatively short.  We 
therefore performed a follow-up study with a larger number of patients and longer 
breathing periods more typical of clinical exams.  Fifty (50) lung cancer patients whose 
clinical dose calculation was performed on RACT4D-CT were included for comparison.  This 
group was designated the “follow-up” patient group.  Table 3.2 summarizes patient 
characteristics for the follow-up patient group.  Of these 50 patients, 25 received SBRT and 
25 received IMRT.  As before, RACTcine was reconstructed using the same cine CT data as the 
4D-CT simulation.  Averaging, however, was only performed with the maximum number of 
images at each couch position (as would be performed clinically in our cine CT-based 
planning paradigm).  As before, the clinical plan was copied to the RACTcine image set, dose 
was recalculated, and dose distributions on RACT4D-CT and RACTcine were compared. 
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Table 3.2:  Follow-up group patient characteristics.   
IMRT  SBRT 
Patient # Avg. T (s) CD/Avg. T  Patient # Avg. T (s) CD/Avg. T 
1 7.0 1.3  26 3.4 1.6 
2 6.2 1.2  27 4.6 1.7 
3 6.2 1.1  28 3.1 1.6 
4 6.2 1.2  29 4.9 1.3 
5 6.2 1.2  30 5.2 1.2 
6 6.2 1.2  31 --- --- 
7 6.1 1.2  32 4.2 1.4 
8 5.8 1.3  33 5.6 1.3 
9 5.5 1.3  34 5.7 1.6 
10 5.3 1.3  35 4.5 1.6 
11 5.2 1.1  36 2.6 1.9 
12 5.2 1.3  37 6.0 1.6 
13 5.1 1.4  38 4.6 1.9 
14 5.1 1.5  39 7.9 1.5 
15 5.0 1.4  40 7.6 1.2 
16 4.8 1.3  41 5.9 1.0 
17 4.7 1.3  42 5.2 1.3 
18 4.7 1.3  43 4.9 1.1 
19 4.6 1.3  44 4.8 1.3 
20 4.5 1.1  45 4.7 1.2 
21 4.4 1.4  46 4.7 1.3 
22 4.4 1.6  47 4.7 1.7 
23 4.4 1.4  48 4.6 1.4 
24 4.4 1.4  49 4.4 1.3 
25 4.3 1.4  50 4.1 1.4 
Average 5.3 1.3  Average 4.9 1.4 
SD 0.8 0.1  SD 1.2 0.2 
Respiratory trace could not be retrieved for patient 31.   
For abbreviations, see Table 3.1. 
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3.3.2 Analysis 
RACTcine plans were compared to the RACT4D-CT plan using the gamma (γ) index 
(Depuydt et al., 2002; Low et al., 1998; Low et al., 2003) inside the planning target volume 
(PTV).  The γ index is defined in equations ( 5 ) and ( 6 ).  The variables re and rr represent 
points on the evaluated and reference distributions respectively, where d and D are the 
distance-to-agreement and dose difference pass/fail criteria selected by the user.   
     
Γ67889, 6:889  ;::<8889,:=8889>' ? @:<8889,:=8889>   ( 5 ) 
 A6:889  BCDEΓ67889, 6:889FGE67889F  ( 6 ) 
 
Pass/fail criteria for the γ index are typically 5%/3 mm or 3%/3 mm in clinical 
situations such as IMRT quality assurance (Depuydt et al., 2002; Low et al., 1998; Low et al., 
2003).  In these cases, dose distributions are calculated in a phantom and are compared to 
film measurements.  Since we compared two calculated distributions, the pass/fail criteria 
were tightened to 2%/1mm to reflect a lower percent dose difference limit of dose 
calculation accuracy (Papanikolaou et al., 2004) and the spatial resolution of the CT scanner 
in the transverse plane with a 512 × 512 image matrix and 50 cm FOV. 
DOSELAB software, a publicly-available dose-comparison software package, was used 
to calculate γ indices in each of the 3 orthogonal planes (Childress et al., 2003; Childress et 
al., 2005).  Dose planes contained the full extent of the dose grid.  The intersection of the 
clinical PTV and the orthogonal dose planes were the areas of interest (Figure 3.3).  
Maximum and mean γ indices and percentages of points passing the γ criteria were 
measured for these areas.  The PTV was formed clinically according to the procedure 
described in a recent publication from authors at M. D. Anderson (Ezhil et al., 2009).  First, 
the IGTV was formed by contouring the “motion envelope” on MIP4D-CT and confirming 
extent on the 4D-CT phase images.  The IGTV was expanded to the internal clinical target 
 volume (ICTV) using an 8 mm 
a 5 mm or 3 mm expansion depending on the type and frequency of image
in treatment.  For PTVs with 
region was calculated.   
 
Figure 3.3:  Intersection of planning target volume (PTV) and orthogonal
Reproduced with permission from Riegel 
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for the RACTcine vs. RACT4D-CT comparison.  Note that statistical analysis was not performed 
because only one comparison was performed for the follow-up group. 
3.4 Results 
3.4.1 Primary Patient Group 
For the RACTcine1 vs. RACT4D-CT and RACTcine1.5 vs. RACT4D-CT comparisons, 22 of 23 
patients demonstrated 100% of points within the PTV on coronal, sagittal, and transverse 
planes passing our 2%/1mm γ criteria.  The lone patient who demonstrated any failing 
points had 1.4% and 0.3% of points fail on coronal and sagittal planes respectively for the 
RACTcine1 vs. RACT4D-CT comparison.  Though already extremely low, the failures decreased to 
0.6% and 0% on coronal and sagittal planes respectively in the RACTcine1.5 vs. RACT4D-CT 
comparison, then disappeared completely in the RACTcine2 comparison.   All patients 
demonstrated 100% passing points within the PTV for all geometrical orientations in the 
RACTcine2 vs. RACT4D-CT comparison. 
Maximum and mean γ indices for the RACTcine1, RACTcine1.5, and RACTcine2 
comparisons within the PTV for regular respiratory patterns are shown in Figure 3.4 and 
results for irregular respiratory patterns are shown in Figure 3.5.  Maximum and mean 
values are very low, well under 1, which demonstrates that dose calculation on RACTcine is 
very similar to dose calculation on RACT4D-CT, regardless of how many breathing cycles are 
used for averaging.  The data shows, however, that increasing the CD does, in general, 
decrease the γ index to even lower levels.  The maximum and mean γ indices from the 
RACTcine2 vs. RACT4D-CT comparison are significantly lower than the RACTcine1 vs. RACT4D-CT and 
RACTcine1.5 vs. RACT4D-CT indices for several comparisons (coronal and transverse plane) with 
irregular respiration (arrows in Figure 3.5).  The RACTcine1.5 vs. RACT4D-CT γ indices were not 
significantly higher for regular respiration, contrary to what we had anticipated. 
 
 
 
  
 
 
 
Figure 3.4:  (A) Maximum and (B) mean gamma (γ) indices for patients with regular 
respiratory patterns.  Error bars are standard error (N=11).  
from Riegel et al. (Riegel et al., 2008)
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Figure 3.5:  (A) Maximum and (B) mean gamma (γ) indices for patients with irregular 
respiratory patterns.  Error bars are standard error (N=12).  Green arrows are significant 
differences as determined by ANOVA/Tukey HSD tests.
Riegel et al. (Riegel et al., 2008)
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3.4.2 Follow-up Patient Group 
 Gamma criteria were met for 100% of points within the PTV for 49 of 50 patients.  
Patient 22 had 1% of points within the PTV fail the 2%/1mm criteria on the coronal γ 
distribution.   
 Figure 3.6 shows the maximum and mean γ indices within the PTV for the 3 
orthogonal dose planes.  All are well below 1, again supporting that calculation on RACTcine 
is very similar to calculation on RACT4D-CT.  Figure 3.7 compares maximum and mean γ 
indices within the PTV for SBRT and IMRT treatment techniques.  The maximum γ index is 
higher in IMRT treatment techniques, but the mean γ index is higher in SBRT treatment 
techniques.  This discrepancy is most likely caused by the small PTVs utilized in SBRT:  Dose 
was calculated using a 4 mm isotropic grid interpolated to 1 mm on each dose plane for γ 
analysis.  A 4 × 4 × 4 mm3 cube occupies a larger percentage of the total volume for a small 
volume than a large volume, thereby weighting the mean towards the higher γ value. 
 
 Figure 3.6:  (A) Maximum and (B) mean gamma indices inside the PTV for the follow
patient group.  Error bars are standard error.
al. (Riegel et al., 2008) 
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 Figure 3.7:  (A) Maximum and (B) mean gamma indices inside the PTV for the follow
patient group, separated by treatment 
therapy.  SBRT = stereotactic body radiation therapy.
Riegel et al. (Riegel et al., 2008)
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3.5 Discussion 
Several authors have explored 4-D dose calculation (Flampouri et al., 2006; 
Guckenberger et al., 2007; Keall et al., 2004; Rietzel et al., 2005), but the technique is not 
commonly used clinically due to the need for 4D-CT (which, as described above, is not 
readily available for many institutions) and increased calculation time.  At M. D. Anderson, 
dose calculation with RACT4D-CT is currently utilized for treatment planning of thoracic 
lesions.  Admiraal et al. have shown that this technique can produce similar results to 4-D 
dose calculation (Admiraal et al., 2008).  We developed a technique to create RACT image 
sets directly from the cine CT images which does not require a respiratory trace or sorting 
into phase or amplitude bins.  RACTcine, however, is not identical to RACT4D-CT:  Including all 
the cine CT images in RACT processing may cause CT number differences from the RACT4D-
CT.  An early paper by Geise et al. cites that a 4-10% change in electron density may produce 
a 2% error in dose (Geise et al., 1977).  In the case of regions highly affected by motion, 
especially irregular motion, CT number fluctuation may exceed this limit.  
The current chapter has shown that calculating dose on RACTcine image sets is 
negligibly different than calculating dose on RACT4D-CT.  Discrepancies can be decreased 
further by including more than one period of a respiratory pattern in each CD of cine CT 
(Figure 3.4 and Figure 3.5).  Patient 22 in the primary group was the only patient to 
demonstrate any points failing the 2%/1mm γ criteria in the RACTcine1 and RACTcine1.5 
comparisons, but these failing points disappeared as the CD increased to 2 breathing cycles.  
Our findings suggest that RACTcine could replace RACT4D-CT for the purposes of dose 
calculation with negligible differences in resulting dose distributions. 
As briefly described in section 3.3.1, the first set of patients suffers from several 
problems:  First, the sample size is small because the typical criteria for CD selection is 1 
average breathing cycle plus 1 gantry rotation (Pan et al., 2004), therefore making patients 
with 2 breathing cycles per CD rare.  Second, as a consequence of the first point, some 
patients with esophageal or liver malignancies were added to the core of lung cancer 
patients to increase sample size.  Third, patients with multiple respiratory cycles per CD are 
often breathing rapidly and the average respiratory periods of these scans are typically 
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smaller than those of the general population receiving 4D-CT.  The average breathing period 
of patients used in the first part of the study was less than 3 s, while most patients have a 
breathing period between 4 and 5 s (Pan et al., 2006). 
 To address these concerns, we included a second “follow-up” set of 50 lung cancer 
patients whose respiratory periods were closer to the population average.  Multiple 
RACTcine image sets, however, could not be reconstructed because less than 2 breathing 
cycles were captured at each couch position.  The fact that γ analysis of the follow-up 
patient group is similar to results of the first supports the conclusion that RACTcine is 
sufficiently similar to RACT4D-CT for dose calculation. 
 Patient 40 demonstrated a substantial change in density distribution from motion 
blurring on RACT4D-CT and RACTcine.  Patient 40 was also the only patient to show failing 
points in the follow-up group of patients.  The differing density values caused the observed 
disagreement in dose distributions, particularly at the superior and inferior regions of the 
tumor, which was located near the diaphragm (Figure 3.8).  Regardless, the regions of 
disagreement were small and the points failing within the PTV represented only 1% of the 
PTV volume.  Other patients demonstrated similar differences near high contrast 
boundaries, though not beyond our 2%/1mm failure criteria. 
 
 Figure 3.8:  (A) Coronal RACT
follow-up group.  Note that our 
of tumor motion.  Reproduced with permission from Riegel 
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4D-CT and (B) Coronal γ distribution for patient 40 of the 
2%/1mm γ criteria are violated at the maximum extents 
et al. (Riegel et al., 2008)
 
 
 Even when changes in 
high-motion areas can still affect dose agreement within the PTV.  Moving structures in the 
beam path can modulate the depth dose curves, which 
disagreement behind moving 
and end-expiration phases of a 4
one oblique beam.  Figure 3.
primary group where this effect can be observed.  
patient parallel to the transverse plane, this may explain why 
transverse slices more than coronal or sagittal 
Figure 3.5, where the RACTcine1.5
RACTcine1 mean γ index inside the PTV for regular and irregular respiration on transverse 
slices only, not coronal or sagittal.
 
Figure 3.9:  The "dose shadowing" effect, demonstrated by calculating dose on end
inspiration and end-expiration of a 4D
image (A) between the end-
changes in anatomy due to motion.  The gamma (γ) index distribution for a single oblique 
beam (B) shows the streaks of dose disagreement behind the moving anatomy.
Reproduced with permission from Riegel 
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Figure 3.10:  Shadowing effect seen in patient 20 of the primary group.
highlight areas of moving anatomy on the coronal RACT
(B).  Stripes of disagreement can be seen medial to the beam entrances behind the 
moving anatomy.  Reproduced with permission from Riegel 
 
This geometric ambiguity could be remedied by performing a true 3
a 2-D γ analysis of 3 orthogonal plane
chapter.  At the time this study was performed, no such analytical tool existed at our 
institution.  Spezi et al. suggested that an approximate
performing 2-D γ analyses on successive dose planes and “stacking” the 
γ distribution (Spezi et al., 2006)
indices in a full 3-D γ distribution are less than indices in a “stack” of 2
(Gillis et al., 2005; Spezi et al., 2006; Wendling et al., 2007)
encountered in this chapter, we do not expect a “stacked” 3
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analysis (which would produce lower values than a stacked analysis) to yield significant (if 
any) failures using our established criteria. 
We had originally anticipated that irregular respiratory patterns would be less 
affected by the over-emphasis averaging than regular respiratory patterns.  As explained 
briefly in section 3.3.1, for regular respiratory patterns, the same fraction of the respiratory 
cycle is emphasized at each couch position.  The over-emphasized phase, however, is 
different each time.  The results of section 3.4.1 and Figure 3.4 and Figure 3.5 have shown 
this to be untrue:  Disagreement was approximately twice greater for 1, 1.5, and 2 
breathing cycle RACTcine image sets visualizing irregular respiratory motion.  This greater 
disagreement can most likely be attributed to extreme changes in respiratory amplitude, 
which can produce severe artifacts on RACT images (Gould et al., 2008).  Recall, however, 
that respiratory patterns were classified as “regular” and “irregular” by period not 
amplitude.  Respiratory frequency and amplitude are often correlated (Davis et al., 1975), 
which would explain why artifacts caused by irregular amplitude would show up with 
patients separated by irregularity of respiratory period.  These artifacts are localized to the 
“slabs” of tissue imaged at each couch position defined by the beam width, but may occur 
at multiple couch positions if the irregularity persists through the entire scan. 
The results of Chapter 2 and Chapter 3  suggest that increasing the CD during cine CT 
acquisition will produce better results for both target delineation (to better capture the 
extremes of an irregular breathing pattern) and dose calculation.   Increasing CD, however, 
increases scan time and patient dose.  Previous experience with cine CT has shown that 
RACTcine and MIPcine can be produced using as little as 40 mA and still maintain acceptable 
image quality, which could drastically reduce patient dose from a cine CT scan (Pan et al., 
2007). 
While the negligible differences between RACTcine and RACT4D-CT for dose calculation 
is encouraging, it is important to note that the similarity of RACTcine to RACT4D-CT for dose 
calculation does not necessarily imply similarity of RACTcine to 4-D dose calculation.  We did 
not explicitly compare RACTcine to 4-D dose calculation.  This topic should be investigated.  
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Given the low γ indices produced in spite of conservative 2%/1mm γ criteria, however, we 
do not expect that additional differences would be significant. 
3.6 Conclusions 
The previous two chapters focused on applying image sets processed from cine CT to 
different, but equally important, parts of the treatment planning process:  Target 
delineation ( Chapter 2 ) and dose calculation ( Chapter 3 ).  For tumors influenced by 
respiratory motion, RACT generated from unsorted cine CT images provided a similar 
environment for dose calculation as RACT generated from sorted, 10-phase 4D-CT images.  
Substituting RACTcine for RACT4D-CT for the purposes of dose calculation can provide centers 
without 4D-CT access to an image set that may emulate 4-D dose calculation. 
The results of the previous two chapters support the over-arching hypothesis that 
image sets processed from cine CT can be used for treatment planning of mobile thoracic 
lesions.  As described in section 2.6, however, target delineation was only shown for small 
lesions.  The next chapter explores the incorporation of PET/CT to aid in segmentation of 
larger mobile tumors using an automatic segmentation algorithm. 
 
 
 
 
 
 
 
 
61 
 
Chapter 4  SEGMENTATION OF MOVING TARGETS WITH PET/CT:  CORRELATION OF 
THRESHOLDS WITH LESION SIZE, MOTION EXTENT, AND SOURCE-TO-BACKGROUND 
RATIO 
4.1 Introduction 
 The use of fluorodeoxyglucose positron emission tomography (FDG-PET) in the 
treatment planning process for lung cancer has become popular in recent years due to 
evidence that data from PET imaging can significantly change various aspects of treatment.  
Several studies have found that incorporating PET information into CT simulation can 
change treatment intent from curative to palliative (Brink et al., 2004; Ciernik et al., 2003; 
Dizendorf et al., 2003; Mah et al., 2002), reduce interobserver variation (Ashamalla et al., 
2005; Caldwell et al., 2001; Ciernik et al., 2003; Mah et al., 2002), and alter GTV delineation 
where PET effectively discriminates between malignant tissue and atelectasis (Ashamalla et 
al., 2005; Erdi et al., 2002; Nestle et al., 1999; van Baardwijk et al., 2006).  Recall from 
Chapter 2 that we successfully demonstrated target delineation of small, mobile stage I 
NSCLC using image sets processed from cine CT, but based on findings by Muirhead et al. 
(Muirhead et al., 2008) and common clinical experience at M. D. Anderson, we anticipated 
that these image sets alone would be insufficient for treatment planning of larger tumors.  
We hypothesized that PET would provide additional information to make target delineation 
possible.   
 Target volume delineation of lung cancer with PET/CT has been extensively reported 
in the literature (Biehl et al., 2006; Black et al., 2004; Brambilla et al., 2008; Caldwell et al., 
2003; Davis et al., 2006; Drever et al., 2007; Erdi et al., 1997; Nestle et al., 2005; Okubo et 
al., 2008; Park et al., 2008; Paulino et al., 2004), yet little consensus exists on exactly how to 
use PET to define a GTV (van Baardwijk et al., 2006).  One of the first studies by Erdi et al. 
found that 36-44% of maximum activity concentration (ACmax) correlated well with known 
sphere volumes in a stationary phantom (Erdi et al., 1997).  In a later publication, the group 
settled on a single threshold of 42% (Erdi et al., 2002).  Paulino et al. suggested an SUV 
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threshold of 2.5 g/mL (Paulino et al., 2004), a value that originated from differentiation of 
benign versus malignant lesions in PET imaging of NSCLC (Patz et al., 1993).   
 Subsequent publications questioned the use of a single threshold and proposed 
other techniques.  As described in section 1.2, several studies show that target size and 
source-to-background ratio (SBR) are important parameters (Biehl et al., 2006; Brambilla et 
al., 2008; van Baardwijk et al., 2007).  Nestle et al., in an attempt to incorporate background 
into the contouring scheme, proposed thresholds at 15% of mean activity concentration 
plus background activity concentration (Nestle et al., 2005).  Black et al., using phantom 
scans of different-sized spheres, developed a linear function of mean standardized uptake 
value (SUVmean) (Black et al., 2004).  Few studies, however, investigated motion as a 
parameter for threshold-based automatic segmentation of the PET image.  Caldwell et al. 
found conventional segmentation techniques produced volumes too small to cover the 
motion extent of the tumor on PET imaging.  They suggested using a threshold at 15% of 
ACmax to include motion (Caldwell et al., 2003).  In a subsequent study attempting to define 
a motion-inclusive tumor volume, Okubo et al. found that 35% was the optimal threshold 
for large stationary or moving spheres.  Given the shortcomings of single threshold values 
for stationary objects, however, the validity of single-threshold values for segmentation of 
motion-inclusive target volumes remains questionable.   
4.2 Purpose 
The purpose of this chapter was to develop a threshold-based segmentation 
technique that accounted for tumor size, motion, and SBR.  We therefore modeled activity 
concentration threshold dependence on object volume, motion amplitude, and SBR for 
moving targets using an extensive series of phantom scans performed at varying object 
volume, motion, and SBR.  We validated the model with 24 lung tumors that were imaged 
with 4D-CT and PET/CT for radiation therapy simulation and compared IGTVs formed with 
our model to IGTVs formed with 6 segmentation methods previously reported in the 
literature (Black et al., 2004; Caldwell et al., 2003; Erdi et al., 1997; Nestle et al., 2005; 
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Okubo et al., 2008; Paulino et al., 2004).  A reliable segmentation technique that 
incorporates volume, motion, and SBR into threshold determination could provide radiation 
oncologists with a tool to segment tumors whose contrast on cine CT image sets is 
insufficient for tumor delineation. 
4.3 Methods 
4.3.1 Terminology 
 For clarity, terminology and notation used in this chapter will be summarized in this 
section.  Many segmentation methods utilize activity concentration (AC) or standardized 
uptake value (SUV) measurements in some way.  AC is typically in units of Becquerel per 
milliliter (Bq/mL).  SUV for voxel i is defined in equation ( 7 ) as the AC of the voxel ACi 
divided by the injected activity A0 in Bq normalized to patient mass in grams (M).  Defined 
as such, the units of SUV are grams per milliliter (g/mL).  One can make SUV unitless by 
normalizing to density of soft tissue, which is assumed equal to that of water (1 g/mL).  
Pixel-by-pixel densities are not used to normalize SUV. 
 
HIJ  KL MN   ( 7 ) 
 
 Maximum activity concentration will be denoted ACmax.  A threshold value will be 
denoted ACn%.  For example, 15% of ACmax is described as AC15%.  Mean activity 
concentration, which requires an ROI in which to take the mean, is denoted O%""""""" which can 
be interpreted as “mean activity concentration of voxels above n% of ACmax.  All ROIs in this 
chapter were formed using seed-based region growing (thresholds were not applied to the 
entire image), so all ROIs are closed shapes.  Mean activity concentration in background is 
designated by P""""""".  ROIs produced from these methods will be denoted similarly.  For 
example, the IGTV produced by taking all voxels above 15% of ACmax will be indicated 
“IGTV15%.”  More complex methods will be defined accordingly.   
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 It is also worthwhile to review the distinction between “GTV” and “IGTV,” as both 
will be included in the discussion with reference to the literature.  “IGTV” is a term coined 
by M. D. Anderson and is not recognized outside the institution.  In this chapter, the term 
“GTV” will be used when motion was neglected or there was no intent to capture motion.  
For example, when a study investigated delineation of gross tumor with a free-breathing 
helical CT where no attempt was made to incorporate motion information (whether 
through inhale/exhale breath-holds, expanding to ITV, etc.), the gross tumor volume is 
“GTV.”  IGTV will be used to reference gross tumor volume with a motion envelope 
included, in other words, where the intent was to capture motion.  Most papers in the 
literature explore GTV delineation, not IGTV delineation.  In fact, 4 of the 6 segmentation 
methods utilized in this study were not originally intended to form IGTVs.  It is, however, 
our intention to include motion and compare with a motion-inclusive ROI, so all segmented 
ROIs in this chapter will be referred to as “IGTV.” 
 
4.3.2 Development of the Regression Model 
4.3.2.1 Phantom Scanning 
The goal of the phantom scans was to determine the AC threshold on PET 
(IGTVPET_n%) which best matched the IGTV defined on cine CT (IGTVCT) for a range of sphere 
sizes, motion extents, and SBRs.  The best-matched thresholds would then be used to 
develop a segmentation model with linear regression techniques. 
The NEMA IEC thorax phantom (Data Spectrum, Chapel Hill, NC) was used to form 
the regression function.  The phantom has 6 spheres of varying size set inside a background 
tank.  The 6 spheres had inner diameters equal to 10, 13, 17, 22, 28, 37 mm.  These spheres 
and the background tank were filled to 6 SBRs:  5:1, 10:1, 15:1, 20:1, 30:1, and 50:1.  A 
sinusoidal motion platform was placed on the flat couch of a General Electric Discovery VCT 
64-slice PET/CT scanner (GE Health Care, Waukesha, WI).  The phantom was placed on the 
motion platform (Figure 4.1) and moved sinusoidally with a range of motion amplitudes (0, 
 5, 10, 15, 20, 25, 30 mm peak
the sinusoidal motion were chosen to represent typical motion extent
Stevens et al., 2001) and respiratory frequency 
imaged per motion amplitude per SBR, with 7 amplitudes and 6 SBRs requires 42 PET scans 
to capture 252 combinations of the 3 variables.  
 
Figure 4.1:  NEMA IEC thorax phantom on 1
PET/CT scanner.  Reproduced with permission from Riegel 
 
Coincidence data were collected for 18 minutes in 3
through list-mode acquisition at each motion extent and SBR.  After completion of the scan, 
the volume imaging protocol (ViP) replay feature was used to split t
three 6-minute scans for repeatability.  Images were reconstructed using 
expectation maximization (OSEM
of view.  Using a 128 × 128 image matrix, voxel sizes
were transferred to a commercial treatment planning system (
Philips Medical Systems, Milpitas, CA)
 Cine CT was used to capture
reference volume.  The spheres 
filled with water.  The scan protocol utilized cine CT at 120 kV, 
8 × 2.5 mm, CD of 4.8 s, cine interval of 0.4 s, and gantry rotation of 0.4 s.  In order to 
contour the maximum motion extent, th
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(Pan et al., 2006).  To summarize, 6 
 
-D motion on flat couch of GE Discovery VCT 
et al.  (Riegel et al., 2010)
-D mode and were recorded 
he 18 minute scan into 
ordered
) reconstruction, 21 subsets and 2 iterations at 50 cm field 
 were 3.9 by 3.9 by 3.3 mm.  PET images 
Pinnacle3, version 
 for delineation of the 6 spheres. 
 motion envelopes at each extent to obtain the 
were drained of liquid while the background tank 
100 mA, x-ray collimation of 
e minimum intensity projection was produced
spheres 
 
 
-subsets 
8.1w, 
was kept 
 
 directly from the cine CT data 
were empty and the background tank was full, the min
value over the image sequence, 
4.2).  Furthermore, this method allowed us to capture the inner diameter
sphere, which was consistent with
min-IPcine images were transferred to 
contouring. 
 
Figure 4.2:  Minimum intensity projection
diameter spheres of NEMA IEC phantom.  
amplitude. 
 
4.3.2.2 Target Delineation
IGTVs of the 6 spheres on the min
based 3-D region growing.  These ROIs, termed IGTV
reference volumes to which PET threshold volumes would be optimized.  A threshold of 
425 HU was used to limit the region growing algorithm 
1998). 
The motion-blurred spheres on PET imaging were segmented by determining AC
in each sphere and auto-segmenting 10
intervals) of ACmax using seed
Because PET acquisition occurred on different days for each SBR, care was taken to 
reposition the phantom on the scanner bed.  To further ensure PET/CT registration and 
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-IPcine, which records the lowest pixel 
captured the motion path of the empty spheres
 of the moving 
 the activity-filled volume imaged by the PET scan.  All 
the commercial treatment planning system 
 from cine CT (min-IPcine) for 37 and 28 mm 
From left to right:  0, 10, 20, and 30 mm motion 
 
-IPcine images were auto-segmented using seed
CT for this chapter, served as the 
(Goo et al., 2005; Kemerink et al., 
-20 ROIs at different percentage thresholds (in 1% 
-based region growing.  These ROIs are termed IGTV
 (Figure 
for 
 
-
-
max 
PET_n%.  
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mitigate the effects of phantom repositioning, the centroids of IGTVPET_n% and IGTVCT 
volumes were registered. 
When IGTVCT and IGTVPET_n% were contoured for all spheres, motion extents, and 
SBRs, the ROIs were converted to mesh surfaces using a software tool in the treatment 
planning system.  The mesh surfaces were exported from the treatment planning system 
and the separation between the surfaces was analyzed by in-house software. 
4.3.2.3 Analysis 
To assess differences between IGTVCT and each IGTVPET_n%, we developed an 
algorithm to measure the separation between two mesh surfaces similar to the method 
used by Pevsner et al. which can assess concave volumes (Pevsner et al., 2006).  This 
method was a modification of the method put forth by Remeijer et al. (Remeijer et al., 
1999) and was recently used by Rietzel et al. to compare GTVs drawn on MIP to the union of 
GTVs from 10-phase 4D-CT (Rietzel et al., 2008).  Our technique was developed in MATLAB 
(Mathworks, Natick, MA) and was termed the “surface separation” algorithm.  The main 
advantage of the surface separation method over simply comparing volume magnitudes 
(Nestle et al., 2005; Park et al., 2008) or concordance (Giraud et al., 2002) is that this 
method provides specific geometric information of where the volumes disagree.  
Furthermore, this information can be visualized in a polar-azimuthal plot (Figure 4.3). 
 A brief explanation of the surface separation analysis is provided here.  For a more 
detailed description please see the Appendix.  First, slice-by-slice contours were converted 
to a triangular mesh by the treatment planning system (this feature is commonly used in 
conjunction with model-based auto-segmentation, but is convenient for our purposes as 
well).  Triangular meshes were created for the IGTVCT and IGTVPET_n% volumes for all n.  In 
the treatment planning system, region of interest (ROI) and mesh information are stored in 
text files called “plan.roi.”  Mesh data are stored in Visualization ToolKit (VTK) format.  
These data consist of two matrices:  First, 3 columns of x, y, and z coordinates which 
represent the vertices of the mesh; Second, 3 columns of indices which specify how the 
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vertices are connected to form the triangular mesh surface.  Our software extracted this 
mesh information to recreate the mesh surface in MATLAB. 
 The software was designed to compare a “test” volume to a “reference” volume.  In 
this particular application, IGTVCT was the reference volume and IGTVPET_n% was the test 
volume.  The surface separation “operator” will be signified by the “|” character in this 
chapter.  For example, comparing IGTVPET_27% (the test volume) to IGTVCT (the reference 
volume) is denoted “IGTV PET_27%|IGTVCT”.  Rays were projected from the centroid of the 
reference volume at equally-spaced altitudinal and azimuthal angles (in our study, 5° 
spacing was used).  For each ray, we calculated the intersection of the ray and every plane 
defined by the triangles of the mesh surface to “sample” the reference mesh surface.  For 
each sampling point on the reference mesh, we calculated the closest distance to the test 
mesh by projecting the sampling point to the planes defined by the triangles of the test 
mesh surface.  Our algorithm was validated using a series of low and high resolution 
spherical meshes of varying size (Figure 4.3).   
 
 
 
 
 
 
 Figure 4.3:  (Top) The test mesh (
surface separation algorithm.  Blue lines
points on the reference mesh and the test mesh surface.  (Bottom) Deviations are 
expressed in terms of altitudinal and azimuthal angles.
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red) is compared with a reference mesh (black) with the 
 represent shortest distances between sampling 
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 In our study, for each sphere volume, motion extent, and SBR, the surface 
separation algorithm was iterated to compare IGTVCT and IGTVPET_n%, a series of meshes 
created by different thresholds of ACmax.  For each iteration, the deviations between the 
surfaces were squared and summed to determine which threshold n% produced the 
minimal sum of squared differences between IGTVCT and IGTVPET_n%.  The resulting threshold 
n% was the “optimal” threshold for that sphere volume, motion, and SBR.  The algorithm 
was repeated for each of 3 image sets per experimental condition and the average optimal 
threshold was used for regression. 
 Multiple regression was utilized to determine a model f(x,y,z) that best described 
the relationship between volume, motion, and SBR (3 independent variables) and optimal 
threshold (1 dependent variable).  This model was termed the “volume/motion/SBR” 
model.  We first attempted to fit optimal threshold values normalized to ACmax, but quickly 
realized that ACmax was substantially degraded by partial-volume averaging (related to 
object size) and motion blur (related to motion extent).  The normalization factor of the 
dependent variable, therefore, was a function of two independent variables we were fitting 
against.  In order to avoid unnecessary complication in the regression procedure, we 
normalized the threshold AC values to a background measurement.  The mean AC in a 
spherical ROI at the center of the phantom was used for the background measurement 
(P""""""").   
 Partial volume averaging and motion blur likewise affected the measurement of SBR.  
We therefore used the SBR measurement for the largest sphere (where the effect of partial 
volume averaging was minimal) without motion for regression.  SBR was defined as the 
ratio of QR%"""""""" and the previously-described P""""""" as shown in equation ( 8 ).  
 

S  TL%"""""""""U""""""""   ( 8 ) 
 
SBR was measured 3 times, once on each image set per experimental condition.  The 
average of the 3 SBR measurements was used for regression.  Sphere volume was measured 
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on the treatment planning system using the segmented ROIs from the 0 mm motion 
condition.  Nominal motion values were used in the regression. 
 We also wanted to examine the relative influence of volume, motion, and SBR on 
optimal threshold.  For this purpose, typical regression coefficients are unreliable; they have 
different units and different scales from each other and therefore cannot be compared.  We 
can, however, transform the variables such that the mean of each variable is 0 and the 
standard deviation is 1 and re-run the regression.  The resulting regression coefficients, 
often called standardized regression coefficients, allow us to infer relative importance of 
each variable (Kim et al., 1981).  The transformation is shown in equation ( 9 ), where x is 
the unstandardized variable, !V and sx are the mean and standard deviation of the 
unstandardized variable respectively, and xstd is the standardized variable.  The magnitude 
of the standardized coefficients, denoted by βn, represents the relative importance of each 
term in the regression function. 
 
!0W'  %+%V0X   ( 9 ) 
 
4.3.3 Application of the Regression Function to Patients 
4.3.3.1 Imaging 
 Lung cancer patients who underwent 4D-CT and PET/CT simulation in the same 
imaging session were retrospectively included in the study under an IRB-approved protocol 
if the patient demonstrated one or more solid lesions with relatively homogeneous uptake 
on PET without invasion into the chest wall or mediastinal regions.  PET/CT and 4D-CT 
simulations were performed on an 8-slice PET/CT scanner (General Electric Discovery ST, 
General Electric Medical System, Waukesha, WI).  The 4D-CT protocol used 120 kV, 100 mA, 
0.5 s gantry rotation, 0.25 s cine interval, and cine duration equal to 1 average breathing 
cycle plus 1 s.  For PET imaging, patients were injected with 477 to 740 MBq and PET was 
acquired in 2-D mode for 3 minutes per bed position from the base of skull to mid-thigh.  
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Attenuation correction was performed with respiratory-averaged CT (Chi et al., 2007; Pan et 
al., 2005).  Images were reconstructed with OSEM iterative reconstruction utilizing 30 
subsets and 2 iterations, with a 3.91 mm FWHM loop filter, 5.45 mm FWHM post filter, and 
z-axis filtering applied.  Both PET and CT imaging used a 50 cm field-of-view with a 128 × 
128 and 512 × 512 image matrix respectively, producing pixel sizes of 3.9 mm and 
approximately 1 mm respectively.  PET slice thickness was 3.27 mm and CT slice thickness 
was 2.5 mm.  PET and 4D-CT images were transferred to treatment planning system for 
contouring. 
4.3.3.2 Target Delineation 
 To form the “reference” IGTVCT, the motion envelope was contoured on the MIPcine.  
A seed-based 3-D region growing auto-segmentation algorithm was used to minimize 
observer variation and bias.  As with the phantom scans used in model development, a 
threshold of -425 HU was used to limit the region growing algorithm (Goo et al., 2005; 
Kemerink et al., 1998).  A radiation oncologist reviewed and adjusted the IGTVCT contours if 
necessary. 
 
Table 4.1:  Tumor delineation methods on PET 
Study Delineation Technique ROI Notation 
Caldwell et al. (Caldwell et al., 2003) 15% of ACmax IGTV15% 
Okubo et al. (Okubo et al., 2008) 35% of ACmax IGTV35% 
Erdi et al. (Erdi et al., 2002) 42% of ACmax IGTV42% 
Paulino et al. (Paulino et al., 2004) SUV = 2.5 g/mL IGTV2.5 
Nestle et al. (Nestle et al., 2005) 15% of YR%""""""""+ BG IGTV15%+BG 
Black et al. (Black et al., 2004) 0.307 × SUVmean + 0.588 IGTVSUVmean 
Riegel et al. (Riegel et al., 2010) Volume/motion/SBR model  IGTVV,M,SBR 
ROI = region of interest 
ACmax = maximum activity concentration 
ACmean = mean activity concentration 
SUV = standardized uptake value 
BG = background 
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 IGTVs were delineated on PET data sets based on 6 segmentation methods from the 
literature (collectively referred to as IGTVPET).  These methods are summarized in Table 4.1.  
IGTV15%, IGTV35%, IGTV42%, and IGTV2.5 were all single thresholds of ACmax or SUV (Caldwell et 
al., 2003; Erdi et al., 2002; Okubo et al., 2008; Paulino et al., 2004).  IGTV15%+BG was more 
complex, as it was formed by calculating 15% of YR%"""""""", adding the result to a background 
measurement, and setting the threshold at this value.  As described in Nestle et al., P""""""" 
was measured in a small ROI defined in the adjacent anatomical structure with the highest 
background activity (Nestle et al., 2005).  Though IGTVSUVmean only requires a measurement 
of SUVmean as input for the linear function, the starting threshold required to measure 
SUVmean is not specified.  The authors address this circular problem by starting at an 
arbitrary threshold, taking the mean, (we used HIYR%"""""""""") and iterating through the 
regression function several times, each time producing a new SUVmean for input into the 
next iteration (Black et al., 2004).  As per the author’s suggestion, we iterated 5 times.  All 
IGTVs were formed using seed-based region-growing automatic segmentation in the 
treatment planning system.   
 IGTV was contoured using our motion-inclusive model by measuring the tumor 
volume, motion, and SBR and plugging them into the model.  Tumor volume and motion 
were determined by auto-segmenting the end-inspiration and end-expiration phases of the 
4D-CT.  Volume was measured at end-expiration, and motion was measured as the distance 
between the end-inspiration and end-expiration centroids.  SBR was calculated by equation 
( 8 ) where P""""""" was measured by segmenting the ipsilateral lung, removing any areas of 
high uptake (tumors, inflammation, imperfect segmentation near the mediastinum, etc.), 
and measuring mean AC in the remaining lung voxels (van Baardwijk et al., 2007).   IGTV 
produced using the volume/motion/SBR model (IGTVV,M,SBR) was created by seed-based 
region-growing auto-segmentation of the PET images.  Prior to threshold calculation, 
however, a recovery coefficient (described in the next section) was applied to the SBR. 
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4.3.3.3 Recovery Coefficient 
 The measured SBR value was degraded by partial volume averaging (Soret et al., 
2007) and tumor motion (Boucher et al., 2004).  Recall that true SBR was used for multiple 
regression to develop our model (section 4.3.2.3).  We therefore corrected for size and 
motion degradation by multiplying the degraded SBR by a recovery coefficient (RC).  The RC 
was developed from the phantom data.  QR%"""""""" for each sphere size and motion condition 
was compared with the largest stationary sphere, such that the RC for each size and motion 
condition was defined as: 
 
S!, Z  QR%""""""""26.5,0QR%""""""""!, Z  ( 10 ) 
 
where x is volume in cubic centimeters and y is extent of motion in millimeters.  RCs were 
averaged over the 3 phantom trials.  The largest nominal sphere volume is 26.5 cm3 and “0” 
represents the stationary scan condition.  Multiple regression was used to fit an RC function 
of volume and motion.  Recovered SBR is simply the product of the degraded SBR and the 
RC for the size and motion of the object of interest.    
4.3.3.4 Analysis 
 The AC thresholds that best matched IGTVCT were determined for each patient in the 
same manner as the phantoms.  ROIs were segmented on PET images at a range of ACn% at 
1% intervals of ACmax.  Each threshold volume was compared with IGTVCT using the surface 
separation tool.  The threshold that produced the minimal sum of squares was considered 
the “best fit” threshold.  This provided an independent standard to compare against 
performance of the segmentation techniques.  AC thresholds produced by each of the 7 
segmentation methods were correlated with the measured “best fit” AC threshold.   
 Each IGTVPET was geometrically compared with IGTVCT two ways:  First, by measuring 
the magnitude of each IGTVPET and IGTVCT volume, and second, by measuring the surface 
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separation between each IGTVPET and IGTVCT using the algorithm described in section 
4.3.2.3.  Using this tool, we calculated the mean surface separation between IGTVCT and 
each IGTVPET (IGTVPET|IGTVCT).  We were, essentially, comparing radius (via surface 
separation) and volume of the IGTVs, similar to the analysis of Nestle et al. in which the 
authors calculated the virtual radius of the tumor from the measured volume assuming a 
spherical shape (Nestle et al., 2005).  IGTVPET volume magnitudes were compared with 
IGTVCT for statistically significant differences by log-transforming the data to ensure 
normality (Limpert et al., 2001) and performing a paired t-test (α=0.05).  Surface separation 
for each IGTVPET|IGTVCT pair was compared with IGTVV,M,SBR|IGTVCT using a paired t-test 
(α=0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.4:  Transverse, sagittal, and coronal PET images of the 37 mm inner diameter 
sphere moving at 20 mm sinusoidal motion amplitude.  The green contour 
IGTVCT derived from cine CT.  Purple contours represent IGTV
concentration thresholds.  The optimal threshold (the threshold 
ROI most similar to the green ROI) was determined with the surface 
Reproduced with permission from Riegel 
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PET_n% at a range of activity 
that created the purple 
separation algorithm.
et al. (Riegel et al., 2010) 
 
represents 
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4.4 Results 
4.4.1 Volume/Motion/SBR Segmentation Model 
 PET images for each of the 252 combinations of volume, motion, and SBR were 
segmented as described in section 4.3.2.2.  An example of these contours is shown in Figure 
4.4.   Approximately 20 percentage thresholds were contoured for each 
volume/motion/SBR combination, resulting in approximately 5000 ROIs to analyze with the 
surface separation algorithm.  Optimal thresholds were unable to be determined for 5 
volume/motion combinations at SBR of 5:1 (1.2 cm3 at 30 mm motion, 0.5 cm3 at 15-30 mm 
motion).  The substantial motion blurring caused the spheres to be indiscernible from 
background.  Nominal sphere volume and SBR versus measured values used for regression 
are shown in Table 4.2.  Note that ROIs segmented with a -425 HU threshold are within ±1 
mm (approximately 1 CT pixel) of the sphere’s true inner radius. 
 
 
Table 4.2:  Nominal and actual volumes and SBRs 
Volume (cm
3
) SBR (unitless) 
Nominal Measured Nominal Measured 
26.5 28.6 5 4.33 ± 0.02 
11.5 12.7 10 8.12 ± 0.25 
5.6 6.4 15 14.88 ± 0.22 
2.6 3.1 20 19.91 ± 0.73 
1.2 1.4 30 28.88 ± 1.40 
0.5 0.7 50 52.15 ± 1.95 
SBR = source-to-background, measured in the largest stationary 
sphere 
 
  
 
 
 
 
Figure 4.5:  Optimal thresholds (normalized to background) versus motion, 
background (SBR), and sphere volume.  Volume is denoted by the different colors and 
symbols shown in the legend (which lists nominal sphere diameters).  Error bars represent 
1 standard deviation.  Reproduced with permission from Riegel 
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et al. (Riegel et al., 2010)
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Figure 4.5 is a 3-D scatter plot of the optimal thresholds for each of the 252 
combinations of volume, motion, and SBR.  Since our data is four-dimensional and is 
therefore difficult to visualize, motion, SBR, and optimal threshold were placed on separate 
axes, with sphere inner diameter represented by different symbols and color for each value.  
There are clear patterns to the data and isolating the patterns by keeping one variable 
constant is helpful to suggest terms for the regression model.  The relationship of optimal 
threshold with SBR, for example, is close to linear (Figure 4.6).  Optimal threshold versus 
motion and volume, however, are more complicated (Figure 4.7 and Figure 4.8).  After 
trying several combinations of functions that were physically appropriate to the phenomena 
(quadratic functions, for example, were not considered because there is no reason to 
expect maxima or minima, and therefore do not make sense physically), we settled on the 
model shown in equation ( 11 ).  Threshold normalized to background is denoted by w, x is 
volume in cubic centimeters, y is motion in millimeters, z is SBR (unitless), and Bn are the 
regression coefficients. 
 
 
Figure 4.6:  Optimal threshold versus source-to-background for stationary spheres.  Each 
line represents a different sphere diameter as denoted in the legend.  Note the linear 
nature of the relationship.  Error bars are 1 standard deviation (3 measurements).  
Reproduced with permission from Riegel et al. (Riegel et al., 2010) 
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Figure 4.7:  Optimal threshold versus motion for source-to-background = 19.9.  Each line 
represents a sphere diameter as shown in the legend.  Error bars are 1 standard deviation 
(3 measurements).  Reproduced with permission from Riegel et al. (Riegel et al., 2010) 
 
 
Figure 4.8:  Optimal threshold versus volume for source-to-background = 19.9.  Each line 
represents motion extent (0 mm to 30 mm).  Error bars are 1 standard deviation (3 
measurements).  Reproduced with permission from Riegel et al. (Riegel et al., 2010) 
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lna  
-!- bN ? 
Z- bN ? 
b lnc ? 
d e!- bN lncf ?

g eZ- bN lncf ? 
hxZ- bN ? 
Y  ( 11 ) 
 
There are a few noteworthy aspects of this equation.  First, because the residuals 
increased with increasing SBR, we took the natural logarithm of the threshold values w.  We 
therefore took the natural log of SBR in the model to maintain the previously linear 
relationship with optimal threshold.   For volume, the choice of cube root is not entirely 
surprising because radius is proportional to the cube root of volume.  For motion, we 
originally tried a logarithmic function.  We measured optimal threshold, however, at a 
motion extent of 0 mm and log is undefined at zero.  A cube root, therefore, was chosen 
because it behaves similarly to natural log but is defined at zero.  The second three terms in 
the equation are interaction terms and were included in the model because we found their 
inclusion created a substantially better fit to the data.   
 lna 
0.0634!- bN ? 0.12Z- bN ? 0.7327 lnc ? 0.0597 e!- bN lncf n
0.12 eZ- bN lncf n 0.025xZ- bN n 0.9504  
( 12 ) 
 
 The volume/motion/SBR model with regression-determined coefficients is shown in 
equation ( 12 ).  This function produced an R2 value of 0.96 and an adjusted R2 value (which 
accounted for increasing R2 due to additional terms in the fitting function) of 0.96.  Several 
surfaces of the regression function (because the function is a family of surfaces) are shown 
in Figure 4.9.   
 The standardized regression coefficients, often denoted as βn, are listed in Table 4.3.  
Of the 3 independent variables, SBR was the most influential (β3 = 1.0606), followed by 
motion (β2 = 0.2114), then volume (β1 = 0.0841).  Both interaction terms with SBR, however, 
were more influential than motion and volume alone. 
 Figure 4.9:  Surfaces of regressi
surfaces displayed is calculated for 
Reproduced with permission from Riegel 
 
 
Table 4.3:   Regression 
Variable
Volume
Motion
Volume • SBR
Motion • SBR
Volume • 
Constant
Bn = unstandardized regression coefficients
βn = standardized regression coefficients
“•” denotes interaction term
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on function defined in equation ( 12 ).  Each of the 4 
spheres of inner diameter 10, 17, 28, and 37 mm.
et al. (Riegel et al., 2010) 
coefficients for model in equation ( 11
 Bn βn 
 0.0634 0.0841 
 0.12 0.21 
SBR 0.7327 1.0606 
 0.0597 0.275 
 -0.12 -0.73 
Motion -0.025 -0.110 
 -0.9504 -0.0321 
 
 
 
 
  
 ). 
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4.4.2 Application to Patient Studies 
 The RC function developed from phantom data (R2=0.95) is shown in equation ( 13 ).  
Again, x is volume in cubic centimeters and y is motion extent in millimeters.  Volume and 
motion measurements were plugged into equation ( 13 ), and the degraded SBR and RC 
were multiplied to obtain the recovered SBR. 
 S!, Z  0.199!+- ? 0.014Z ? 0.073!+-Z ? 0.8839  ( 13 ) 
 
 Twenty-four tumors (23 patients) scanned from May 2004 to February 2009 fit our 
criteria, were adequately registered, and were included in the analysis.  IGTV15% could not 
be segmented for 6 tumors because -g% fell below background AC.  Similarly, IGTV2.5 
could not be segmented for 2 tumors for the same reason.  As such, t-tests were performed 
with paired values, limiting the sample to 18 and 22 tumors respectively. 
 Volume, motion, and SBR measurements for the 24 tumors as well as threshold 
values calculated from the volume/motion/SBR model are shown in Table 4.4.  Linear 
correlations (y = mx+b) of the measured “best fit” threshold value and the threshold 
predicted by each segmentation technique for every patient are shown in Figure 4.10.  The 
correlation of IGTVV,M,SBR thresholds with measured values has the slope closest to 1 (m = 
0.8991) implying good correlation of predicted with best-fit values, the y-intercept closest 
to 0 (b = 1.3963) implying little systematic over- or underestimation, and  the highest R2 
value (R2 = 0.8577). 
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Table 4.4:  Volume, motion, and source-to-background characteristics of 24 lung tumors, 
with model-produced threshold  
Tumor 
Volume 
(cm
3
) 
Motion 
(mm) 
Corrected SBR Threshold 
1 21.1 10.8 30.07 4.3685 
2 15.3 7.8 26.37 4.1071 
3 1.1 10.3 7.21 1.4395 
4 0.8 6.2 48.19 4.3495 
5 1.0 6.6 19.63 2.6316 
6 28.0 1.5 13.47 3.6915 
7 2.5 13.6 18.38 2.3723 
8 1.5 2.4 25.08 3.6546 
9 0.7 4.6 20.17 2.7718 
10 0.6 2.2 13.05 2.3129 
11 13.6 1.0 39.76 7.6571 
12 1.1 8.0 5.49 1.2723 
13 10.3 8.6 25.90 3.7288 
14 0.4 8.8 13.41 1.9457 
15 3.6 4.0 7.87 1.7821 
16 2.2 15.0 8.57 1.5572 
17 4.8 3.1 9.19 2.0621 
18 2.7 2.7 25.17 3.8271 
19 0.7 1.5 20.59 3.2432 
20 1.6 6.3 29.31 3.4625 
21 1.5 2.7 14.60 2.5703 
22 5.2 0.6 17.73 3.7687 
23 0.1 1.0 11.52 2.1201 
24 0.5 5.1 23.55 2.9347 
SBR = source-to-background ratio 
Threshold is normalized to background and is therefore unitless. 
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Figure 4.10:  Correlation between predicted 
threshold values and measured optimal 
threshold values for each segmentation 
method.  Best-fit lines, their equations, and 
R
2
 values of the fit are shown in each plot.
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  Figure 4.11 shows IGTVs contoured for each delineation method for 
typical case.  IGTVCT is denoted by the thick red line.  For this patient, the volume magnitude 
of IGTVV,M,SBR most accurately matched 
separation was less than 2 mm for 
 
Figure 4.11:  (A) Transverse, (B) sagittal, and (C) coronal 
internal gross tumor volume (
IGTVCT, shown in red, was delineated 
using methods described in 
(IGTVV,M,SBR) is shown in green.
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IGTVCT (-1.1%) followed by IGTV15% (
IGTV15%, IGTV2.5, IGTV15%+BG, IGTVSUVmean, and 
PET/CT images of tumor 13 with 
IGTV) contours.  PET is displayed with a “thermal” colormap.  
on MIPcine.  Other IGTVs were delineated on PET 
Table 4.1.  The contour from the volume/motion/SBR 
 
tumor 13, a 
-10.1%).  Surface 
IGTVV,M,SBR.   
 
model 
  Figure 4.12 provides another patient example, tumor 1.  For this patient, the volume 
magnitude of IGTVV,M,SBR most accurately matched IGTV
(-12.2%).  Surface separation was again less than 2 mm for IGTV
IGTVSUVmean, and IGTVV,M,SBR.  IGTV
 
Figure 4.12:  (A) Transverse, (B) sagittal
internal gross tumor volume (
IGTVCT, shown in red, was delineated on 
using methods described in 
(IGTVV,M,SBR) is shown in green.
 
 Volume and surface separation analyses for all patients are summarized in 
and illustrated in Figure 4.13
Of the 7 segmentation methods, 6 underestimated mean volume compared to the motion
inclusive IGTVCT.  IGTV15%, IGTV
IGTVCT.  IGTV15%+BG, IGTVSUVmean
from IGTVCT.  IGTVV,M,SBR produced the smallest difference with 
Figure 4.13 shows IGTV2.5 slightly closer to 
87 
CT (-11.0%) followed by IGTV
15%, IGTV2.5, IGTV
V,M,SBR had the lowest mean surface separation at 1 mm.
, and (C) coronal PET/CT images of tumor 1 with 
IGTV) contours.  PET is displayed with a “thermal” colormap.  
MIPcine.  Other IGTVs were delineated on PET 
Table 4.1.  The contour from the volume/motion/SBR 
 
 (volume analysis) and Figure 4.14 (surface separation analysis)
35%, IGTV42%, and IGTV2.5 were significantly smaller than 
, and IGTVV,M,SBR volumes were not significantly different 
IGTVCT (-5.15%). 
IGTVCT than IGTV15%+BG, which was not 
2.5         
15%+BG, 
 
 
model 
Table 4.5 
.  
-
 Note that 
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significantly different than IGTVCT.  Though this appears contradictory, IGTVCT displayed on 
the graph is the average of all patients whereas the statistical comparison with IGTV2.5 used 
only the tumors that could be contoured (in this case, N=22).  The same is true for IGTV15% 
(N=18).   
 Mean surface separation (Figure 4.14) produced results consistent with the volume 
comparison.  IGTV15%|IGTVCT, IGTV35%|IGTVCT, IGTV42%|IGTVCT, and IGTV2.5|IGTVCT produced 
surface separations significantly larger than IGTVV,M,SBR|IGTVCT.  IGTV15%+BG|IGTVCT and 
IGTVSUVmean|IGTVCT were not significantly different from IGTVV,M,SBR|IGTVCT. 
 
 
Table 4.5:  Comparison of IGTVPET with IGTVCT for different segmentation methods 
Notation 
Volume ± 
SEM (cm
3
) 
p 
(IGTVPET-
IGTVCT) ± 
SEM 
Percent 
Difference 
(%) 
Mean Surface 
Separation 
(mm) 
p 
IGTV15%* 10.93±2.71 0.01 +1.05±0.89 +10.7% 1.9±0.7 0.02 
IGTV35% 4.15±0.99 <0.01 -4.17±1.24 -50.1% 2.4±0.8 <0.01 
IGTV42% 3.12±3.93 <0.01 -5.21±1.38 -62.5% 3.0±1.1 <0.01 
IGTV2.5† 6.93±2.14 <0.01 -1.99±0.73 -22.3% 2.4±1.7 0.04 
IGTV15%+BG 6.36±1.67 0.14 -1.96±0.60 -23.6% 1.7±0.5 0.44 
IGTVSUVmean 7.02±1.67 0.33 -1.30±0.65 -15.7% 1.6±0.5 0.98 
IGTVV,M,SBR 7.89±1.76 0.39 -0.43±0.55 -5.15% 1.6±0.5 --- 
IGTVCT 8.32±2.16 --- --- --- --- --- 
Statistically significant differences are in green print.  Non-significance p-values are in red. 
SEM = standard error of the mean 
*N = 18.  Statistics were calculated using paired values. 
†N = 22.  Statistics were calculated using paired values. 
 
 
89 
 
 
Figure 4.13:  Volumes (in cubic centimeters) of IGTVPET and IGTVCT.  Error bars represent 
standard error of the mean (N = 24 tumors for IGTV35%, IGTV42%, IGTV15%+BG, IGTVSUVmean, 
IGTVV,M,SBR, N = 22 for IGTV2.5, N = 18 for IGTV15%).  p-values are shown with each column 
(green = significant, red = non-significant). 
 
 
Figure 4.14:  Surface separation (in millimeters) between IGTVPET and IGTVCT.  Error bars 
represent standard error of the mean (N = 24 tumors for IGTV35%, IGTV42%, IGTV15%+BG, 
IGTVSUVmean, IGTVV,M,SBR, N = 22 for IGTV2.5, N = 18 for IGTV15%).  p-values are shown with 
each column (green = significant, red = non-significant). 
0
2
4
6
8
10
12
14
16
1 2 3 4 5 6 7 8
V
o
lu
m
e
 [
cm
3
]
p=0.01
p<0.01
p<0.01
p<0.01
p=0.14
p=0.33 p=0.39
IG
T
V
1
5
%
+
B
G
IG
T
V
S
U
V
m
e
a
n
IG
T
V
1
5
%
IG
T
V
3
5
%
IG
T
V
4
2
%
IG
T
V
2
.5
IG
T
V
V
,M
,S
B
R
IG
T
V
C
T
0
0.5
1
1.5
2
2.5
3
3.5
1 2 3 4 5 6 7
S
u
rf
a
ce
 S
e
p
a
ra
ti
o
n
 [
m
m
]
p=0.04
p=0.02
p<0.01
p<0.01
p=0.44 p=0.98
IG
T
V
S
U
V
m
e
a
n
IG
T
V
3
5
%
IG
T
V
V
,M
,S
B
R
IG
T
V
1
5
%
+
B
G
IG
T
V
1
5
%
IG
T
V
4
2
%
IG
T
V
2
.5
90 
 
4.5  Discussion 
 We successfully developed an expression for optimal AC threshold as a function of 
object volume, motion, and SBR.  The volume/motion/SBR model, described in equation       
( 12 ), fit the data well (adjusted R2 = 0.96).  By determining standardized regression 
coefficients, we found that SBR was the most influential variable in the model.  In applying 
this model to 24 lung tumors, we found the volume/motion/SBR model generated an 
IGTVPET that accurately matched IGTVCT in volume magnitude (mean of 5.15% 
underestimation) and surface separation (mean of 1.6 mm).  The volume/motion/SBR 
model produced the smallest volume differences and tied for the smallest surface 
separation compared with 6 other segmentation techniques.   
 This investigation is the most comprehensive examination of threshold-based 
segmentation of PET imaging of moving targets to date.  It is the first to investigate the 
relationship between motion, size, and SBR for large ranges of SBR (5:1 to 50:1) and motion 
(0-30 mm), and the first to use the surface separation algorithm to determine optimal 
threshold volume.  Several studies have explored elements of the current work, but not to 
the same depth.  Yaremko et al. determined optimal thresholds for moving and static 
spheres in air, sizes ranging from 0.56 mL to 57.37 mL with 25 mm motion amplitude 
(Yaremko et al., 2005).  Caldwell et al. investigated feasibility of using PET to delineate ITV 
by assessing PET images of 3 moving spheres (inner diameters = 1.3, 2.9, 6.6 cm) at 3 
motion amplitudes (7, 16, 27 mm).  The authors did not, however, determine optimal 
thresholds for each experimental condition but qualitatively found 15% of ACmax produced 
an adequate ITV (Caldwell et al., 2003).  Black et al. examined the influence of size and, 
indirectly, SBR by developing a linear function of mean SUV, but motion was not included 
(Black et al., 2004).   
 There are several recent studies of moving phantoms that are similar to the model-
development portion of this investigation.  Park et al. examine the effects of target size, 
motion, and background activity on optimal thresholds in a phantom (Park et al., 2008).  
The authors use the NEMA IEC phantom (sphere diameters identical to the current work), 
sinusoidal motion with amplitudes of 0, 10, 20 mm (adjusted with an exponential shaping 
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parameter), and SBRs of 4.0, 8.3, and infinite (no background) to determine optimal 
thresholds for these varying conditions.  After re-normalizing the threshold values in Figure 
4.5 to ACmax for comparison, we found that the optimal thresholds in our study were 
generally lower than those determined by Park et al. 
 One significant difference between the two studies was the purpose of determining 
optimal thresholds.  Park et al. intended to show the difficulty of obtaining the “true target 
volume” without gated (4-D) PET, which required comparing PET volumes to the known 
sphere volume, i.e. the stationary sphere.  This explains the large difference in thresholds at 
2 cm motion (90% in Park et al. vs. 18% in the current study for the smallest sphere with 
SBR = 8) (Park et al., 2008).  The goal of this chapter was to match PET threshold volumes 
with motion-inclusive IGTV often used in 4D-CT-based simulation, not the volume of the 
spheres themselves.  Our values, however, were lower for the stationary spheres as well, 
especially for the smallest sphere (75% in Park et al. vs. 40% in the current study with SBR = 
8).  This difference can most likely be explained by the fact that Park et al. compared 
volume magnitudes and we compared surfaces.  Volume was estimated by summing the 
number of voxels above the threshold and multiplying by voxel volume, which, for Park et 
al., was 4.7 × 4.7 × 3.27 mm.  The width of one voxel was almost one half the inner diameter 
of the smallest sphere, which causes partial volume averaging and inaccurate calculation of 
the volume.  The surface separation algorithm essentially measures between meshes 
interpolated from the voxel-based contours.  Though not technically higher resolution, the 
interpolated meshes give us a finer estimation of the best-fit threshold volume.   
 Brambilla et al. investigated target volume delineation in the NEMA IEC thorax 
phantom as a function of several variables, including SBR, sphere diameter, injected activity, 
and emission scan duration (motion was not examined) (Brambilla et al., 2008).  Using 
multiple linear regression and standardized regression coefficients, the authors found that 
for sphere diameters less than 10 mm (additional microspheres of inner diameter 4.1, 4.7, 
6.5, and 8.1 mm were added to the phantom for analysis), sphere diameter and SBR were 
significant predictors of optimal target threshold (as a percentage of ACmax).  SBR 
dependence, however, could be neglected with little effect on optimal threshold to a first 
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approximation.  For sphere diameters greater than 10 mm, again sphere diameter and SBR 
were significant predictors of optimal target threshold, but the opposite relationship 
between the two was observed:  Sphere diameter was less significant and, to a first 
approximation, could be neglected.  Injected activity and emission scan duration were not 
included in the current work because Brambilla et al. found both to be non-significant 
predictors of optimal threshold.   
 The multiple regression techniques used in the current study are similar to those 
used in Brambilla et al.  In selecting their regression model, the authors determined from 
previous studies that optimal threshold normalized to ACmax is related to 1/SBR (Brambilla 
et al., 2008).  In the present study, we found a nearly linear relationship between SBR and 
optimal threshold normalized to background.  These findings are consistent:  An inverse 
relationship between SBR and threshold normalized to “signal” is equivalent to a linear 
relationship between SBR and threshold normalized to “background.”   Brambilla et al. also 
used standardized regression coefficients in their study and found that SBR is the most 
influential variable for sphere diameters greater than 10 mm, which is consistent with the 
findings of the current study. 
 Okubo et al. used the NEMA IEC body phantom on a motion platform to examine 
optimal thresholds of moving spheres.  In a stationary phantom at SBRs of 10:1, 15:1, and 
20:1, the authors found 35% of ACmax was a reasonable threshold (Okubo et al., 2008) after 
excluding the smaller spheres (inner diameter 10-17 mm) due to partial volume averaging.  
The 35% of ACmax threshold was applied to PET images of moving spheres at an SBR of 20:1.  
Motion was characterized as sinusoidal with a 4-sec period to 10, 20, and 30 mm 
amplitudes (peak-to-peak).  The authors found that a 35% threshold overestimated actual 
sphere size in the sagittal plane and underestimated the actual sphere size in the axial 
plane.  The extent in the sagittal plane, however, was smaller than the ideal IGTV.  For 
comparison, we segmented the 28 mm inner diameter sphere, at 30 mm motion extent, 
and SBR = 19.9, at 35% of ACmax and compared with the stationary sphere (Figure 4.15).  
Axial extent was underestimated and sagittal extent was overestimated compared with the 
stationary sphere, consistent with the findings of Okubo et al.  The motion envelope 
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(IGTVCT), however, was underestimated in both axial and sagittal directions, suggesting that 
35% of ACmax is too high a threshold to capture the entire extent of motion. 
 
 
Figure 4.15:  Reference volume for stationary sphere (black mesh, inner diameter = 28 
mm) compared with 35% maximum activity concentration of same volume sphere at 30 
mm motion extent and source-to-background = 19.9 (red mesh).  Note that the 35% 
threshold underestimates the axial and overestimates the sagittal extent of the sphere, 
but underestimates the full motion envelope of the tumor.  Reproduced with permission 
from Riegel et al. (Riegel et al., 2010) 
 
 Several contouring methods, including those of Okubo et al. and Caldwell et al. 
discussed above, were applied to 24 lung tumors along with our volume/motion/SBR 
model.  Our patient validation study is similar to a study by Nestle et al. which focused on a 
comparison of PET segmentation techniques for NSCLC (Nestle et al., 2005) but there are 
several key differences.  First, in the previous study, PET was acquired using a standalone 
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PET scanner with 137Cs transmission scanning for attenuation correction.  The current study 
utilizes an integrated PET/CT scanner with RACT attenuation correction.  Second, the 
previous study contained 5 tumors able to be fully delineated on CT, whereas 24 tumors in 
our study were delineated on CT.  Third, free-breathing CT was used to delineate the GTV in 
the previous study (which required additional coregistration because the PET and CT were 
not hardware-fused) and a margin was applied to account for breathing motion (1.5 mm 
lateral, 2 mm anterior-posterior, 3 mm superior-inferior).  We explicitly determined the 
“motion envelope” of the tumor (IGTV) using 4D-CT.   
 The PET segmentation methods used in this study can be roughly split into two 
groups:  The “first order” methods, which utilize a single threshold of activity concentration 
or SUV to form IGTV, and the “second order” methods, which incorporate additional 
variables into threshold determination.  IGTV15%, IGTV35%, IGTV42%, and IGTV2.5 fall into the 
first category, while IGTV15%+BG, IGTVSUVmean, and IGTVV,M,SBR fall into the second.  Our 
analysis suggests there are advantages to using more complex methods.  IGTVV,M,SBR, 
IGTV15%+BG, and IGTVSUVmean produced smaller surface separations than all first order 
methods and volume magnitude differences smaller than all but 1 first order method 
(IGTV15%) when compared with IGTVCT.  Though IGTV15% performed relatively well in the 
volumetric analysis (the percent difference with CT was second smallest), 6 tumors (25%) 
were unable to be contoured because 15% of ACmax was below the background activity 
concentration in those patients.  The paired t-test with the remaining pairs showed IGTV15% 
being significantly larger than IGTVCT and the inability to contour IGTV15% in high background 
limits the applicability of such a method. 
 Of the second order techniques, IGTVV,M,SBR produced the smallest average volume 
difference with IGTVCT (-5.15%) and tied IGTVSUVmean for the smallest average surface 
separation (1.6 mm).  The differences, however, were not statistically significant.  The 
second order methods had the smallest standard deviations in both volume difference and 
surface separation, suggesting they are more adaptable and more consistently delineate 
tumor over a sample of patients with varying characteristics.  IGTVV,M,SBR demonstrated the 
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best adaptability by producing the lowest standard error of the mean in volume difference 
from CT. 
 The lack of statistical superiority of our segmentation technique (that includes 
motion) over the other second-order methods (that neglect motion) may indicate the 
importance of SBR relative to the other variables in the segmentation procedure in a clinical 
setting.  Recall that we demonstrated SBR was the most influential variable in the model via 
the standardized regression coefficients.  The fact that both IGTV15%+BG and IGTVSUVmean 
explicitly or implicitly account for SBR (the former by simply forming a threshold above a 
background measurement and the latter by using SUVmean, a value normalized to injected 
activity divided by patient weight which is essentially “background” if one assumes the 
patient is uniform) and both perform nearly as well as a method that accounts for size, 
motion, and SBR seems to suggest that considering SBR in segmentation is essential and the 
other variables could be neglected.  Our results, however, indicate that including size and 
motion in the segmentation technique can further increase the accuracy of the PET contour 
when compared with CT, though the improvement was not statistically significant. 
 The current manifestation of the volume/motion/SBR model represents a first 
approximation to modeling real moving tumors and there are several ways the model can 
be improved.   The measurement of SBR, and particularly the measurement of background, 
is evidently critical for segmentation and the various factors that affect SBR should be 
further investigated.  The selection of the background ROI for tumors bordering two tissues 
with different uptake such as lung and chest wall, for example, should be evaluated.  Since 
the model is normalized to background, the selection of background ROI can substantially 
affect the resulting threshold.  The size- and motion-dependent recovery coefficient to 
restore degraded SBR could also be further refined.  Additionally, several assumptions were 
made in the development of the volume/motion/SBR model that should be explored 
further:  First, the model was developed using one-dimensional sinusoidal motion, which is 
obviously not the case for many lung tumors (Boldea et al., 2008; Mageras et al., 2004).  An 
asymmetric breathing pattern may be more appropriate (Lujan et al., 1999).  Second, the 
model was developed with spherical objects; tumors with spiculations or substantial 
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asymmetry may not conform to the model.  Third, we assumed that motion during the 4D-
CT exam was essentially the same as motion during the PET exam.  Motion patterns, 
including amplitude, frequency, and baseline position, can change over time (Nehmeh et al., 
2004) leading to mismatching motion envelopes or misregistration.  Fourth, the model was 
developed assuming homogeneous uptake, which is a reasonable assumption for smaller 
tumors, but not for larger tumors where heterogeneity, hypoxia, or necrosis often occur.  
The impact of AC heterogeneity on the volume/motion/SBR model should be evaluated. 
 Nevertheless, the volume/motion/SBR model has produced promising results and 
could be fine-tuned to produce more accurate contours.  Though the model itself is 
somewhat complex, application is relatively simple.  Only 4 measurements are required:  
Tumor volume, motion extent, QR%"""""""" of the tumor, and P""""""".  First order techniques may 
be simpler, but the findings of Biehl et al. suggest that a single threshold is inappropriate for 
target delineation (Biehl et al., 2006) and, given the results of our validation, we must 
concur.  Nestle et al. found that 40% threshold of ACmax underestimates GTVCT with a 
population-based expansion to account for motion (Nestle et al., 2005).  We had similar 
findings for both IGTV42% and IGTV35% when compared with a motion envelope explicitly 
determined on 4D-CT (as illustrated qualitatively in Figure 4.15 for IGTV35% and 
quantitatively in Figure 4.13 and Figure 4.14).  Sura et al. found high local failure rates when 
using PET to visually aid delineation of GTV (Sura et al., 2008), so caution must be exercised 
when using methods which substantially underestimate gross tumor. 
 Segmentation by threshold is a common method of target delineation with PET, but 
gradient methods have been investigated as well.  Drever et al. compared threshold-based 
segmentation with Sobel edge-detection and a watershed technique (Drever et al., 2007).  
Sobel edge-detection operates by finding the maximum gradient values in the image and 
the watershed technique combines edge detection and region-growing (Drever et al., 2007).  
The authors found that both gradient techniques failed to accurately segment stationary 
targets in a phantom and that a threshold-based technique was most successful.  Though 
gradient segmentation is beyond the scope of this work, exploration of gradient-based 
segmentation is important and should be pursued in future studies.  For moving lung 
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tumors, however, we anticipate that a gradient-based approach will be problematic.  
Motion blur substantially decreases the AC gradient in the direction of motion, creating a 
situation where the edge of the tumor produces a high gradient in planes perpendicular to 
motion but a low gradient in planes parallel to motion.  A single gradient threshold may be 
inadequate. 
4.6 Conclusions 
 A segmentation model for moving lung lesions in PET was developed that 
incorporates tumor volume, motion, and SBR into determination of optimal activity 
concentration threshold (volume/motion/SBR model).  The model, calibrated with an 
extensive series of phantom scans at varying size, motion, and SBR, was applied to 24 lung 
tumors to form IGTVs. These IGTVs, as well as IGTVs generated from 6 segmentation 
methods published in the literature, were compared with IGTV defined on cine CT.  The 
volume/motion/SBR model produced IGTVs that correlated well with IGTV defined on cine 
CT.  Segmentation techniques that used a single threshold produced significantly different 
IGTVs than the reference CT.   
 One significant objection to the clinical validation of the volume/motion/SBR model 
with respect to the over-arching purpose of this dissertation is the use of 4D-CT to 
determine motion extent.  Recall that a primary motivation for incorporating PET into 
treatment planning in this work was to avoid using 4D-CT for complicated tumors.  
Measuring motion with 4D-CT defeats this purpose.  We have shown in Chapter 2 , 
however, that substantial motion information can be gleaned from MIPcine and RACTcine 
(image sets processed directly from cine CT), so it is probable that estimates of motion 
extent could be made with cine CT image sets. 
 The final chapter combines elements of Chapter 2 and Chapter 4 to contour more 
complex tumors. 
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Chapter 5  FEASIBILITY OF TARGET DELINEATION OF STAGE III NON-SMALL CELL LUNG 
CANCER WITH CINE PET/CT 
5.1 Introduction 
 We have, thus far, focused on early stage lung cancer. We demonstrated the utility 
of contouring stage I NSCLC with MIPcine and RACTcine in Chapter 2.  We developed and 
validated a motion-inclusive PET contouring technique for relatively simple lesions in 
Chapter 4.  In the final chapter, we assess the feasibility of combining these techniques to 
contour locally advanced NSCLC with “cine PET/CT” imaging. 
 Ultimately, application of this contouring technique to stage III NSCLC would impact 
the greatest number of patients because a combination of chemotherapy and radiation 
therapy is a standard of care for stage III NSCLC (along with surgical resection for stage IIIA).  
There are several differences between stage I and stage III NSCLC, including tumor size, 
shape, uptake heterogeneity in PET imaging, and nodal involvement, which make applying 
the cine PET/CT contouring technique non-trivial.  These different aspects of stage III 
disease were not considered during development of the volume/motion/SBR segmentation 
model.  The largest sphere volume, for example, was approximately 27 cm3, whereas many 
stage III GTVs can be greater than 100 cm3.  Extrapolation from the model may be 
necessary.  Such differences may cause problems when the model is applied to more 
complex cases.  
5.2 Purpose 
 The purpose of this final study was to explore the feasibility of using PET together 
with MIPcine and RACTcine for target delineation of stage III NSCLC by qualitatively assessing 
target volumes formed by the PET-based volume/motion/SBR model in stage III NSCLC. 
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5.3 Methods 
 Five patients were included in the feasibility study.  Four patients had stage III NSCLC 
and each underwent 4D-CT and PET/CT as part of their treatment simulation.  One patient 
had stage I NSCLC.  The patient with stage I NSCLC was previously contoured in Chapter 2 as 
“patient 26” and was 1 of 3 patients with a tumor near the diaphragm who demonstrated 
substantial differences between contouring on cine CT image sets and 4D-CT.  The patient 
did not receive a PET/CT at time of simulation but did receive a diagnostic PET/CT two 
weeks prior which was used for the feasibility study. 
 
Table 5.1:  Patients for cine PET/CT feasibility study 
Patient Stage T N M 
Volume 
(cm
3
) 
Motion 
(mm) 
Corrected 
SBR 
Tx 
1 IA 1 0 0 10.7 17.8 23.2 SBRT 
2 IIIB 3 3 0 215.0 8.1 25.0 IMRT 
3 IIIB 4 0 0 5.8 2.9 17.7 SBRT 
4 IIIA 3 1 0 20.0 8.9 25.4 PROTON 
5 IIIB 4 2 0 86.3 1.0 64.7 IMRT 
T = tumor grade based on tumor size 
N = regional nodal status 
M = distant metastasis 
SBR = source-to-background ratio 
Tx = Treatment modality 
SBRT = stereotactic body radiation therapy 
IMRT = intensity modulated radiation therapy 
 
 Tumor volume and motion were estimated using 4D-CT.  If volumes could not be 
adequately defined using CT alone, volume estimates were made with rough threshold 
segmentation of PET.  QR%"""""""" was measured as described in Chapter 4  and P""""""" was 
measured by manually drawing an ROI in the lung and taking the mean activity 
concentration.  Volume, motion, QR%"""""""", and P""""""" served as input for the 
volume/motion/SBR model.  Threshold calculations were performed on a simple 
spreadsheet (Excel, Microsoft, Inc., Redmond, WA), which included the recovery coefficient 
(Figure 5.1).  IGTVPET formed from volume/motion/SBR thresholds were applied and 
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qualitatively compared with fused MIPcine imaging to assess feasibility of using the model to 
contour in tandem with CT imaging.  In particular, we looked for concordance of IGTVPET 
with high contrast tumor/lung boundaries on CT. 
  
 
 
Figure 5.1:  Microsoft Excel spreadsheet used to calculate thresholds using 
volume/motion/SBR model. 
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5.4 Results 
5.4.1 Patient 1 
 This patient is the only stage I NSCLC patient and was contoured in Chapter 2 as 
patient #26.  The PET data set, acquired two weeks prior to 4D-CT simulation, was manually 
registered to the tumor.   The fused PET/CT data set, along with volume/motion/SBR model 
contour, is shown in Figure 5.2.  Note the excellent agreement between anterior, posterior, 
and superior borders of the model-produced threshold and the MIP data set.  The inferior 
border is well-described by the volume/motion/SBR model threshold.  It is difficult, 
however, to say for certain whether or not the model is performing well because PET and 
CT were acquired on different days and there is no guarantee the patient was breathing 
similarly from day to day.  The coincidence of the contour with the CT data set, however, is 
striking. 
 
 
Figure 5.2:  Sagittal PET/CT data set and volume/motion/SBR contour (green line) for 
patient 1.  For this particular patient, PET was performed prior to 4D-CT simulation and 
was manually registered to the maximum intensity projection. 
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5.4.2 Patient 2 
 The primary in patient 2 was a large tumor adjacent to the chest wall and aorta.  The 
tumor demonstrated significant AC heterogeneities, which contributed to an 
underestimated tumor boundary compared with CT (green contour, Figure 5.3).  In this 
case, QR%produced a mean value too high to segment the tumor.  Manually drawing an 
ROI and taking the mean within the tumor produced a better result (blue contour), but the 
maximum motion extent is still underestimated. 
 
 
Figure 5.3:  Coronal PET/CT data set and volume/motion/SBR contours for patient 2.  
Green line represents contour when opqr%""""""""" is used in volume/motion/SBR model.  Blue 
line represents contour when mean AC in manually drawn contour in middle of tumor is 
used in volume/motion/SBR model.   
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5.4.3 Patient 3 
 This patient had two lesions, one of which was invading the anterior chest wall and 
demonstrated 3 mm motion in the anterior-posterior direction.  The result was a masking of 
the anterior extent of the tumor by the moving chest wall.  We applied the model to this 
lesion and obtained the contour shown in Figure 5.4.  Note that the posterior extent is 
slightly overestimated by the model, which may suggest overestimation in the anterior 
direction.  There is, however, an asymmetric blur to the PET activity concentration gradient 
that can be explained by the asymmetric breathing pattern observed when scrolling 
through the 4D-CT phase imaging.  The tumor spends more time in the posterior part of the 
motion envelope, resulting in sharper AC gradients on the posterior edge.  For this patient, 
we obtained a better result using P""""""" in the chest wall rather than the lung. 
 
 
Figure 5.4:  Sagittal PET/CT data set and volume/motion/SBR contour (green line) for 
patient 3.   
 
 
 5.4.4 Patient 4 
 The tumor in patient 4
resulting volume/motion/SBR threshold 
CT and provides a good example of the ability of PET to distinguish between malignant 
tissue and atelectasis (which was noted in the n
PET/CT data set and threshold contours are shown in 
 
Figure 5.5:  Coronal (left) and transverse (right) PET/CT 
contour (green line) for patient 4.  Note the atelectasis present in the left upper lobe on 
the transverse CT image. 
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volume correlates well with the lateral border on 
uclear medicine report of the PET/CT scan).  
Figure 5.5. 
data set and volume/motion/SBR 
.  The 
 
 5.4.5 Patient 5 
 A similar case to patient 4, the tumor in patient 5
mediastinal involvement with more heterogeneity in the metabolic uptake of FDG.  Again, 
the volume/motion/SBR model produces a volume that agrees well with the lateral border 
on CT.  The superior-anterior border also matc
contours are shown in Figure 
 
Figure 5.6:  Sagittal (left) and transverse (right) PET/CT 
contour (green line) for patient 5.  
5.5 Discussion 
 The current chapter explored the feasibility of applying the volume/motion/SBR 
model, which was developed using phantom scans and validated with reasonably simple 
tumors, to more complicated stage III NSCLC tumors.  The results were mixed:  The 
volume/motion/SBR model produced qualitatively good thresholds for some tumors 
(patients 1, 4, and 5) but not in others (patients 2 and 3).  Obviously, further study will be 
needed to validate the use of the volume/motion/SBR method in this application.  
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 There are several differences between stage I and stage III NSCLC that could be 
obstacles to full clinical use.  First, stage III NSCLC tumors are larger and often display 
heterogeneous uptake on PET.  As we saw in patient 2, this could cause problems for the 
volume/motion/SBR algorithm, which was not developed with heterogeneous tumors.  
Second, larger tumors are often adjacent to different kinds of tissue, which makes the 
selection of “background” for the segmentation algorithm tricky.  The background ROI for 
patient 3 is a good example; placing the ROI in the chest wall gave a better threshold value 
than placing the ROI in the lung.  Third, and probably most importantly, stage III NSCLC by 
definition has nodal involvement.  Mediastinal and hilar lymph nodes have been shown to 
move substantially with respiratory motion (Donnelly et al., 2007; Pantarotto et al., 2009; 
Sher et al., 2007) and therefore could benefit from the volume/motion/SBR model, but we 
have not validated the model for this application.  Furthermore, GTVs for stage III NSCLC 
often encompass large regions of the mediastinum if multiple nodes are present.  A 
localized threshold-based segmentation technique such as the volume/motion/SBR model 
may be inappropriate for such an application. 
5.6 Conclusions 
 Applying the volume/motion/SBR model to stage III NSCLC may be feasible, but 
further study into the appropriateness of the application and effectiveness of the model 
must be performed. 
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Chapter 6  DISCUSSION 
6.1 Significance and Impact 
 Radiation therapy is becoming increasingly important for NSCLC.  SBRT has been 
shown to be as effective as resection for inoperable stage I NSCLC (Chang et al., 2007; 
Timmerman et al., 2007).  Retrospective studies have shown promising results for the use of 
SBRT in operable stage I NSCLC (Onishi et al., 2007) and investigations are currently 
underway to prospectively evaluate SBRT in operable stage I NSCLC (including a multicenter 
clinical trial led by M. D. Anderson.)  Chemoradiation substantially benefits patients with 
stage III NSCLC (Govindan, 2003). 
 Considering the high dose gradients associated with IMRT and high biologically 
equivalent doses in SBRT, imaging is becoming ever more critical for target definition of lung 
tumors.  One of the more recent technologies for imaging lung cancer is 4D-CT, which can 
capture the motion of the tumor during the patient’s respiratory cycle.  This information 
can be used to define a “motion envelope” of the tumor, what M. D. Anderson has dubbed 
the “internal gross tumor volume” or IGTV.  Implementation of 4D-CT, however, can be 
costly and we have developed a simpler, more cost-effective alternative which provides 
significant motion information by generating MIP and RACT, image sets commonly used in 
target delineation, directly from cine CT.  The purpose of this dissertation was to investigate 
the feasibility of using these image sets in conjunction with PET imaging to define IGTV on 
tumors of varying complexity. 
 We began in Chapter 2 by examining small, mobile stage I NSCLC tumors.  We 
considered 2 groups of tumors:  “High-contrast” tumors located in the middle of the lung 
parenchyma and “low-contrast” tumors adjacent to structures of equal or greater density.  
The average volume ratios for high-contrast and low-contrast tumors were 1.05±0.14 and 
0.97±0.13 respectively.  It was therefore shown that IGTVs contoured with MIPcine and 
RACTcine are similar to or slightly larger than IGTVs contoured with 4D-CT (Riegel et al., 
2009).  In both phantom and patient studies, we found that MIPcine captured the maximum 
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extent of motion more effectively than MIP4D-CT.  In Chapter 3, we turned to calculation of 
dose, another important aspect of treatment planning.  Because RACTcine utilizes all the 
images in the cine CT image sequence, there is the possibility of weighting the average 
towards one phase of the breathing cycle.  By calculating dose on RACT image sets formed 
by averaging 1, 1.5, and 2 breathing cycles, we showed that discrepancies between dose 
distributions calculated on RACTcine and RACT4D-CT were minimal (71 of 73 patients had all 
points within the PTV pass 2%/1mm γ index criteria).  Including more breathing cycles 
reduced discrepancies even further (Riegel et al., 2008).  Once dose calculation with 
RACTcine and stage I NSCLC contouring with MIPcine and RACTcine were shown to be feasible 
alternatives to 4D-CT, we tackled tumor contouring using PET in the hopes that it would 
provide sufficient motion-inclusive targeting information to use with MIPcine and RACTcine for 
more complex tumors, such as stage III NSCLC which have been shown to cause difficulties 
in MIP contouring (Muirhead et al., 2008).  A threshold-based segmentation model was 
developed in Chapter 4 using an extensive series of phantom scans at varying sphere 
volume, motion amplitude, and SBR (Riegel et al., 2010).  This model was applied to 24 lung 
tumors and performed better than 6 commonly-used segmentation methods at defining 
IGTV (-5.15% volume underestimation compared with CT), though the difference was only 
significant when compared with “first order” methods (simple thresholds of ACmax or SUV).  
Finally, we combined the cine CT contouring technique from Chapter 2 with the 
segmentation model from Chapter 4 to assess the feasibility of using structural and 
functional image modalities together to contour tumor on stage III NSCLC and a complex 
stage I NSCLC in Chapter 5.  The results were mixed in that the volume/motion/SBR model 
was applicable and effective in some patients but not in all.  With further research, the 
integration of cine CT and PET could prove to be a useful tool for physicists and radiation 
oncologists to accurately define motion-inclusive target volumes for lung tumors.  
 Though much work remains before clinical implementation, it is worthwhile to 
consider how a “cine PET/CT” simulation could be implemented in the clinic.  The typical 
workflow for CT simulation begins at the scanner and ends at the treatment planning 
workstation.  At M. D. Anderson, several pieces of hardware and software are utilized to 
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perform PET/CT and 4D-CT in the same imaging session:  A PET/CT scanner, respiratory 
surrogate, respiratory surrogate computer and accompanying tracking software, a picture 
archiving and communication system (PACS) workstation (Advantage Window [AW], 
General Electric Medical Systems, Waukesha, WI), and 4D-CT sorting software (Advantage 
4-D, General Electric Medical Systems, Waukesha, WI).  At M. D. Anderson, 4D-CT images 
are generated on the AW workstation and transferred directly to treatment planning 
servers (they are not interpreted diagnostically).  PET images are interpreted diagnostically 
by nuclear medicine physicians and, due to the inability to interactively view PET/CT 
imaging on our institution-wide PACS system, physicians utilize the AW as a “mini-PACS” to 
interpret PET images.  They are then sent to the treatment planning servers for planning.   
 To perform PET/CT and cine CT, only two pieces of hardware are required:  A PET/CT 
scanner and a personal computer networked to the scanner console.  The only additional 
piece of software required is the relatively simple code to process cine CT image sets, which 
can be implemented on a standard Windows-based personal computer.  If one is only 
concerned with using imaging for radiation therapy treatment planning (and not diagnostic 
value), 4D-CT and PET images can be sent directly to treatment planning servers, bypassing 
the need for a mini-PACS (though some digital storage back-up mechanism obviously must 
be in place).  If the patient has not received a diagnostic PET/CT scan, however, it is 
beneficial to use the PET for staging purposes due to the ability to detect distant metastasis 
and the potential to change treatment intent from curative to palliative (Brink et al., 2004; 
Ciernik et al., 2003; Dizendorf et al., 2003; Mah et al., 2002).  The different workflows are 
shown diagrammatically in Figure 6.1.   
 Three imaging exams should be performed in the treatment position (flat table top, 
wing-board to support arms above the head, etc.) in order to gain adequate information for 
treatment planning:  (1) Cine CT of the thoracic cavity near the tumor using a long cine 
duration (approximately 2 average breathing cycles) to maximize respiratory waveform 
sampling for MIPcine (Riegel et al., 2009) and minimize weighting for RACTcine (Riegel et al., 
2008), (2) PET from base of skull to mid-thigh, and (3) free-breathing helical CT from the 
skull to the knees.  Cine CT is acquired to produce MIPcine and RACTcine, which are used for 
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contouring purposes in high-contrast regions and motion measurement for the 
volume/motion/SBR model.  RACTcine is additionally used for dose calculation and, together 
with the free-breathing helical CT, PET attenuation correction (Pan et al., 2006).  PET is used 
to assess distant metastasis and is utilized for contouring with the volume/motion/SBR 
model (SBR is measured on the PET scan).  Though helical CT of moving tumors does 
produce artifacts, it could be used to roughly estimate tumor volume for the 
volume/motion/SBR model input.  The robustness of the model with respect to this input 
should be studied further. 
 One counterargument to cine PET/CT as a cost-saving measure compared with 4D-
CT is the expense of the PET scan itself, both in the cost of the PET/CT scanner and FDG for 
each patient.  Any costs cut by excluding 4D-CT, the argument goes, would be offset by 
costs of the PET scan.  While it is true that the cost of PET scanning is by no means trivial, 
the utility of PET imaging versus 4D-CT imaging is greater.  Currently, the use of 4D-CT is 
restricted to treatment planning and, in some limited cases, assessment of ventilation 
(Guerrero et al., 2006).  PET, however, has significant utility in diagnosis in addition to 
applications in radiation oncology.  It is feasible that the cooperative purchase of a PET/CT 
scanner shared by departments of radiology, nuclear medicine, and radiation oncology 
could defray the costs, making the cost of cine PET/CT to the radiation oncology 
department manageable.  Diagnostic scans could increase patient throughput on the 
machine and help recoup costs. 
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Figure 6.1:  Workflow for (top) 4D-CT and PET acquisition versus (bottom) cine CT and PET 
acquisition. 
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6.2 Future Work 
6.2.1 Weighted Maximum Intensity Projection (wMIP) 
 One of the findings of Chapter 2 was that some tumors near the diaphragm 
demonstrated substantial IGTV differences when contouring with MIPcine and RACTcine.  This 
was mostly caused by the motion of the liver obscuring the inferior extent of the tumor’s 
motion envelope.  We developed an image processing technique called “weighted MIP” to 
solve this problem.  Essentially, the weighted MIP or “wMIP” is formed by taking the MIP of 
a subset of images from the cine CT image sequence at the lung/liver junction.  These 
images can be processed to include images of the tumor but exclude images of the liver, 
thereby discarding images that would overwrite inferior motion extent of the tumor. 
 Future work with wMIP will consist of contouring lesions that would otherwise be 
difficult to contour with cine CT alone and automating the image selection process.  
Automation could be achieved by using the liver itself as a respiratory surrogate.  Since we 
are only concerned with the images at the lung/liver interface (which, of course, moves 
during the respiratory cycle), we could segment the lung at each slice in this region using a 
CT number threshold and derive a respiratory trace by measuring the changing lung area 
over the temporal cine CT sequence.  Increasing and decreasing lung area would indicate 
end inspiration (no liver in slice) and expiration (liver in slice) respectively. 
6.2.2 Improvement in PET Uptake Quantification 
 An interesting byproduct of Chapter 4 was the development of the recovery 
coefficient (RC) to correct for partial volume averaging and motion blur of the PET image.  
Though RCs based on object size have been explored, few publications of size- and motion-
based RCs exist (Park et al., 2008).   
 Though the function used to model the RC fit the data well overall, there were 
regions of inaccuracy.  Further research, including validation with gated 4D-PET/CT as the 
gold standard, is warranted. 
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 In diagnostic PET for NSCLC, the commonly-accepted SUV for malignancy is 2.5 g/mL 
(Patz et al., 1993).  This value, however, was determined by correlating SUV (without any 
size or motion correction) with histological results.  For large, stationary tumors, SUV was 
likely not affected.  For small, mobile tumors, however, SUV would have been 
underestimated.  This may have caused dispersion in the data, clouding the relationship 
between SUV and histology.  It may be worthwhile, therefore, to update the study using 
current technology.  We intend to retrospectively recruit a large number of lung cancer 
patients who have received PET and 4D-CT, measure the motion and size via 4D-CT, apply a 
size- and motion-dependent RC to correct for partial volume averaging and motion blur, 
and compare corrected SUVs with histology to determine an appropriate benign/malignant 
SUV threshold. 
6.2.3 Fine-Tuning the Volume/Motion/SBR Model 
 The volume/motion/SBR model is far from perfect for all the reasons listed in 
section 4.5.  Ultimately, we hope to use this model in situations where CT cannot 
adequately define tumor boundaries, such as the stage III patients in the feasibility study 
described in Chapter 5.  In order to do that, the model must be robust enough to work 
under a variety of conditions.  Investigating asymmetry of the breathing cycle, irregular 
tumor geometry, the effect of heterogeneous uptake, and improvements to the recovery 
coefficient model are a few of several avenues to pursue to further refine the segmentation 
model for this purpose.   
6.2.4 Nodal Involvement in Stage III Non-Small Cell Lung Cancer 
 Perhaps the biggest difference between stage I and stage III NSCLC is the presence of 
regional lymph node metastasis.  As briefly discussed in Chapter 5, it is worthwhile to 
consider the appropriateness of using a localized threshold-based segmentation technique 
for contouring mobile hilar and mediastinal lymph nodes.  Regardless of whether or not the 
volume/motion/SBR model is used, the efficacy of PET in contouring nodal involvement in 
conjunction with MIPcine and RACTcine should be evaluated by comparing with 4D-CT.  We 
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should, in essence, repeat the experimental setup detailed in Chapter 2, this time 
comparing IGTVs delineated on MIPcine + RACTcine + PET versus IGTVs delineated on MIP4D-CT 
+ 4D-CT phases + PET.  In addition to intraobserver variation, interobserver variation should 
be assessed. 
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Chapter 7  CONCLUSIONS AND RECOMMENDATIONS 
 The results of this work are promising.  We have shown that RACTcine is a viable 
alternative to RACT4D-CT for the purposes of dose calculation and can be implemented 
reasonably.  We have shown MIPcine and RACTcine can be used to contour moving stage I 
NSCLC located in the lung parenchyma and we have presented evidence that PET (via the 
segmentation model) can be used in conjunction with MIP and RACT to contour smaller 
tumors adjacent to structures of equal or greater density.  Though more research is 
required to assess the efficacy of PET in stage III disease, the work presented here provides 
a solid foundation for future investigations. 
 The cine PET/CT workflow in Figure 6.1 reduces the complexity of the motion-
inclusive simulation process and could substantially reduce the costs of motion-inclusive 
imaging for radiation therapy simulation.  Though more research is required to fine-tune 
the technique, we have 4 recommendations:   
• If 4D-CT is not available, we recommend acquiring cine CT and free-breathing helical 
CT for treatment simulation of lung cancer patients, including the use of MIPcine and 
RACTcine for contouring and RACTcine for dose calculation.  Any motion information is 
better than none.  
• If 4D-CT is available, we recommend that MIPcine be used with phase imaging 
because it more accurately captures the maximum motion extent of the tumor than 
MIP4D-CT.  Dose calculation with either RACT4D-CT or RACTcine is recommended. 
• If PET/CT is available, we recommend that IGTV be contoured primarily on CT (cine 
CT or 4D-CT) using volume/motion/SBR model as a supplemental guide when 
contouring small, mobile tumors with relatively homogenous uptake on PET.  
Further research is required to recommend use in larger, more complex lesions. 
• If cine CT is acquired, we recommend that cine duration be set as long as possible (2 
average breathing cycles is a good target) to maximize sampling of the respiratory 
waveform and minimize density weighting effects. 
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Chapter 8  APPENDIX  
A detailed description of the surface separation algorithm is provided here.  The 
code is basically split into two main parts:  First, the “reference” surface mesh is sampled by 
calculating the intersection of equally-spaced vectors projected from the center of the 
reference ROI and the triangular mesh surface; second, the shortest distance between the 
sampling point on the reference mesh and the test mesh surface is calculated. 
8.1 Sampling the Reference Surface 
The centroid (the center of mass assuming unit density) of the reference ROI is 
determined by averaging the pixel coordinates inside the ROI.  Vertices of the reference 
mesh are transformed such that the reference ROI centroid is the origin of the coordinate 
system.  Rays are projected from the origin (the centroid) at regular azimuthal and 
altitudinal angles.  For our study, we used an angular interval of 5°.   
The mesh surface is made of hundreds or thousands of adjacent triangles which 
connect the vertices of the mesh.  Each triangle defines a plane.  Our task is twofold:  We 
must calculate the intersection of the sampling vector with the plane and also determine 
whether or not the intersection is inside the triangle defined with the mesh vertices.  
Furthermore, we must iterate this process for all triangles, for every sampling ray. 
Mathematically, if we consider r1, r2, and r3 to be vertices of a triangle on the 
reference surface mesh, the plane that contains the triangle is defined by equation ( 14 ): 
 st, u  6-8889 ? 68889 n 6-8889t ? 6b8889 n 6-8889u  ( 14 ) 
 
where u and v are barycentric coordinates of a point in the plane of the triangle (Moller et 
al., 1997).  The equation for the ray originating from the reference centroid (denoted by v, 
the origin of the coordinate system) is: 
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Sw  v9 ? xℓ89 n v9zw  ( 15 ) 
 
where ℓ89 is the directional ray vector and t is the length of the ray (in this case, a parametric 
variable).   
 According to Moller and Trumbore (Moller et al., 1997), we can simultaneously 
determine the intersection of the ray with the plane and whether or not the intersection is 
inside the triangle by setting equation ( 14 ) equal to equation ( 15 ) and solving for the 
vector [t u v].   
 
v9 ? xℓ89 n v9zw  6-8889 ? 68889 n 6-8889t ? 6b8889 n 6-8889u  ( 16 ) 
 
By rearranging and putting this equation into matrix form, 
 
{v% n 6-,%v| n 6-,|v} n 6-,} ~  {
v% n ℓ% 6,% n 6-,% 6b,% n 6-,%v| n ℓ| 6,| n 6-,| 6b,| n 6-,|v} n ℓ} 6,} n 6-,} 6b,} n 6-,} ~ 
wtu  ( 17 ) 
 
we can take the inverse of the middle matrix to determine [t u v].  
 
wtu  {
v% n ℓ% 6,% n 6-,% 6b,% n 6-,%v| n ℓ| 6,| n 6-,| 6b,| n 6-,|v} n ℓ} 6,} n 6-,} 6b,} n 6-,} ~
+-
{v% n 6-,%v| n 6-,|v} n 6-,} ~  ( 18 ) 
 
 Because u and v represent barycentric coordinates, they are relative to the vertices 
of the triangle.  Therefore, if the solution of u and v satisfies the following conditions, 
 0  t  1  0  u  1  t ? u  1    
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then the intersection of the ray and the plane lies within the triangle defined by r1, r2, and 
r3, and the coordinates of the intersection can be found by plugging the solution for t into 
equation ( 15 ).  The intersection coordinates are deposited into a new matrix of points that 
“sample” the reference mesh surface.  If the point lies outside the triangle, it is discarded.  
This is repeated for all triangles and all sampling rays. 
 For typical convex shapes, the number of sampling points will equal the number of 
sampling rays.  There are clinical scenarios, however, when the tumor contains spiculations 
and will cause multiple intersections of the ray with the mesh surface.  The algorithm is 
designed to include these multiple intersections in the surface separation calculation. 
8.2 Determination of Shortest Distance between Reference and Test Surfaces 
 First, the test surface mesh is transformed to the reference ROI centroid coordinate 
system.  The next step is to measure the separation between the reference surface and the 
test surface by calculating the shortest distance from each sampling point to the test 
surface.  There are two outcomes:  Either the shortest distance is on a face of the surface 
mesh (inside the triangle formed by the vertices) or it is on the edge of the surface mesh 
(one of the lines connecting the vertices).  The algorithm is designed to consider each 
scenario separately and determine which distance is smaller.   
8.2.1 Faces 
First, to measure the distance from the sampling point to each plane formed by the 
surface triangles, we must calculate the projection of the sampling point q on every plane.  
To do so, we must establish orthogonal basis vectors within each plane using the Gram-
Schmidt process (Lay, 1997).  To summarize, if p1, p2, and p3 are vertices of a triangle on the 
test surface mesh and q is the point to be projected onto that plane, consider the vectors !-8889  88889 n -8889, !88889  b88889 n -8889 , and Z9  9 n -8889.  Orthogonal basis vectors are formed using 
equations ( 19 ) and ( 20 ): 
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u-88889  !-8889  ( 19 ) 
u88889  !88889 n %88889·8888988889·88889 u-88889  ( 20 ) 
 
The projection of the sampling point onto a p-dimensional space is defined by Lay (Lay, 
1997): 
 
 
Z  |89·888889888889·888889 t-88889 ? ? |89·888889888889·888889 t88889  ( 21 ) 
 
 
Where t-,  , t is an orthogonal basis of the plane.  In our case, the orthogonal basis is 
provided by the Gram-Schmidt process, and the projection is demonstrated in equation        
( 22 ): 
 
 
Z  |89·8888988889·88889 u-88889 ? |89·8888988889·88889 u88889 ? -88889  ( 22 ) 
 
 
We now have two points that define a line normal to the plane:  q, the sampling point on 
the reference mesh, and Z, the projection of q on the plane.  Using the method described in 
the previous section, we determine whether or not this line falls inside the vertices of the 
plane-defining triangle p1, p2, and p3.  If Z lies within the triangle, the distance Z n  is 
placed in a matrix where “candidate” shortest distances are stored.  If it lies outside the 
triangle, it is discarded.   
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8.2.2 Edges 
 The sampling point is then projected on each edge of the triangle using equation        
( 21 ) with only 1 basis vector for each edge.  The edges are defined thusly:  u-88889  88889 n -8889, u88889  b88889 n -8889, ub88889  b88889 n 88889.  The vectors to be projected are defined as such:  Z-88889  9 n -8889,  Z88889  9 n 88889 ).  The projections are therefore: 
 
Z-  |88889·8888988889·88889 u-88889 ? -88889   
Z  |88889·8888988889·88889 u88889 ? -88889  ( 23 ) 
Zb  |88889·8888988889·88889 ub88889 ? 88889   
 
 The distances from the sampling point q to each projection is stored in the 
“candidate” matrix, along with the distance from q to the triangle face (if the normal lies 
inside the triangle).  This represents one iteration of the process.  The process is repeated 
for all triangles and the shortest distance of all the triangles is recorded as the surface 
separation for that particular sampling point.  The process is iterated over all sampling 
points.  A visualization of the surface separation algorithm is shown in Figure 8.1. 
 
 Figure 8.1:  End result of the surface separation algorithm.  Black mesh is "reference" 
mesh.  Red mesh is "test" mesh.  Blue lines represent shortest distances from the 
sampling points on the reference mesh to the test mesh surface.
 
121 
 
 
 
122 
 
REFERENCES 
American Cancer Society, "Cancer Facts & Figures 2009," Atlanta: American Cancer Society; 
2009. 
 
Admiraal MA, Schuring D, Hurkmans CW. "Dose calculations accounting for breathing 
motion in stereotactic lung radiotherapy based on 4D-CT and the internal target 
volume." Radiother Oncol. (2008) 86(1), 55-60. 
 
Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis 
A, Ross P, Evola A. "The contribution of integrated PET/CT to the evolving definition 
of treatment volumes in radiation treatment planning in lung cancer." Int J Radiat 
Oncol Biol Phys. (2005) 63(4), 1016-1023. 
 
Bacharach SL. "PET/CT attenuation correction: breathing lessons." J Nucl Med. (2007) 48(5), 
677-679. 
 
Bartko JJ. "Measurement and reliability: statistical thinking considerations." Schizophr Bull. 
(1991) 17(3), 483-489. 
 
Beutel J. Handbook of medical imaging. Vol 2:  Medical Image Processing and Analysis. 
Bellingham, Wash.: SPIE Press; 2000. 
 
Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD. "18F-FDG 
PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: 
is a single standardized uptake value threshold approach appropriate?" J Nucl Med. 
(2006) 47(11), 1808-1812. 
 
123 
 
Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D. "Defining a 
radiotherapy target with positron emission tomography." Int J Radiat Oncol Biol 
Phys. (2004) 60(4), 1272-1282. 
 
Boldea V, Sharp GC, Jiang SB, Sarrut D. "4D-CT lung motion estimation with deformable 
registration: quantification of motion nonlinearity and hysteresis." Med Phys. (2008) 
35(3), 1008-1018. 
 
Boucher L, Rodrigue S, Lecomte R, Benard F. "Respiratory gating for 3-dimensional PET of 
the thorax: feasibility and initial results." J Nucl Med. (2004) 45(2), 214-219. 
 
Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ. 
"Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung 
cancer." Int J Radiat Oncol Biol Phys. (2004) 59(1), 78-86. 
 
Bradley JD, Nofal AN, El Naqa IM, Lu W, Liu J, Hubenschmidt J, Low DA, Drzymala RE, Khullar 
D. "Comparison of helical, maximum intensity projection (MIP), and averaged 
intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning 
in lung cancer." Radiother Oncol. (2006) 81(3), 264-268. 
 
Brambilla M, Matheoud R, Secco C, Loi G, Krengli M, Inglese E. "Threshold segmentation for 
PET target volume delineation in radiation treatment planning: the role of target-to-
background ratio and target size." Med Phys. (2008) 35(4), 1207-1213. 
 
Brandner ED, Wu A, Chen H, Heron D, Kalnicki S, Komanduri K, Gerszten K, Burton S, Ahmed 
I, Shou Z. "Abdominal organ motion measured using 4D CT." Int J Radiat Oncol Biol 
Phys. (2006) 65(2), 554-560. 
 
124 
 
Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, Henke M, Ghanem N, Moser 
E, Nitzsche EU. "Impact of [18F]FDG-PET on the primary staging of small-cell lung 
cancer." Eur J Nucl Med Mol Imaging. (2004) 31(12), 1614-1620. 
 
Brooks RA, Di Chiro G. "Theory of image reconstruction in computed tomography." 
Radiology. (1975) 117(3 Pt 1), 561-572. 
 
Bushberg JT. The essential physics of medical imaging. 2nd ed. Philadelphia: Lippincott 
Williams & Wilkins; 2002. 
 
Cai J, Read PW, Baisden JM, Larner JM, Benedict SH, Sheng K. "Estimation of error in 
maximal intensity projection-based internal target volume of lung tumors: a 
simulation and comparison study using dynamic magnetic resonance imaging." Int J 
Radiat Oncol Biol Phys. (2007) 69(3), 895-902. 
 
Caldwell CB, Mah K, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, Ehrlich LE. "Observer 
variation in contouring gross tumor volume in patients with poorly defined non-
small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion." Int J Radiat 
Oncol Biol Phys. (2001) 51(4), 923-931. 
 
Caldwell CB, Mah K, Skinner M, Danjoux CE. "Can PET provide the 3D extent of tumor 
motion for individualized internal target volumes? A phantom study of the 
limitations of CT and the promise of PET." Int J Radiat Oncol Biol Phys. (2003) 55(5), 
1381-1393. 
 
Chang JY, Roth JA. "Stereotactic body radiation therapy for stage I non-small cell lung 
cancer." Thorac Surg Clin. (2007) 17(2), 251-259. 
 
125 
 
Chen GT, Kung JH, Beaudette KP. "Artifacts in computed tomography scanning of moving 
objects." Semin Radiat Oncol. (2004) 14(1), 19-26. 
 
Chi PC, Mawlawi O, Nehmeh SA, Erdi YE, Balter PA, Luo D, Mohan R, Pan T. "Design of 
respiration averaged CT for attenuation correction of the PET data from PET/CT." 
Med Phys. (2007) 34(6), 2039-2047. 
 
Childress NL, Rosen, II. "The design and testing of novel clinical parameters for dose 
comparison." Int J Radiat Oncol Biol Phys. (2003) 56(5), 1464-1479. 
 
Childress NL, White RA, Bloch C, Salehpour M, Dong L, Rosen, II. "Retrospective analysis of 
2D patient-specific IMRT verifications." Med Phys. (2005) 32(4), 838-850. 
 
Chu JC, Ni B, Kriz R, Amod Saxena V. "Applications of simulator computed tomography 
number for photon dose calculations during radiotherapy treatment planning." 
Radiother Oncol. (2000) 55(1), 65-73. 
 
Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lutolf UM, Steinert HC, 
Von Schulthess GK. "Radiation treatment planning with an integrated positron 
emission and computer tomography (PET/CT): a feasibility study." Int J Radiat Oncol 
Biol Phys. (2003) 57(3), 853-863. 
 
Cover KS, Lagerwaard FJ, Senan S. "Color intensity projections: a rapid approach for 
evaluating four-dimensional CT scans in treatment planning." Int J Radiat Oncol Biol 
Phys. (2006) 64(3), 954-961. 
 
Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Gregoire V. "Tri-dimensional 
automatic segmentation of PET volumes based on measured source-to-background 
126 
 
ratios: influence of reconstruction algorithms." Radiother Oncol. (2003) 69(3), 247-
250. 
 
Davis JB, Reiner B, Huser M, Burger C, Szekely G, Ciernik IF. "Assessment of 18F PET signals 
for automatic target volume definition in radiotherapy treatment planning." 
Radiother Oncol. (2006) 80(1), 43-50. 
 
Davis JN, Stagg D. "Interrelationships of the volume and time components of individual 
breaths in resting man." J Physiol. (1975) 245(2), 481-498. 
 
Depuydt T, Van Esch A, Huyskens DP. "A quantitative evaluation of IMRT dose distributions: 
refinement and clinical assessment of the gamma evaluation." Radiother Oncol. 
(2002) 62(3), 309-319. 
 
Dice LR. "Measures of the amount of ecologic association between species." Ecology. (1945) 
26297-302. 
 
Dizendorf EV, Baumert BG, von Schulthess GK, Lutolf UM, Steinert HC. "Impact of whole-
body 18F-FDG PET on staging and managing patients for radiation therapy." J Nucl 
Med. (2003) 44(1), 24-29. 
 
Donnelly ED, Parikh PJ, Lu W, Zhao T, Lechleiter K, Nystrom M, Hubenschmidt JP, Low DA, 
Bradley JD. "Assessment of intrafraction mediastinal and hilar lymph node 
movement and comparison to lung tumor motion using four-dimensional CT." Int J 
Radiat Oncol Biol Phys. (2007) 69(2), 580-588. 
 
Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, Dosani RA, Mestas G, 
Siegel AD, Chadha TT, et al. "Radiation therapy in the management of medically 
127 
 
inoperable carcinoma of the lung: results and implications for future treatment 
strategies." Int J Radiat Oncol Biol Phys. (1992) 24(1), 3-9. 
 
Drever LA, Roa W, McEwan A, Robinson D. "Comparison of three image segmentation 
techniques for target volume delineation in positron emission tomography." J Appl 
Clin Med Phys. (2007) 8(2), 93-109. 
 
Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, Humm JL. "Segmentation of 
lung lesion volume by adaptive positron emission tomography image thresholding." 
Cancer. (1997) 80(12 Suppl), 2505-2509. 
 
Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE, Humm JL, Squire OD, Chui 
CS, Larson SM, Yorke ED. "Radiotherapy treatment planning for patients with non-
small cell lung cancer using positron emission tomography (PET)." Radiother Oncol. 
(2002) 62(1), 51-60. 
 
Ezhil M, Vedam S, Balter P, Choi B, Mirkovic D, Starkschall G, Chang JY. "Determination of 
patient-specific internal gross tumor volumes for lung cancer using four-dimensional 
computed tomography." Radiat Oncol. (2009) 44. 
 
Feng S, Liang Q, Kinser RD, Newland K, Guilbaud R. "Testing equivalence between two 
laboratories or two methods using paired-sample analysis and interval hypothesis 
testing." Anal Bioanal Chem. (2006) 385(5), 975-981. 
 
Flampouri S, Jiang SB, Sharp GC, Wolfgang J, Patel AA, Choi NC. "Estimation of the delivered 
patient dose in lung IMRT treatment based on deformable registration of 4D-CT data 
and Monte Carlo simulations." Phys Med Biol. (2006) 51(11), 2763-2779. 
 
128 
 
Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y. 
"Phase III study of concurrent versus sequential thoracic radiotherapy in 
combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-
small-cell lung cancer." J Clin Oncol. (1999) 17(9), 2692-2699. 
 
Gagne IM, Robinson DM. "The impact of tumor motion upon CT image integrity and target 
delineation." Med Phys. (2004) 31(12), 3378-3392. 
 
Gauden S, Ramsay J, Tripcony L. "The curative treatment by radiotherapy alone of stage I 
non-small cell carcinoma of the lung." Chest. (1995) 108(5), 1278-1282. 
 
Geise RA, McCullough EC. "The use of CT scanners in megavoltage photon-beam therapy 
planning." Radiology. (1977) 124(1), 133-141. 
 
Gillis S, De Wagter C, Bohsung J, Perrin B, Williams P, Mijnheer BJ. "An inter-centre quality 
assurance network for IMRT verification: results of the ESTRO QUASIMODO project." 
Radiother Oncol. (2005) 76(3), 340-353. 
 
Giraud P, Elles S, Helfre S, De Rycke Y, Servois V, Carette MF, Alzieu C, Bondiau PY, Dubray B, 
Touboul E, Housset M, Rosenwald JC, Cosset JM. "Conformal radiotherapy for lung 
cancer: different delineation of the gross tumor volume (GTV) by radiologists and 
radiation oncologists." Radiother Oncol. (2002) 62(1), 27-36. 
 
Glide-Hurst CK, Hugo GD, Liang J, Yan D. "A simplified method of four-dimensional dose 
accumulation using the mean patient density representation." Med Phys. (2008) 
35(12), 5269-5277. 
 
Goo JM, Tongdee T, Tongdee R, Yeo K, Hildebolt CF, Bae KT. "Volumetric measurement of 
synthetic lung nodules with multi-detector row CT: effect of various image 
129 
 
reconstruction parameters and segmentation thresholds on measurement 
accuracy." Radiology. (2005) 235(3), 850-856. 
 
Gould KL, Pan T, Loghin C, Johnson NP, Sdringola S. "Reducing radiation dose in rest-stress 
cardiac PET/CT by single poststress cine CT for attenuation correction: quantitative 
validation." J Nucl Med. (2008) 49(5), 738-745. 
 
Govindan R. "Management of patients with non-small cell lung cancer and poor 
performance status." Curr Treat Options Oncol. (2003) 4(1), 55-59. 
 
Guckenberger M, Wilbert J, Krieger T, Richter A, Baier K, Meyer J, Flentje M. "Four-
dimensional treatment planning for stereotactic body radiotherapy." Int J Radiat 
Oncol Biol Phys. (2007) 69(1), 276-285. 
 
Guckenberger M, Wilbert J, Meyer J, Baier K, Richter A, Flentje M. "Is a single respiratory 
correlated 4D-CT study sufficient for evaluation of breathing motion?" Int J Radiat 
Oncol Biol Phys. (2007) 67(5), 1352-1359. 
 
Guerrero T, Sanders K, Castillo E, Zhang Y, Bidaut L, Pan T, Komaki R. "Dynamic ventilation 
imaging from four-dimensional computed tomography." Phys Med Biol. (2006) 
51(4), 777-791. 
 
Hudson HM, Larkin S. "Accelerated image reconstruction using ordered subsets of 
projection data." IEEE Trans Med Imag. (1994) 13601-609. 
 
International Commission on Radiation Units and Measurements. Prescribing, recording, 
and reporting photon beam therapy. Bethesda, Md.: International Commission on 
Radiation Units and Measurements; 1999. 
 
130 
 
Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, 
Mohan R, Dong L. "4D Proton treatment planning strategy for mobile lung tumors." 
Int J Radiat Oncol Biol Phys. (2007) 67(3), 906-914. 
 
Keall PJ, Siebers JV, Joshi S, Mohan R. "Monte Carlo as a four-dimensional radiotherapy 
treatment-planning tool to account for respiratory motion." Phys Med Biol. (2004) 
49(16), 3639-3648. 
 
Keall PJ, Starkschall G, Shukla H, Forster KM, Ortiz V, Stevens CW, Vedam SS, George R, 
Guerrero T, Mohan R. "Acquiring 4D thoracic CT scans using a multislice helical 
method." Phys Med Biol. (2004) 49(10), 2053-2067. 
 
Keall PJ, Mageras GS, Balter JM, Emery RS, Forster KM, Jiang SB, Kapatoes JM, Low DA, 
Murphy MJ, Murray BR, Ramsey CR, Van Herk MB, Vedam SS, Wong JW, Yorke E. 
"The management of respiratory motion in radiation oncology report of AAPM Task 
Group 76." Med Phys. (2006) 33(10), 3874-3900. 
 
Kemerink GJ, Lamers RJ, Pellis BJ, Kruize HH, van Engelshoven JM. "On segmentation of lung 
parenchyma in quantitative computed tomography of the lung." Med Phys. (1998) 
25(12), 2432-2439. 
 
Khan FM. The physics of radiation therapy. 3rd ed. Philadelphia: Lippincott Williams & 
Wilkins; 2003. 
 
Kim J, Ferree Jr. GD. "Standardization in Causal Analysis." Sociological Methods & Research. 
(1981) 10187-210. 
 
Lagerwaard FJ, Van Sornsen de Koste JR, Nijssen-Visser MR, Schuchhard-Schipper RH, Oei 
SS, Munne A, Senan S. "Multiple "slow" CT scans for incorporating lung tumor 
131 
 
mobility in radiotherapy planning." Int J Radiat Oncol Biol Phys. (2001) 51(4), 932-
937. 
 
Lange K, Carson R. "EM reconstruction algorithms for emission and transmission 
tomography." J Comput Assist Tomogr. (1984) 8(2), 306-316. 
 
Lay DC. Linear algebra and its applications. 2nd ed. Reading, Mass.: Addison-Wesley; 1997. 
 
Limpert E, Werner AS, Abbt M. "Log-normal distributions across the sciences:  Keys and 
clues." BioScience. (2001) 51(5), 341-352. 
 
Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall 
G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. "Assessing 
respiration-induced tumor motion and internal target volume using four-
dimensional computed tomography for radiotherapy of lung cancer." Int J Radiat 
Oncol Biol Phys. (2007) 68(2), 531-540. 
 
Low DA, Harms WB, Mutic S, Purdy JA. "A technique for the quantitative evaluation of dose 
distributions." Med Phys. (1998) 25(5), 656-661. 
 
Low DA, Dempsey JF. "Evaluation of the gamma dose distribution comparison method." 
Med Phys. (2003) 30(9), 2455-2464. 
 
Low DA, Nystrom M, Kalinin E, Parikh P, Dempsey JF, Bradley JD, Mutic S, Wahab SH, Islam 
T, Christensen G, Politte DG, Whiting BR. "A method for the reconstruction of four-
dimensional synchronized CT scans acquired during free breathing." Med Phys. 
(2003) 30(6), 1254-1263. 
 
132 
 
Lowry R. "VassarStats:  Web Site for Statistical Computation." Poughkeepsie, Lowry, 
Richard, 2008. http://faculty.vassar.edu/lowry/VassarStats.html 
 
Lujan AE, Larsen EW, Balter JM, Ten Haken RK. "A method for incorporating organ motion 
due to breathing into 3D dose calculations." Med Phys. (1999) 26(5), 715-720. 
 
Mageras GS, Pevsner A, Yorke ED, Rosenzweig KE, Ford EC, Hertanto A, Larson SM, Lovelock 
DM, Erdi YE, Nehmeh SA, Humm JL, Ling CC. "Measurement of lung tumor motion 
using respiration-correlated CT." Int J Radiat Oncol Biol Phys. (2004) 60(3), 933-941. 
 
Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, Ehrlich LE, Tirona R. "The 
impact of (18)FDG-PET on target and critical organs in CT-based treatment planning 
of patients with poorly defined non-small-cell lung carcinoma: a prospective study." 
Int J Radiat Oncol Biol Phys. (2002) 52(2), 339-350. 
 
Marin D, Nelson RC, Schindera ST, Richard S, Youngblood RS, Yoshizumi TT, Samei E. "Low-
tube-voltage, high-tube-current multidetector abdominal CT: improved image 
quality and decreased radiation dose with adaptive statistical iterative 
reconstruction algorithm--initial clinical experience." Radiology. (2010) 254(1), 145-
153. 
 
McClelland JR, Blackall JM, Tarte S, Chandler AC, Hughes S, Ahmad S, Landau DB, Hawkes DJ. 
"A continuous 4D motion model from multiple respiratory cycles for use in lung 
radiotherapy." Med Phys. (2006) 33(9), 3348-3358. 
 
Moller T, Trumbore B. "Fast, Minimum Storage Ray-Triangle Intersection." J Graphics Tools. 
(1997) 2(1), 21-28. 
 
133 
 
Muirhead R, McNee SG, Featherstone C, Moore K, Muscat S. "Use of Maximum Intensity 
Projections (MIPs) for target outlining in 4DCT radiotherapy planning." J Thorac 
Oncol. (2008) 3(12), 1433-1438. 
 
NCI. "Stage Information for Non-Small Cell Lung Cancer." Rockville, National Cancer 
Institute, 2010. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-
lung/HealthProfessional/page4 
 
Nehmeh SA, Erdi YE, Pan T, Yorke E, Mageras GS, Rosenzweig KE, Schoder H, Mostafavi H, 
Squire O, Pevsner A, Larson SM, Humm JL. "Quantitation of respiratory motion 
during 4D-PET/CT acquisition." Med Phys. (2004) 31(6), 1333-1338. 
 
Nestle U, Walter K, Schmidt S, Licht N, Nieder C, Motaref B, Hellwig D, Niewald M, Ukena D, 
Kirsch CM, Sybrecht GW, Schnabel K. "18F-deoxyglucose positron emission 
tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact 
in patients with atelectasis." Int J Radiat Oncol Biol Phys. (1999) 44(3), 593-597. 
 
Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rube C, Kirsch CM. 
"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for 
target volume definition in radiotherapy of patients with non-Small cell lung cancer." 
J Nucl Med. (2005) 46(8), 1342-1348. 
 
Nestle U, Kremp S, Grosu AL. "Practical integration of [18F]-FDG-PET and PET-CT in the 
planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, 
ICRU-target volumes, problems, perspectives." Radiother Oncol. (2006) 81(2), 209-
225. 
 
Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, 
Hosono M. "Static and moving phantom studies for radiation treatment planning in 
134 
 
a positron emission tomography and computed tomography (PET/CT) system." Ann 
Nucl Med. (2008) 22(7), 579-586. 
 
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa 
K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, 
Yamada K, Araki T. "Hypofractionated stereotactic radiotherapy (HypoFXSRT) for 
stage I non-small cell lung cancer: updated results of 257 patients in a Japanese 
multi-institutional study." J Thorac Oncol. (2007) 2(7 Suppl 3), S94-100. 
 
Pan T, Lee TY, Rietzel E, Chen GT. "4D-CT imaging of a volume influenced by respiratory 
motion on multi-slice CT." Med Phys. (2004) 31(2), 333-340. 
 
Pan T. "Comparison of helical and cine acquisitions for 4D-CT imaging with multislice CT." 
Med Phys. (2005) 32(2), 627-634. 
 
Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Luo D, Liu HH, Castillo R, Mohan R, Liao Z, 
Macapinlac HA. "Attenuation correction of PET images with respiration-averaged CT 
images in PET/CT." J Nucl Med. (2005) 46(9), 1481-1487. 
 
Pan T, Mawlawi O, Luo D, Liu HH, Chi PC, Mar MV, Gladish G, Truong M, Erasmus J, Jr., Liao 
Z, Macapinlac HA. "Attenuation correction of PET cardiac data with low-dose 
average CT in PET/CT." Med Phys. (2006) 33(10), 3931-3938. 
 
Pan T, Sun X, Luo D. "Improvement of the cine-CT based 4D-CT imaging." Med Phys. (2007) 
34(11), 4499-4503. 
 
Pantarotto JR, Piet AH, Vincent A, van Sornsen de Koste JR, Senan S. "Motion analysis of 100 
mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive 
strategies." Int J Radiat Oncol Biol Phys. (2009) 74(4), 1092-1099. 
135 
 
 
American Association of Physicists in Medicine, "Tissue inhomogeneity corrections for 
megavoltage photon beams," Madison, WI: American Association of Physicists in 
Medicine; 2004. 
 
Park K, Huang L, Gagne H, Papiez L. "Do maximum intensity projection images truly capture 
tumor motion?" Int J Radiat Oncol Biol Phys. (2009) 73(2), 618-625. 
 
Park SJ, Ionascu D, Killoran J, Mamede M, Gerbaudo VH, Chin L, Berbeco R. "Evaluation of 
the combined effects of target size, respiratory motion and background activity on 
3D and 4D PET/CT images." Phys Med Biol. (2008) 53(13), 3661-3679. 
 
Patz EF, Jr., Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC. "Focal 
pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning." 
Radiology. (1993) 188(2), 487-490. 
 
Paulino AC, Johnstone PA. "FDG-PET in radiotherapy treatment planning: Pandora's box?" 
Int J Radiat Oncol Biol Phys. (2004) 59(1), 4-5. 
 
Pevsner A, Davis B, Joshi S, Hertanto A, Mechalakos J, Yorke E, Rosenzweig K, Nehmeh S, 
Erdi YE, Humm JL, Larson S, Ling CC, Mageras GS. "Evaluation of an automated 
deformable image matching method for quantifying lung motion in respiration-
correlated CT images." Med Phys. (2006) 33(2), 369-376. 
 
Remeijer P, Rasch C, Lebesque JV, van Herk M. "A general methodology for three-
dimensional analysis of variation in target volume delineation." Med Phys. (1999) 
26(6), 931-940. 
 
136 
 
Riegel AC, Berson AM, Destian S, Ng T, Tena LB, Mitnick RJ, Wong PS. "Variability of gross 
tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion." Int 
J Radiat Oncol Biol Phys. (2006) 65(3), 726-732. 
 
Riegel AC, Ahmad M, Sun X, Pan T. "Dose calculation with respiration-averaged CT 
processed from cine CT without a respiratory surrogate." Med Phys. (2008) 35(12), 
5738-5747. 
 
Riegel AC, Chang JY, Vedam SS, Johnson V, Chi PC, Pan T. "Cine computed tomography 
without respiratory surrogate in planning stereotactic radiotherapy for non-small-
cell lung cancer." Int J Radiat Oncol Biol Phys. (2009) 73(2), 433-441. 
 
Riegel AC, Bucci KM, Mawlawi O, Johnson V, Ahmad M, Sun X, Luo D, Chandler AG, Pan T. 
"Target definition of moving lung tumors in positron emission tomography:  
Correlation of optimal activity concentration thresholds with object size, motion 
extent, and source-to-background ratio." Med Phys. (2010) 37(4), 1742-1752. 
 
Rietzel E, Chen GT, Choi NC, Willet CG. "Four-dimensional image-based treatment planning: 
Target volume segmentation and dose calculation in the presence of respiratory 
motion." Int J Radiat Oncol Biol Phys. (2005) 61(5), 1535-1550. 
 
Rietzel E, Pan T, Chen GT. "Four-dimensional computed tomography: image formation and 
clinical protocol." Med Phys. (2005) 32(4), 874-889. 
 
Rietzel E, Liu AK, Doppke KP, Wolfgang JA, Chen AB, Chen GT, Choi NC. "Design of 4D 
treatment planning target volumes." Int J Radiat Oncol Biol Phys. (2006) 66(1), 287-
295. 
 
137 
 
Rietzel E, Liu AK, Chen GT, Choi NC. "Maximum-intensity volumes for fast contouring of lung 
tumors including respiratory motion in 4DCT planning." Int J Radiat Oncol Biol Phys. 
(2008) 71(4), 1245-1252. 
 
Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, 
Byhardt RW, Turrisi AT, et al. "Radiation Therapy Oncology Group (RTOG) 88-08 and 
Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III 
trial in regionally advanced, unresectable non-small-cell lung cancer." J Natl Cancer 
Inst. (1995) 87(3), 198-205. 
 
Shepp LA, Vardi Y. "Maximum likelihood reconstruction for emission tomography." IEEE 
Trans Med Imag. (1972) 1(2), 113-122. 
 
Sher DJ, Wolfgang JA, Niemierko A, Choi NC. "Quantification of mediastinal and hilar lymph 
node movement using four-dimensional computed tomography scan: implications 
for radiation treatment planning." Int J Radiat Oncol Biol Phys. (2007) 69(5), 1402-
1408. 
 
Soret M, Bacharach SL, Buvat I. "Partial-Volume Effect in PET Tumor Imaging." J Nucl Med. 
(2007) 48(6), 932-945. 
 
Spezi E, Lewis DG. "Gamma histograms for radiotherapy plan evaluation." Radiother Oncol. 
(2006) 79(2), 224-230. 
 
Starkschall G, Desai N, Balter P, Prado K, Luo D, Cody D, Pan T. "Quantitative assessment of 
four-dimensional computed tomography image acquisition quality." J Appl Clin Med 
Phys. (2007) 8(3), 2362. 
 
138 
 
Stevens CW, Munden RF, Forster KM, Kelly JF, Liao Z, Starkschall G, Tucker S, Komaki R. 
"Respiratory-driven lung tumor motion is independent of tumor size, tumor location, 
and pulmonary function." Int J Radiat Oncol Biol Phys. (2001) 51(1), 62-68. 
 
Suh Y, Sawant A, Venkat R, Keall PJ. "Four-dimensional IMRT treatment planning using a 
DMLC motion-tracking algorithm." Phys Med Biol. (2009) 54(12), 3821-3835. 
 
Sura S, Greco C, Gelblum D, Yorke ED, Jackson A, Rosenzweig KE. "(18)F-fluorodeoxyglucose 
positron emission tomography-based assessment of local failure patterns in non-
small-cell lung cancer treated with definitive radiotherapy." Int J Radiat Oncol Biol 
Phys. (2008) 70(5), 1397-1402. 
 
Timmerman RD, Park C, Kavanagh BD. "The North American experience with stereotactic 
body radiation therapy in non-small cell lung cancer." J Thorac Oncol. (2007) 2(7 
Suppl 3), S101-112. 
 
Underberg RW, Lagerwaard FJ, Cuijpers JP, Slotman BJ, van Sornsen de Koste JR, Senan S. 
"Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for 
stage I lung cancer." Int J Radiat Oncol Biol Phys. (2004) 60(4), 1283-1290. 
 
Underberg RW, Lagerwaard FJ, Slotman BJ, Cuijpers JP, Senan S. "Use of maximum intensity 
projections (MIP) for target volume generation in 4DCT scans for lung cancer." Int J 
Radiat Oncol Biol Phys. (2005) 63(1), 253-260. 
 
van Baardwijk A, Baumert BG, Bosmans G, van Kroonenburgh M, Stroobants S, Gregoire V, 
Lambin P, De Ruysscher D. "The current status of FDG-PET in tumour volume 
definition in radiotherapy treatment planning." Cancer Treat Rev. (2006) 32(4), 245-
260. 
 
139 
 
van Baardwijk A, Bosmans G, Boersma L, Buijsen J, Wanders S, Hochstenbag M, van Suylen 
RJ, Dekker A, Dehing-Oberije C, Houben R, Bentzen SM, van Kroonenburgh M, 
Lambin P, De Ruysscher D. "PET-CT-based auto-contouring in non-small-cell lung 
cancer correlates with pathology and reduces interobserver variability in the 
delineation of the primary tumor and involved nodal volumes." Int J Radiat Oncol 
Biol Phys. (2007) 68(3), 771-778. 
 
Wendling M, Zijp LJ, McDermott LN, Smit EJ, Sonke JJ, Mijnheer BJ, van Herk M. "A fast 
algorithm for gamma evaluation in 3D." Med Phys. (2007) 34(5), 1647-1654. 
 
Xu F, Mueller K. "Real-time 3D computed tomographic reconstruction using commodity 
graphics hardware." Phys Med Biol. (2007) 52(12), 3405-3419. 
 
Yaremko B, Riauka T, Robinson D, Murray B, Alexander A, McEwan A, Roa W. "Thresholding 
in PET images of static and moving targets." Phys Med Biol. (2005) 50(24), 5969-
5982. 
 
Zou KH, Warfield SK, Bharatha A, Tempany CM, Kaus MR, Haker SJ, Wells WM, 3rd, Jolesz 
FA, Kikinis R. "Statistical validation of image segmentation quality based on a spatial 
overlap index." Acad Radiol. (2004) 11(2), 178-189. 
 
 
 
  
140 
 
 
 
 
 
 
 
 
 
VITA 
Adam Christopher Riegel was born in Philadelphia, Pennsylvania on March 15, 1982, the son 
of Christine Galione Riegel and Bruce Marvin Riegel.  After graduating from Upper Dublin 
High School in Fort Washington, Pennsylvania in 2000, he entered Vassar College in 
Poughkeepsie, New York for his undergraduate education.  Adam received the degree of 
Bachelor of Arts with a major in physics and correlate sequence in mathematics from Vassar 
in May 2004.  Adam worked as a research associate in the radiation oncology department at 
St. Vincent’s Comprehensive Cancer Center in New York City for a year.  In August 2005, he 
entered the medical physics program at The University of Texas Health Science Center at 
Houston Graduate School of Biomedical Sciences. 
